Sentence,class,file
"Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  50no nuclear, perinuclear, or cytoplasmic staining; no grains  or speckles; and a high signal and low background.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  51“before” and “after” images.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  52almost all RPE cells are correctly identified and accurately  counted.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
"Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  53DISCUSSION To our knowledge, RPE cell-shape metrics (quantitatively  described by form factor, eccentricity, and other character - istics) are rarely used for RPE sheet analysis [ 14], and when  they are used, only human RPE cells are analyzed.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  54sheet organization.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
"Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  55Here, we attempted to evaluate RPE sheets based on  local organization.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
"Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  56and software protocols to examine two retinal degenera - tion mutations ( rd8 and IRBP−/−), asking whether collateral  damage in the adjacent RPE sheets occurred in either model.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  57current software for processing and analysis of the resulting  higher power images.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  58APPENDIX 2.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  5911.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
Molecular Vision  2015; 21:40-60 <http://www.molvis.org/molvis/v 21/40> © 2015 Molecular Vision  6036.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/mv-v21-40.PMC4301600.pdf
"Osong Public Health Res Perspect 2014 5(S), S3 eS7 http://dx.doi.org/10.1016/j.phrp.2014.10.006pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/main.PMC4301634.pdf
"Osong Public Health Res Perspect 2014 5(S), S43 eS49 http://dx.doi.org/10.1016/j.phrp.2014.10.007pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/3c/26/main.PMC4301635.pdf
"Osong Public Health Res Perspect 2014 5(S), S24 eS29 http://dx.doi.org/10.1016/j.phrp.2014.10.008pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/55/59/main.PMC4301636.pdf
We searched utilization information and the number of tests and their cost on the website of the Health Insurance Review and AssessmentService by using the code of each test ( http://hira.or.kr/ rdd_disease.do?method ZlistInfoMdfee&pgmid ZHIR AA020044020200 ).,OADS,/arxiv_data1/oa_pdf/55/59/main.PMC4301636.pdf
"Osong Public Health Res Perspect 2014 5(S), S18 eS23 http://dx.doi.org/10.1016/j.phrp.2014.10.009pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/4c/8a/main.PMC4301637.pdf
BMC Infect Dis 2009 May;9: 60.http://dx.doi.org/10.1186/1471-2334-9-60 .IGRA and TST for diagnosing latent TB infection S23,Non-OADS,/arxiv_data1/oa_pdf/4c/8a/main.PMC4301637.pdf
"Osong Public Health Res Perspect 2014 5(S), S30 eS36 http://dx.doi.org/10.1016/j.phrp.2014.10.010pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/a6/3c/main.PMC4301638.pdf
Global Tuberculosis Report; 2013. http://www.who.int/tb/publications/global_report/en/ [accessed 03.12.14].,Non-OADS,/arxiv_data1/oa_pdf/a6/3c/main.PMC4301638.pdf
Annual report on the notiﬁedtuberculosis inKorea; 2013. http://tbfree.cdc.go.kr/tbfree/cmm/BoardView.do?boardType=REPORT&no=402&id=4500 [accessed 03.12.14].,OADS,/arxiv_data1/oa_pdf/a6/3c/main.PMC4301638.pdf
"Osong Public Health Res Perspect 2014 5(S), S8 eS17 http://dx.doi.org/10.1016/j.phrp.2014.11.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/26/1f/main.PMC4301639.pdf
"We selected the following variables as related factors in the reported data: age, sex, region, registration type, disease code (based on the International Classiﬁcation of Disease-10 , available at http://apps.who.int/classiﬁcations/icd10/ ), medicine, andtreatment results.",OADS,/arxiv_data1/oa_pdf/26/1f/main.PMC4301639.pdf
"Osong Public Health Res Perspect 2014 5(S), S37 eS42 http://dx.doi.org/10.1016/j.phrp.2014.11.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/da/0d/main.PMC4301640.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/da/0d/main.PMC4301640.pdf
"Atlanta, GA: CDC; 2012.Available from: http://www.cdc.gov/tb/publications/factsheets/ testing/HIVscreening.htm [accessed 15.11.14].",Non-OADS,/arxiv_data1/oa_pdf/da/0d/main.PMC4301640.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0 ) which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/cb/main.PMC4301641.pdf
"Osong Public Health Res Perspect 2014 5(S), S1 eS2 http://dx.doi.org/10.1016/j.phrp.2014.11.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e5/cb/main.PMC4301641.pdf
Availablefrom: http://www.whitehouse.gov/the-press-ofﬁce/2014/ 09/26/fact-sheet-global-health-security-agenda-getting- ahead-curve-epidemic-th [accessed 07.11.14].,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/main.PMC4301641.pdf
Available from: http://www.unaids.org/en/ resources/campaigns/2014/2014gapreport/factsheet/ [accessed 07.11.14].,Non-OADS,/arxiv_data1/oa_pdf/e5/cb/main.PMC4301641.pdf
Available at: http://www.mathworks.com/ matlabcentral/ﬁleexchange/9608-fcs-data-reader (accessed 7 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/67/19/acn30002-0067.PMC4301676.pdf
"Visual search test (primary outcome measure) We adapted a validated, reaction time-based, visual search test where subjects had to search for an everyday objectin a crowded desk scene 7(see: http://www.eyesearch.ucl.",Non-OADS,/arxiv_data1/oa_pdf/24/a3/acn30002-0074.PMC4301677.pdf
4The scale was calibrated 0 (no problem) to 100 (impossible): http://www.eye-search.ucl.ac.uk/es/es_sc_adl.php (Fig.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/acn30002-0074.PMC4301677.pdf
This isthe ﬁrst web-based therapy for visual search disorders and is available for suitable patients to use for free anywhere with internet access: https://www.eyesearch.ucl.ac.uk/.,Non-OADS,/arxiv_data1/oa_pdf/24/a3/acn30002-0074.PMC4301677.pdf
"For Permissions, please e-mail: journals.permissions@oup.com.JNCI J Natl Cancer Inst (2015) 107(1): dju379 doi:10.1093/jnci/dju379 First published online November 30, 2014 Article 1 of 11 article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/c5/dju379.PMC4301703.pdf
Details are accessible at: http://www.controlled-trials.,Non-OADS,/arxiv_data1/oa_pdf/52/c5/dju379.PMC4301703.pdf
The study was registered  with the International Standard Randomized Controlled Trial  Number Register - ISRCTN 73338115 ( http://www.controlled-tri- als.com/ISRCTN73338115 ).,Non-OADS,/arxiv_data1/oa_pdf/52/c5/dju379.PMC4301703.pdf
The study was registered with the International  Standard Randomized Controlled Trial Number Register - ISRCTN  73338115 ( http://www.controlled-trials.com/ISRCTN73338115 ).,Non-OADS,/arxiv_data1/oa_pdf/97/ff/dju380.PMC4301704.pdf
Available at: http://www.ons.gov.uk/ons/taxonomy/index.,OADS,/arxiv_data1/oa_pdf/97/ff/dju380.PMC4301704.pdf
Available at: http://seer.cancer.gov/ statfacts/html/ovary.html .,Non-OADS,/arxiv_data1/oa_pdf/97/ff/dju380.PMC4301704.pdf
Available at:  http://info.cancerresearchuk.org/cancerstats/types/ovary/ incidence/ .,Non-OADS,/arxiv_data1/oa_pdf/97/ff/dju380.PMC4301704.pdf
"1 of 2 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence   (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work,  in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/f0/dju386.PMC4301705.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/keu283.PMC4301708.pdf
Trial registration: https://clinicaltrials.gov/ (NCT01294696).,Non-OADS,/arxiv_data1/oa_pdf/53/3a/keu332.PMC4301711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/3a/keu332.PMC4301711.pdf
"http://primer.oarsi.org/ (20 December2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/53/3a/keu332.PMC4301711.pdf
"Theseresults were organized into the Plant Protein Annotation Suite database (Plant-PrAS), which can be freely accessed online at http://plant-pras.riken.jp/.",OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
The genome and the functionalgene annotations of rice have been updated in the MichiganState University Rice Genome Annotation Project database (MSU Rice; http://rice.plantbiology.msu.edu/) (Kawahara et al.,OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
2013) and in the Rice Annotation Project database (RAP-DB;http://rapdb.dna.affrc.go.jp/) (Sakai et al.,OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
"2011), and inclusion of similarityclustering among protein sequences in the SALAD database(http://salad.dna.affrc.go.jp/salad/) (Mihara et al.",OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
"The search interface of Plant-PrAS We developed a publicly accessible web-based database, Plant-PrAS (http://plant-pras.riken.jp/), which currently stores208,333 protein sequence records derived from genome-wide analysis of six major plant species ( A. thaliana , soybean, poplar, rice, P. patens and C. merolae ) and 26,788 protein sequence records derived from the two reference species (the mouseand yeast).",OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
"2002) sequences wereretrieved from the National Center for Biotechnology Information (NCBI)(ftp://ftp.ncbi.nih.gov/genomes/M_musculus/protein/) and from Munich Information Center for Protein Sequences (MIPS) (ftp://ftpmips.gsf.de/fungi/ yeast/), respectively.",OADS,/arxiv_data1/oa_pdf/2d/f3/pcu176.PMC4301743.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Treg recruitment in CRC 328 www.bjcancer.com | DOI:10.1038/bjc.2014.572,Non-OADS,/arxiv_data1/oa_pdf/2f/58/bjc2014572a.PMC4301825.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f3/31/main.PMC4302071.pdf
"In  adult  monkeys,  selective http://dx.doi.org/10.1016/j.dcn.2014.07.002 1878-9293/©  2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/f3/31/main.PMC4302071.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/de/3a/cjc-34-01-001.PMC4302084.pdf
Available at: http://www.cancer.gov/ cancertopics/types/ovarian.,Non-OADS,/arxiv_data1/oa_pdf/b2/38/cjc-34-01-017.PMC4302086.pdf
Available at: http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/38/cjc-34-01-017.PMC4302086.pdf
Available at: http://2013.europeancancercongress.,Non-OADS,/arxiv_data1/oa_pdf/b2/38/cjc-34-01-017.PMC4302086.pdf
Available at: http://2013.europeancancercongress.,Non-OADS,/arxiv_data1/oa_pdf/b2/38/cjc-34-01-017.PMC4302086.pdf
"Recently, The Cancer Genome Atlas (TCGA) Research Network (http://cancergenome.nih.gov/) described an integrated analysis of the genomic and epigenomic landscapes of almost 500 high-grade serous OC patients with  advanced stage disease, with the aim to identify molecular  abnormalities that influence pathophysiology and outcomes and  could constitute therapeutic targets [16].",Non-OADS,/arxiv_data1/oa_pdf/ef/ef/cjc-34-01-041.PMC4302088.pdf
"Copyright © 2015 Korean Neurological Association   1Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.1REVIEW J Clin Neurol 2015 ;11(1):1-8 Endovascular Therapy for Ischemic Stroke Ramana M R Appireddy,a Andrew M Demchuk,b Mayank Goyal,c   Bijoy K Menon,d Muneer Eesa,e Philip Choi,f Michael D. Hillg aDepartment of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada   bDepartments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, Faculty of Medicine,   University of Calgary, Calgary, AB, Canada   cDepartments of Clinical Neurosciences and Radiology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada   dDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, AB, Canada   eDepartment of Radiology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada   fDepartment of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada   gDepartments of Clinical Neurosciences, Medicine, Radiology, and Community Health Sciences,   Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary, AB, Canada Received  September 2, 2014 Revised  October 23, 2014 Accepted  October 23, 2014 Correspondence Michael D. Hill, MD, MSc, FRCPC Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, Foothills Hospital, University of Calgary, Rm 1242A, 1403 29th Street NW, Calgary, AB T2N 2T9, CanadaTel    +1 403 944 8065 Fax   +1 403 283 2270E-mail    michael.hill@ucalgary.caThe utility of intravenous tissue plasminogen activator (IV t-PA) in improving the clinical out- comes after acute ischemic stroke has been well demonstrated in past clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/50/43/jcn-11-1.PMC4302170.pdf
102  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.102LETTER TO THE EDITOR J Clin Neurol 2015 ;11(1):102-103,Non-OADS,/arxiv_data1/oa_pdf/65/98/jcn-11-102.PMC4302171.pdf
104  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.104LETTER TO THE EDITOR J Clin Neurol 2015 ;11(1):104-105,Non-OADS,/arxiv_data1/oa_pdf/23/c4/jcn-11-104.PMC4302172.pdf
"So the corrected infor - mation of the corresponding author should be as follows: Correspondence Jin Jun Luo, MD, PhD, FAAN, FAANEM Departments of Neurology and Pharmacology, Director, EMG/Neuromuscular Medicine,Temple University School of Medicine,3401 North Broad Street, Suite C525,Philadelphia, PA 19140, USATel: +1-215-707-3915Fax: +1-215-707-8235Email: jluo@temple.eduErratum: Hyperhomocysteinemia and   Neurologic Disorders: a Review Ramin Ansari,a Ali Mahta,a Eric Mallack,b Jin Jun Luoa aDepartment of Neurology, Temple University School of Medicine, Philadelphia, PA, USA   bDepartment of Pediatrics, Weill Cornell Medical Center-New York Presbyterian Hospital, New York, NY, USA  J Clin Neurol 2014 ;10(4):281-288 http://dx.doi.org/10.3988/jcn.2014.10.4.281Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.106ERRATUM J Clin Neurol 2015 ;11(1):106-106 Open Access cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/e9/jcn-11-106.PMC4302173.pdf
"G284R/c.674insT  → G284R/c.539_540insT Accordingly, corrected Table 1 and its legend should be as follows:Erratum: Analysis of Dosage Mutation in PARK2 among Korean  Patients with Early-Onset or Familial Parkinson’s Disease Min Kyung Chu,a Won Chan Kim,b Jung Mi Choi,c Jeong-Hoon Hong,c   Suk Yun Kang,a Hyeo-Il Ma,a Yun Joong Kima,c,d aDepartment of Neurology, Hallym University College of Medicine, Anyang, Korea   bDepartment of Neurology, CHA University College of Medicine, Pocheon, Korea   cIlsong Institute of Life Science, Hallym University, Anyang, Korea   dHallym Institute of Translational Genomics and Bioinformatics, Hallym University Medical Center, Anyang, Korea  J Clin Neurol 2014 ;10(3):244-248 http://dx.doi.org/10.3988/jcn.2014.10.3.244Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.107ERRATUM J Clin Neurol 2015 ;11(1):107-107 Open Access cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/7f/9a/jcn-11-107.PMC4302174.pdf
"20  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.20ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):20-25 Introduction Epilepsy is one of the most common neurologic childhood  disorders.1 Although children with epilepsy frequently present  with neuropsychiatric problems during the course of their life - time, they have only recently been studied systemically.2,3 The  prevalence of attention deficit hyperactivity disorder (ADHD ),  learning disorders, and developmental disorders is higher in children with epilepsy than in normal controls, and approxi -mately half of children with epilepsy require special education  programs.",Non-OADS,/arxiv_data1/oa_pdf/c1/67/jcn-11-20.PMC4302175.pdf
26  Copyright © 2015 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.26ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):26-31 Introduction A ketogenic diet (KD) was first reported to be an effective  treatment for children with intractable epilepsy in the 1920s.1  The primary goal of a KD is to mimic the starvation state in  the body’s tissues and to produce urinary ketosis by restrict - ing carbohydrate intake and shifting the predominant caloric source to fat.,Non-OADS,/arxiv_data1/oa_pdf/bc/f6/jcn-11-26.PMC4302176.pdf
"32  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.32ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):32-41 Introduction Suicide is the tenth leading cause of death worldwide,1 with  approximately 800,000 –1,000,000 people succumbing annu -ally and a mortality rate of 11.6 per 100,000 persons per year.2  The Organization for Economic Co-operation and Develop - ment (OECD ) has reported that suicide is a significant cause of  death in many OECD countries, accounting for over 150,000  deaths in 2011.3 Korea has the highest suicide rate of the 34  OECD countries, at 33.3 deaths per 100,000 population.3 Al- though suicide rates have decreased by more than 20% across OECD countries since 1990, 3 the rate has continued to in - crease in Korea, where suicide has become the fourth leading Suicidality and Its Risk Factors in Korean People with Epilepsy :   A MEPSY Study Jong-Geun Seo,a* Jang-Joon Lee,b* Yong Won Cho,c Se-Jin Lee,d Ji-Eun Kim,e Hye-Jin Moon,c Sung-Pa Parka aDepartment of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea   bDepartment of Neurology, Daegu Fatima Hospital, Daegu, Korea   cDepartment of Neurology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea   dDepartment of Neurology, Yeungnam University College of Medicine, Daegu, Korea   eDepartment of Neurology, Catholic University of Daegu School of Medicine, Daegu, Korea Received  September 15, 2014 Revised  October 20, 2014 Accepted  October 22, 2014 Correspondence Sung-Pa Park, MD, PhD Department of Neurology,   School of Medicine,   Kyungpook National University,   680 Gukchaebosang-ro, Jung-gu,  Daegu 700-842, Korea Tel    +82-53-420-5769  Fax   +82-53-422-4265  E-mail    sppark@mail.knu.ac.kr *These authors contributed equally to  the manuscript as first authors in this  study.Background and Purpose zzPeople with epilepsy (PWE ) are more likely to experience suicid - ality, with suicidal ideation and attempts, than people without epilepsy (PWoE ).",Non-OADS,/arxiv_data1/oa_pdf/ab/d6/jcn-11-32.PMC4302177.pdf
Available from :  http://dx.doi.org/10.1787/health_glance-2013-en.,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/jcn-11-32.PMC4302177.pdf
Available from : http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/jcn-11-32.PMC4302177.pdf
Available from : http://www.whocc.,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/jcn-11-32.PMC4302177.pdf
Available from : http://download.mw.go.kr/front_new/ modules/download.jsp?BOARD_ID=140&CONT_SEQ=299571&FILE_ SEQ=148548.,OADS,/arxiv_data1/oa_pdf/ab/d6/jcn-11-32.PMC4302177.pdf
"42  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.42ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):42-47 Whole-Brain Diffusion-Tensor Changes in Parkinsonian   Patients with Impulse Control Disorders Hye Bin Yoo,a* Jee-Young Lee,b* Jae Sung Lee,a,c Hyejin Kang,c Yu Kyeong Kim,d   In Chan Song,e Dong Soo Lee,c Beom Seok Jeonf aDepartment of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Korea   bDepartments of Neurology and dNuclear Medicine, Seoul National University-Seoul Metropolitan Government Boramae Medical Center,  College of Medicine, Seoul National University, Seoul, Korea   cDepartments of Nuclear Medicine and fNeurology Seoul National University Hospital,   Seoul National University College of Medicine, Seoul, Korea   eDepartment of Diagnostic Radiology, Seoul National University Hospital, Seoul, Korea Received  February 5, 2014 Revised  September 21, 2014 Accepted  September 22, 2014 Correspondence Beom Seok Jeon, MD, PhD Department of Neurology, Seoul National University Hospital, College of Medicine,   Seoul National University,   101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel    +82-2-2072-2876 Fax   +82-2-744-1785E-mail    brain@snu.ac.kr Jae Sung Lee, PhD Department of Nuclear Medicine and WCU Department of Brain and Cognitive Sciences,   Seoul National University,   101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel    +82-2-2072-2938 Fax   +82-2-745-2938E-mail    jaes@snu.ac.kr *These authors are equally   contributed to this work.Background and Purpose zzThe aim of this study was to determine the changes in diffusion- tensor images associated with medication-related impulse control disorder (ICD) in Parkinson’s  disease (PD) patients undergoing chronic dopamine-replacement therapy.",Non-OADS,/arxiv_data1/oa_pdf/15/8d/jcn-11-42.PMC4302178.pdf
Supplementary Materials The online-only Data Supplement is available with this article  at http://dx.doi.org/10.3988/jcn.2015.11.1.42.,Non-OADS,/arxiv_data1/oa_pdf/15/8d/jcn-11-42.PMC4302178.pdf
"48  Copyright © 2015 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.48ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):48-56 Introduction Obesity is a significant health concern worldwide and is now a recognized risk factor for adverse neurological changes, in- cluding dementia (e.g., Alzheimer’s disease), and abnormali - ties on neuroimaging.1,2 Neuropsychological testing also  shows that obese individuals commonly exhibit more subtle cognitive dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/18/18/jcn-11-48.PMC4302179.pdf
"Copyright © 2015 Korean Neurological Association   57Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.57ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):57-65 Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy   Is More Effective Than Aspirin Alone in Preventing Early   Neurological Deterioration and Improving the 6-Month   Outcome in Ischemic Stroke Patients Xingyang Yi,a Wanzhang Chi,b Chun Wang,a Biao Zhang,a Jing Linb aDepartment of Neurology, People’s Hospital of Deyang City, Deyang, China   bDepartment of Neurology, Third Affiliated Hospital of Wenzhou Medical College, Wenzhou, China Received  June 27, 2014 Revised  September 28, 2014 Accepted  September 29, 2014 Correspondence Wanzhang Chi, MD Department of Neurology, Third Affiliated Hospital of Wenzhou Medical College, Wenzhou 325200, ChinaTel    +86-838-2204910 Fax   +86-838-2204910E-mail    yixingyang64@126.comBackground and Purpose zzDual antiplatelet therapy (DAT ) with clopidogrel and aspirin has  been shown to confer greater protection against early neurological deterioration (END ) and  early recurrent ischemic stroke (ERIS ) than aspirin alone in patients who have experienced an  acute ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/c9/52/jcn-11-57.PMC4302180.pdf
"66  Copyright © 2015 Korean Neurological Association    Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.66ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):66-72 Introduction Cholinesterase inhibitors are now widely prescribed for the  treatment of mild to moderate Alzheimer’s disease (AD), and they produce significant cognitive and functional improve - ments compared with placebo.1 The positive effect of cholin- esterase inhibitors on cognition and activities of daily living (ADL) in patients with mild to moderate AD has been well The Effects of Galantamine Treatment on Attention and Its   Relationship with Cognition and Activities of Daily Living   in Patients with Mild to Moderate Alzheimer’s Disease Jae-Hong Lee,a Yun Jeong Hong,a Hee-Joon Bae,b Beom Joon Kim,b Duk-Lyul Na,c   Seol-Heui Han,d Jong-Moo Park,e Jee-Hyang Jeong,f Kyung-Ryeol Chag* aDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea   bDepartment of Neurology, Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea   cDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea   dDepartment of Neurology, Konkuk University Medical Center, Seoul, Korea   eDepartment of Neurology, Eulji General Hospital, Eulji University College of Medicine, Seoul, Korea   fDepartment of Neurology, Ehwa Womans University Mokdong Hospital, Seoul, Korea   gDepartment of Psychiatry, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Received  June 3, 2014 Revised  September 28, 2014 Accepted  September 29, 2014 Correspondence Jae-Hong Lee, MD Department of Neurology,Asan Medical Center,University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel    +82-2-3010-3446 Fax   +82-2-474-4691E-mail    jhlee@amc.seoul.kr *Kyung-Ryeol Cha is now at  Chookryoung Evangelical Hospital, Namyangju, Korea.Background and Purpose zzThe positive effects of galantamine on cognition and activities of  daily living (ADL) in Alzheimer’s disease (AD) are thought to be mediated via improvements  in attention.",Non-OADS,/arxiv_data1/oa_pdf/25/ca/jcn-11-66.PMC4302181.pdf
"J Clin Neurol 2015 ;11(1):66-72 Key Words zz Alzheimer’s disease, galantamine, attention, computerized test.Open Access cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/ca/jcn-11-66.PMC4302181.pdf
"Copyright © 2015 Korean Neurological Association   73Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.73ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):73-79 A Low Baseline Glomerular Filtration Rate Predicts Poor Clinical  Outcome at 3 Months after Acute Ischemic Stroke Hyung Jik Kim,a Jwa-Kyung Kim,a Mi Sun Oh,b Sung Gyun Kim,a Kyung-Ho Yu,b Byung-Chul Leeb aDepartments of Internal Medicine and Kidney Research Institute and bNeurology, Hallym University Sacred Heart Hospital,   Hallym University College of Medicine, Anyang, Korea Received  June 19, 2014 Revised  September 10, 2014 Accepted  September 11, 2014 Correspondence Byung-Chul Lee, MD, PhDDepartment of Neurology,  Hallym University Sacred  Heart Hospital, Hallym UniversityCollege of Medicine,22 Gwanpyeong-ro 170beon-gil,Dongan-gu, Anyang 431-796, KoreaTel    +82-31-380-3741 Fax   +82-31-386-4659E-mail    ssbrain@hallym.or.krBackground and Purpose zzChronic kidney disease (CKD ) is an established risk factor for  numerous cardiovascular diseases including stroke.",Non-OADS,/arxiv_data1/oa_pdf/62/21/jcn-11-73.PMC4302182.pdf
"80  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.80ORIGINAL ARTICLE J Clin Neurol 2015 ;11(1):80-86 Low-Density-Lipoprotein Particle Size Predicts a Poor Outcome  in Patients with Atherothrombotic Stroke Tae-Jin Song,a,b Hyun-Ji Cho,c Yoonkyung Chang,a Minjung Youn,a   Min-Jeong Shin,d Inho Jo,e Ji Hoe Heo,b Yong-Jae Kima aDepartments of Neurology and eMolecular Medicine, Ewha Womans University School of Medicine, Seoul, Korea   bDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea   cDepartment of Neurology, Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, Korea   dDepartment of Food and Nutrition and Institute of Health Sciences, Korea University, Seoul, Korea Received  June 20, 2014 Revised  September 19, 2014 Accepted  September 24, 2014 Correspondence Yong-Jae Kim, MD, PhDDepartment of Neurology, Ewha Womans University School of Medicine,1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, KoreaTel    +82-2-2650-2677 Fax   +82-2-2650-5958E-mail    brain930@ewha.ac.krBackground and Purpose zzLow-density lipoprotein (LDL ) particle size is considered to be  one of the more important cardiovascular risk factors, and small LDL particles are known to  have atherogenic potential.",Non-OADS,/arxiv_data1/oa_pdf/1f/61/jcn-11-80.PMC4302183.pdf
Supplementary Materials The online-only Data Supplement is available with this article  at http://dx.doi.org/10.3988/jcn.2015.11.1.80.,Non-OADS,/arxiv_data1/oa_pdf/1f/61/jcn-11-80.PMC4302183.pdf
Copyright © 2015 Korean Neurological Association   87Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.87CASE REPORT J Clin Neurol 2015 ;11(1):87-91 Introduction Paraneoplastic limbic encephalitis (PLE) is one of the most  frequent presentations of paraneoplastic encephalomyelitis  syndrome.,Non-OADS,/arxiv_data1/oa_pdf/a1/a3/jcn-11-87.PMC4302184.pdf
"Copyright © 2015 Korean Neurological Association   9Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.9REVIEW J Clin Neurol 2015 ;11(1):9-19 Oral Disease-Modifying Therapies for Multiple Sclerosis Woojun Kim,a Manuella Edler Zandoná,b,c Su-Hyun Kim,c Ho Jin Kimc aDepartment of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea   bPontifical Catholic University of Rio Grande do Sul, Science Without Borders, Porto Alegre, Brazil   cDepartment of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea Received  July 31, 2014 Revised  August 31, 2014 Accepted  September 1, 2014 Correspondence Ho Jin Kim, MD, PhD Department of Neurology,  Research Institute and Hospital of National Cancer Center,  323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel    +82-31-920-2438 Fax   +82-31-925-5524E-mail    hojinkim@ncc.re.krClassical multiple sclerosis (MS) treatments using first-line injectable drugs, although widely  applied, remain a major concern in terms of therapeutic adherence and efficacy.",Non-OADS,/arxiv_data1/oa_pdf/2a/a7/jcn-11-9.PMC4302185.pdf
Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/hu - man/002202/WC500104528.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/a7/jcn-11-9.PMC4302185.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Other/2012/04/WC500125687.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/a7/jcn-11-9.PMC4302185.pdf
Available from:  http://products.sanofi.us/aubagio/aubagio.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/a7/jcn-11-9.PMC4302185.pdf
"92  Copyright © 2015 Korean Neurological Association   Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.92CASE REPORT J Clin Neurol 2015 ;11(1):92-96 Novel Compound Heterozygous Nonsense PRX Mutations   in a Korean Dejerine-Sottas Neuropathy Family Ye Ji Choi,a Young Se Hyun,b Soo Hyun Nam,b Heasoo Koo,c   Young Bin Hong,d Ki Wha Chung,b Byung-Ok Choid aDepartments of Neurology and cPathology, Ewha Womans University School of Medicine, Seoul, Korea   bDepartment of Biological Science, Kongju National University, Gongju, Korea   dDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Received  June 19, 2013 Revised  September 9, 2013 Accepted  September 13, 2013 Correspondence Byung-Ok Choi, PhD Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel    +82-2-3410-1296 Fax   +82-2-3410-0052E-mail    bochoi77@hanmail.net Ki Wha Chung, PhD Department of Biological Science, Kongju National University, 56 Gongjudaehak-ro, Gongju 314-701, KoreaTel    +82-41-850-8506 Fax   +82-41-850-0957E-mail    kwchung@kongju.ac.krBackground zzMutations in the gene encoding periaxin (PRX ) are known to cause autosomal  recessive Dejerine-Sottas neuropathy (DSN) or Charcot-Marie-Tooth disease type 4F.",Non-OADS,/arxiv_data1/oa_pdf/89/0f/jcn-11-92.PMC4302186.pdf
"Copyright © 2015 Korean Neurological Association   97Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2015.11.1.97CASE REPORT J Clin Neurol 2015 ;11(1):97-101 Mild Clinical Features and Histopathologically Atypical Cores   in Two Korean Families with Central Core Disease Harboring  RYR1  Mutations at the C-Terminal Region Na-Yeon Jung,a Yeong-Eun Park,b Jin-Hong Shin,a Chang Hun Lee,c Dae-Soo Jung,b Dae-Seong Kima aDepartment of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea   bDepartments of Neurology and cPathology, Pusan National University Hospital, Busan, Korea Received  August 21, 2013 Revised  October 21, 2013 Accepted  October 22, 2013 Correspondence Dae-Seong Kim, MD, PhD Department of Neurology,Pusan National University Yangsan Hospital,20 Geumo-ro, Mulgeum-eup,Yangsan 626-770, KoreaTel    +82-55-360-2450 Fax   +82-55-360-2152E-mail    dskim@pusan.ac.krBackground zzCentral core disease (CCD) is a congenital myopathy characterized by distinc - tive cores in muscle fibers.",Non-OADS,/arxiv_data1/oa_pdf/62/9d/jcn-11-97.PMC4302187.pdf
Contents lists available at ScienceDirect Placenta journal homepage: www.elsevier.com/l ocate/placenta http://dx.doi.org/10.1016/j.placenta.2014.10.012 0143-4004/ ©2014 Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c9/e6/main.PMC4302218.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Placenta 36 (2015) 59 e68,Non-OADS,/arxiv_data1/oa_pdf/c9/e6/main.PMC4302218.pdf
Primers were designed using Geneious (Biomatters Ltd.) and the Primer-Blast program ( http://www.ncbi.nlm.nih.gov/tools/ primer-blast/ ).,OADS,/arxiv_data1/oa_pdf/c9/e6/main.PMC4302218.pdf
Melting temperatures and potential formation of secondary struc- tures were tested using OligoCalc ( http://www.basic.northwestern.edu/biotools/ OligoCalc.html ).,OADS,/arxiv_data1/oa_pdf/c9/e6/main.PMC4302218.pdf
"At present, 42 genes and 69 loci(http://hereditaryhearingloss.org) are implicated innon-syndromic autosomal recessive deafness (locusnotation DFNB).",Non-OADS,/arxiv_data1/oa_pdf/0e/be/cge0087-0049.PMC4302246.pdf
STRC and pSTRC sequences were aligned in UCSC Genome Browser (http://genome.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/0e/be/cge0087-0049.PMC4302246.pdf
Created with AudiogramMaker software (http://www.jacobhaskins.com/).,Non-OADS,/arxiv_data1/oa_pdf/0e/be/cge0087-0049.PMC4302246.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgEditorial J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/8c/b5/jgo-26-1.PMC4302278.pdf
1:1-2 http://dx.doi.org/10.3802/jgo.2015.26.1.1 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/8c/b5/jgo-26-1.PMC4302278.pdf
C. William Helm http://dx.doi.org/10.3802/jgo.2015.26.1.,Non-OADS,/arxiv_data1/oa_pdf/8c/b5/jgo-26-1.PMC4302278.pdf
"Unfortunately, the randomization was  performed before the CRS, but nevertheless this is the start of  the accrual of more definitive data, particularly from ongoing  randomized controlled trials around the world, of which there  are at least 6 currently registered at ClinicalTrials.gov of US  National Institutes of Health (http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/8c/b5/jgo-26-1.PMC4302278.pdf
http://dx.doi.org/10.1245/s10434-014-4157-9.,Non-OADS,/arxiv_data1/oa_pdf/8c/b5/jgo-26-1.PMC4302278.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Concurrent chemoradiotherapy (CCRT) is the primary treatment for locally advanced cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/ff/87/jgo-26-12.PMC4302279.pdf
1:12-18 http://dx.doi.org/10.3802/jgo.2015.26.1.12 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/ff/87/jgo-26-12.PMC4302279.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/ff/87/jgo-26-12.PMC4302279.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/ff/87/jgo-26-12.PMC4302279.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.12 18  www.ejgo.org of radiation therapy oncology group trial (RTOG) 90-01.,Non-OADS,/arxiv_data1/oa_pdf/ff/87/jgo-26-12.PMC4302279.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for  lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine  papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and  lymph node dissection.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/jgo-26-19.PMC4302280.pdf
1:19-24 http://dx.doi.org/10.3802/jgo.2015.26.1.19 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/a5/47/jgo-26-19.PMC4302280.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/a5/47/jgo-26-19.PMC4302280.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/a5/47/jgo-26-19.PMC4302280.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.19 24  www.ejgo.org 5.,Non-OADS,/arxiv_data1/oa_pdf/a5/47/jgo-26-19.PMC4302280.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Despite the rarity of uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC), they  contribute disproportionately to endometrial cancer deaths.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/jgo-26-25.PMC4302281.pdf
"1:25-31 http://dx.doi.org/10.3802/jgo.2015.26.1.25 pISSN 2005-0380 ·eISSN 2005-0399 INTRODUCTION Uterine papillary serous carcinoma (UPSC) and uterine clear  cell carcinoma (UCCC) are rare entities, accounting for 10% to  15% of all endometrial cancer cases [ 1-5].",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/jgo-26-25.PMC4302281.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/cc/e9/jgo-26-25.PMC4302281.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/cc/e9/jgo-26-25.PMC4302281.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/cc/e9/jgo-26-25.PMC4302281.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Presence of high-risk factor in cervical cancer is known to be associated with decreased survival outcomes.",Non-OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
1:3-11 http://dx.doi.org/10.3802/jgo.2015.26.1.3 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.3 10  www.ejgo.org of cervical cancer patients in the high-risk group exhibited  multiple high-risk factors (38.4%) and can be considered  part of the “multiple high-risk” group.,Non-OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
Available from: http://www.clinicaltrial.gov/ct2/show/NCT00980954?term=GOG+0724&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/f3/91/jgo-26-3.PMC4302282.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The purpose of this study is to validate the Gynecologic Oncology Group (GOG) criteria for adjuvant treatment in a  different cohort of patients and to evaluate the simplified risk criteria predicting the prognosis and tailoring adjuvant treatment  in patients with surgically staged endometrial cancer.",Non-OADS,/arxiv_data1/oa_pdf/05/7a/jgo-26-32.PMC4302283.pdf
1:32-39 http://dx.doi.org/10.3802/jgo.2015.26.1.32 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/05/7a/jgo-26-32.PMC4302283.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/05/7a/jgo-26-32.PMC4302283.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/05/7a/jgo-26-32.PMC4302283.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.32 38  www.ejgo.org features.,Non-OADS,/arxiv_data1/oa_pdf/05/7a/jgo-26-32.PMC4302283.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Recent investigations have revealed DNA mismatch repair (MMR) gene mutations are closely related with carcino - genesis of endometrial cancer; however the impact of MMR protein expression on prognosis is not determined.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/jgo-26-40.PMC4302284.pdf
1:40-45 http://dx.doi.org/10.3802/jgo.2015.26.1.40 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/37/0c/jgo-26-40.PMC4302284.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/37/0c/jgo-26-40.PMC4302284.pdf
"http://dx.doi.org/10.3802/jgo.2015.26.1.40 44  www.ejgo.org DISCUSSION In this study, frequencies of MMR-related protein loss were  14% to 28% of endometrial cancers and 40% of enrolled cases  were judged as loss of MMR expression.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/jgo-26-40.PMC4302284.pdf
Available from: http://dx.doi.org/10.1787/health_glance-2013-en.,Non-OADS,/arxiv_data1/oa_pdf/37/0c/jgo-26-40.PMC4302284.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The purpose of this study was to develop a risk prediction score for distinguishing benign ovarian mass from mali­ gnant tumors using CA­125, human epididymis protein 4 (HE4), ultrasound findings, and menopausal status.",Non-OADS,/arxiv_data1/oa_pdf/ee/a3/jgo-26-46.PMC4302285.pdf
1:46­53 http://dx.doi.org/10.3802/jgo.2015.26.1.46 pISSN 2005­0380 ·eISSN 2005­0399,OADS,/arxiv_data1/oa_pdf/ee/a3/jgo-26-46.PMC4302285.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/ee/a3/jgo-26-46.PMC4302285.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/ee/a3/jgo-26-46.PMC4302285.pdf
"http://dx.doi.org/10.3802/jgo.2015.26.1.46 52  www.ejgo.org for premenopausal women and 25.3% for postmenopausal  women), ROMA correctly classified 70.2% of the malignant  samples as high risk and 91.9% of the benign samples as low  risk and, indicating that the simplified HE4 model has better  sensitivity over ROMA, but ROMA has higher specificity.",Non-OADS,/arxiv_data1/oa_pdf/ee/a3/jgo-26-46.PMC4302285.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been recently reported  with favorable oncological outcomes as treatment of advanced epithelial ovarian cancer (EOC).",Non-OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
1:54-61 http://dx.doi.org/10.3802/jgo.2015.26.1.54 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.54 60  www.ejgo.org and different chemosensitivity.,OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
Available from: http://www.nbt.nhs.uk/sites/default/files/filedepot/incoming/WHO_Performance_Status.doc.,OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
Available from: http://www.eortc.be/services/doc/ctc/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
NOW AVAILABLE ONLINE  at http://www.ejgo.org,Non-OADS,/arxiv_data1/oa_pdf/3d/47/jgo-26-54.PMC4302286.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To discuss the feasibility of single-site robotic surgery for benign gynecologic tumors and early stage gynecologic  cancers.",Non-OADS,/arxiv_data1/oa_pdf/4f/97/jgo-26-62.PMC4302287.pdf
1:62-67 http://dx.doi.org/10.3802/jgo.2015.26.1.62 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/4f/97/jgo-26-62.PMC4302287.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/4f/97/jgo-26-62.PMC4302287.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/4f/97/jgo-26-62.PMC4302287.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgAbstract The Asian Society of Gynecologic Oncology International Workshop 2014 on gynecologic oncology was held in Asan Medical  Center, Seoul, Korea on the 23rd to 24th August 2014.",Non-OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
1:68-74 http://dx.doi.org/10.3802/jgo.2015.26.1.68 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/84/5e/jgo-26-68.PMC4302288.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgCorrespondence J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/be/22/jgo-26-75.PMC4302289.pdf
1:75-76 http://dx.doi.org/10.3802/jgo.2015.26.1.75 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/be/22/jgo-26-75.PMC4302289.pdf
http://dx.doi.org/10.3802/jgo.2015.26.1.,OADS,/arxiv_data1/oa_pdf/be/22/jgo-26-75.PMC4302289.pdf
E-mail: ignaciozapardiel@hotmail.com http://dx.doi.org/10.3802/jgo.2015.26.1.75 █              █              █,Non-OADS,/arxiv_data1/oa_pdf/be/22/jgo-26-75.PMC4302289.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e1/f3/srep07944.PMC4302293.pdf
All authors reviewed the final manuscript before submission.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/c1/srep07970.PMC4302294.pdf
Methods In silico Characterization of AM1_1557 .The domain composition of AM1_1557 was determined using SMART (http://smart.embl-heidelberg.de/)53.,OADS,/arxiv_data1/oa_pdf/c8/7e/srep07950.PMC4302295.pdf
analyzed the data and wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/7e/srep07950.PMC4302295.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7950 | DOI: 10.1038/srep07950 10",Non-OADS,/arxiv_data1/oa_pdf/c8/7e/srep07950.PMC4302295.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/d5/srep07945.PMC4302296.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/e4/srep07954.PMC4302298.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4b/91/srep07969.PMC4302299.pdf
Gene prediction and annotation .We predicted the genes by using GENSCAN (http://genes.mit.edu/GENSCAN.html) and Softberry FGENESH (http://linux1.,OADS,/arxiv_data1/oa_pdf/c9/77/srep07963.PMC4302302.pdf
CpGislands were marked by Softberry CpGFinder (http://linux1.softberry.com/berry.,Non-OADS,/arxiv_data1/oa_pdf/c9/77/srep07963.PMC4302302.pdf
"phtml?topic 5cpgfinder&group 5programs), and GC content was analyzed using Isochore (http://www.ebi.ac.uk/Tools/seqstats/emboss_isochore/).",OADS,/arxiv_data1/oa_pdf/c9/77/srep07963.PMC4302302.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/77/srep07963.PMC4302302.pdf
"Especially, LCL derived DNA from the Coriell Cell Repositories (http://ccr.coriell.org/) were used for whole-genome geno- typing and sequencing in the International HapMap Project and the 1000 Genome Project, the two largest international collaborative efforts in human genomics field since the Human Genome Project.",OADS,/arxiv_data1/oa_pdf/f4/29/srep07960.PMC4302305.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7960 | DOI: 10.1038/srep07960 5",Non-OADS,/arxiv_data1/oa_pdf/f4/29/srep07960.PMC4302305.pdf
"Based on publicly available express- ion data (eFP browser, http://bbc.botany.utoronto.ca/efp30), we found that NPF5.5 is also expressed in the embryo.",OADS,/arxiv_data1/oa_pdf/fe/9a/srep07962.PMC4302306.pdf
"The Sandcastle software and full documentation are available for download from http://reedlab.cardiff.ac.uk/sandcastle Affinity capturing damaged DNA .Monoclonal antibodies for UV- induced CPDs and platinum-induced guanine adducts were used to affinity capture DNA damaged with the respective agents, with theresulting enrichment assessed by Q-PCR (full details are given in theMethods section).",OADS,/arxiv_data1/oa_pdf/29/34/srep07975.PMC4302307.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/34/srep07975.PMC4302307.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/da/srep07949.PMC4302308.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Yes, there is potential competing interest.",Non-OADS,/arxiv_data1/oa_pdf/a0/b3/srep07955.PMC4302312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7955 | DOI: 10.1038/srep07955 9",Non-OADS,/arxiv_data1/oa_pdf/a0/b3/srep07955.PMC4302312.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/a8/srep07951.PMC4302313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7956 | DOI: 10.1038/srep07956 5",Non-OADS,/arxiv_data1/oa_pdf/d7/c9/srep07956.PMC4302314.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7968 | DOI: 10.1038/srep07968 7",Non-OADS,/arxiv_data1/oa_pdf/55/49/srep07968.PMC4302317.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/96/srep07973.PMC4302319.pdf
"Date of acces: 20/11/2014, http://www.selectagents.gov/SelectAgentsandToxinsList.",Non-OADS,/arxiv_data1/oa_pdf/a3/64/srep07793.PMC4302321.pdf
http://www.ecdc.europa.eu/en/ publications/_layouts/forms/Publication_DispForm.aspx?List 54f55ad51-4aed- 4d32-b960-af70113dbb90&ID 5989.,Non-OADS,/arxiv_data1/oa_pdf/a3/64/srep07793.PMC4302321.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7793 | DOI: 10.1038/srep07793 4",Non-OADS,/arxiv_data1/oa_pdf/a3/64/srep07793.PMC4302321.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/4a/main.PMC4302332.pdf
http://dx.doi.org/10.1016/j.pmedr.2014.12.0042211-3355/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/4a/main.PMC4302332.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/4a/main.PMC4302332.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/2d/4a/main.PMC4302332.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/4a/main.PMC4302332.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7959 | DOI: 10.1038/srep07959 7",Non-OADS,/arxiv_data1/oa_pdf/d4/09/srep07959.PMC4302367.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/13/59/jjnpp-09-04-16432.PMC4302396.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e6/29/jjnpp-09-04-17368.PMC4302397.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/89/3a/jjnpp-09-04-17532.PMC4302398.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a8/f6/jjnpp-09-04-20131.PMC4302399.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/40/9e/jjnpp-09-04-16576.PMC4302400.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e9/89/jjnpp-09-04-17741.PMC4302401.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/25/d9/jjnpp-09-04-17808.PMC4302402.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0a/8e/jjnpp-09-04-15904.PMC4302403.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/jjnpp-09-04-17565.PMC4302405.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/26/0e/jjnpp-09-04-17186.PMC4302406.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.Isolation of diverse chemical compounds from marine  organisms implies a promising source of natural prod - ucts.",Non-OADS,/arxiv_data1/oa_pdf/aa/c9/jjnpp-09-04-24716.PMC4302407.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/99/TOAIDJ-8-66.PMC4302459.pdf
http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2011/ dec/index-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/4e/d3/TOAIDJ-8-58.PMC4302460.pdf
http://www.phac-aspc.gc.ca/aids-sida/publication/survr eport/2011/dec/index-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/4e/d3/TOAIDJ-8-58.PMC4302460.pdf
http://www.who.int/hiv/data/2012_epi_core_en.png.,OADS,/arxiv_data1/oa_pdf/4e/d3/TOAIDJ-8-58.PMC4302460.pdf
"Available at: http://www.umanitoba.ca/ faculties/medicine/units/mchp/protocol/media/Andersen_and_Newman_Framework.pdf [28] Ross S, Grant A, Counsell C, Gillespie W, Prescott R. Barriers to participation in randomised controlled trials: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/4e/d3/TOAIDJ-8-58.PMC4302460.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/d3/TOAIDJ-8-58.PMC4302460.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/14/TOBEJ-8-120.PMC4302486.pdf
2014 [cited 2014 4/1] Available from:  Available from: http://www.nhlbi.nih.gov/health/health- topics/ topics/cad/ http://www.nhlbi.nih.gov/health/health.,OADS,/arxiv_data1/oa_pdf/0c/e2/icrj-08-166.PMC4302505.pdf
http://emedicine.medscape.com/article/322480-overview .,Non-OADS,/arxiv_data1/oa_pdf/59/6b/NRR-7-1812.PMC4302532.pdf
http://clinicaltrials.gov/ct2/show/NCT00561067 .,Non-OADS,/arxiv_data1/oa_pdf/59/6b/NRR-7-1812.PMC4302532.pdf
The initial approval for this clinical application  by the Food and Drug Administration (FDA) in January  2009  (http://www.geron.com/products/productinformation/spin alcordinjury.aspx) was put on hold after preclinical  studies showed a higher frequency of epithelial cysts  within the grafted spinal cords compared to the rodent  studies.,Non-OADS,/arxiv_data1/oa_pdf/89/c0/NRR-7-1822.PMC4302533.pdf
Available at http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/3d/7f/ccr30002-0163.PMC4302617.pdf
Primers were designedwith Primer3 web based software (http://bioinfo.ut.ee/pri-mer3/).,OADS,/arxiv_data1/oa_pdf/4c/02/ccr30002-0201.PMC4302626.pdf
"were distinctive, therefore, the diag-nosis of BSS was rapidly made by searching both thePub-Med database (http://www.ncbi.nlm.nih.gov/pub-med) and the University of Ryukyu Database for Malfor-mation Syndromes (http://becomerich.lab.u-ryukyu.ac.jp/).",OADS,/arxiv_data1/oa_pdf/04/a7/ccr30002-0224.PMC4302630.pdf
Available at http://www1.appstate.edu/~kms/classes/ psy2664/Documents/trivers.pdf [cited 2013 Sep 13].,OADS,/arxiv_data1/oa_pdf/06/66/ccr30002-0228.PMC4302631.pdf
"Methods Modern and Fossil Localities .Locality records with WGS84 latitude/longitude coordinates were obtained for modern specimens of Macrotus waterhousii (Waterhouse’s Leaf-nosed Bat), Monophyllus redmani (Greater Antillean Long- tongued Bat), and Pteronotus parnellii (Parnell’s Mustached Bat) with GPS in the field and from the MaNIS database (http://manisnet.org).",Non-OADS,/arxiv_data1/oa_pdf/26/38/srep07971.PMC4302782.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/38/srep07971.PMC4302782.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7971 | DOI: 10.1038/srep07971 7",Non-OADS,/arxiv_data1/oa_pdf/26/38/srep07971.PMC4302782.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/57/eb-7-001.PMC4302954.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pEye and Brain 2015:7 1–15Eye and Brain Dove press submit your manuscript | www.dovepress.co m Dove press  1Original rEsEarchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/EB.S6971 3cortical inputs to the middle temporal   visual area in new World owl monkeys christina M cerkevich1 christine E collins2 Jon h Kaas2 1center for the neural Basis of  cognition and systems neuroscience  institute, University of Pittsburgh  school of Medicine, Pittsburgh,    Pa, Usa; 2Department of Psychology,   Vanderbilt University, n ashville,    Tn, Usa correspondence: Jon h Kaas   Department of Psychology, Vanderbilt  University, 301 David K Wilson hall,   111 21st avenue south, nashville,   Tn 37203, Usa   Tel +1 615 322 6029   Fax +1 615 343 8449   Email jon.h.kaas@ vanderbilt.",Non-OADS,/arxiv_data1/oa_pdf/44/57/eb-7-001.PMC4302954.pdf
"Eye and Brain Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/eye-and-brain-journal  Eye and Brain is an international, peer-reviewed, open access journal   focusing on clinical and experimental research in the field of  neuro-ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/44/57/eb-7-001.PMC4302954.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/57/eb-7-001.PMC4302954.pdf
"(2014) Eligibility Criteria by Topic, Blood Pressure (High or Low) , Retrieved July 2014 from http://www.redcrossblood.org/donating-blood/eligibility-requ irements/eligibility- criteria-topic.",Non-OADS,/arxiv_data1/oa_pdf/7a/96/vox0108-0011.PMC4302974.pdf
"Transfus Apher Sci 2014, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ab/c8/vox0108-0001.PMC4302976.pdf
"Genome-wide transcriptome analysis using the Arabidopsis 3 Oligo Microarray Kit (Agilent Technologies, http://www.home.agilent.com/agilent/home.jspx) was conductedwith total RNA as described previously (Fujita et al.",OADS,/arxiv_data1/oa_pdf/09/ea/pce0038-0035.PMC4302978.pdf
The microarray design and data havebeen deposited in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress; accession numbers E-MTAB-2115).,OADS,/arxiv_data1/oa_pdf/09/ea/pce0038-0035.PMC4302978.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.241 Korean J Spine 11(4):241-4, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  241Migration of Rod into Retroperitoneal Region: A Case Report and   Review of the Literature Yaşar Bayri2, Murat Sakir Eksi1, Ramazan Do ğrul2, Demet Yal çinkaya Ko ç3, Deniz Konya4 1Neurosurgeon, Department of Orthopaedic Surgery, UCSF Spine Unit, CA, USA, 2Marmara University Medical School and  Marmara University Neurological Sciences Institute, Istanbul, Turkey, 3Department of Anesthesiology, Marmara University  Health Sciences Institute, Istanbul, Turkey, 4Department of Neurosurgery, Bahçe şehir University Medical School, Istanbul, Turkey Spinal stabilization with fusion is the widely used method for traumatic or pathologic fracture of spine, spinal stenosis, and  spondylolisthesis.",Non-OADS,/arxiv_data1/oa_pdf/83/5d/kjs-11-241.PMC4303277.pdf
"◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Spinal stabilization with instrumentation is a widely used  method for spinal traumas, degenerative spinal disease, and sometimes at congenital spinal malformations.",Non-OADS,/arxiv_data1/oa_pdf/83/5d/kjs-11-241.PMC4303277.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.227 Korean J Spine 11(4):227-31, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  227Postoperative Expansion of Dural Sac Cross-Sectional Area after  Unilateral  Laminotomy for Bilateral Decompression: Correlation with Clinic al Symptoms Seok-Won Chung1, Min-Soo Kang1, Yong-Hwan Shin1, Oon-Ki Baek1, Sang-Ho Lee2 1Department of Neurosurgery, Daegu Wooridul Spine Hospital, Daegu, 2Department of Neurosurgery, Wooridul Spine Hospital, Seoul, Korea Objective:  Dural sac cross-sectional area (DSCSA) is a way to measure the degree of central spinal canal compression.",Non-OADS,/arxiv_data1/oa_pdf/0a/59/kjs-11-227.PMC4303278.pdf
"◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Degenerative lumbar spinal stenosis (DLSS) is defined as a  narrowing of the lumbar spinal canal, lateral nerve root canals or the intervertebral neural foramina by patho-anatomic changes involving bulging disc, hypertrophy of the ligamentum flavum and facet-joints, which causes mechanical compression of spinal nerve roots.",Non-OADS,/arxiv_data1/oa_pdf/0a/59/kjs-11-227.PMC4303278.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.235 Korean J Spine 11(4):235-7, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  235Spontaneous Regression of Cervical Disc Herniation : A Case Repo rt Seong Rok Han, Chan Young Choi Department of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Spontaneous regression of cervical disc herniation is a rare, and such reports are few.",Non-OADS,/arxiv_data1/oa_pdf/41/4c/kjs-11-235.PMC4303279.pdf
"Key Words : Cervical ㆍDiscㆍHerniation ㆍRegression ●Received: August 27, 2014  ●Revised: October 19, 2014 ●Accepted: October 21, 2014 Corresponding Author:  Seong Rok Han , MD, PhD Department of Neurosurgery, Ilsan Paik Hospital, Inje University, 170 Juhwa-ro, Ilsan-Seo-gu, Goyang 411-410, KoreaTel: +82-31-910-7730, Fax: +82-31-915-0885E-mail: hsrkmj@paik.ac.kr ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Spontaneous regression of herniated lumbar disc has been  has been well established3,7).",Non-OADS,/arxiv_data1/oa_pdf/41/4c/kjs-11-235.PMC4303279.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.221 Korean J Spine 11(4):221-6, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  221Influence of Alendronate and Endplate Degeneration to Single Le vel  Posterior Lumbar Spinal Interbody Fusion Sang-Mok Kim, Wootack Rhee, Seongil Ha, Jae Hyeon Lim, Il Tae J ang Department of Neurosurgery, Seoul Nanoori Hospital, Seoul, Korea Objective:  Using alendronate after spinal fusion is a controversial issue due to the inhibition of osteoclast mediated bone  resorption.",Non-OADS,/arxiv_data1/oa_pdf/00/31/kjs-11-221.PMC4303280.pdf
"Key Words : Alendronate ㆍLumbar vertebrae ㆍOsteoporosis ㆍSpinal fusion ㆍEndplate degeneration ●Received: April 23, 2014  ●Revised: November 21, 2014 ●Accepted: November 24, 2014 Corresponding Author: Sang-Mok Kim , MD, PhD Department of Neurosurgery, Seoul Nanoori Hospital, 63-8, Nonhyun- dong, Gangnam-gu, Seoul 135-010, KoreaTel: +82-2-3446-9797, Fax: +82-2-3448-0213E-mail: kimkeith@naver.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Alendronate medication has been the standard treatment for  patients with osteoporosis2,24).",Non-OADS,/arxiv_data1/oa_pdf/00/31/kjs-11-221.PMC4303280.pdf
"LETTER TO EDITORpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.258 Korean J Spine  11(4):258, 2014 www.e-kjs.org 258   Copyright © 2014 The Korean Spinal Neurosurgery SocietyIntramedullary Spinal Neuorocysticercosis Viroj Wiwanitkit Wiwanitkit House, Bangkhae, Bangkok, Thailand ●Received: August 20, 2014  ●Revised: November 31, 2014 ●Accepted: December 2, 2014 Corresponding Author:  Viroj Wiwanitkit , MD Hainan Medical University, Wiwanitkit House, Bangkhae, Bangkok, ThailandTel: +866624132436, Fax: +866624132436E-mail: wviroj@yahoo.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Dear Editor, the report on “spinal neuorocysticercosis” is  very interesting1).",Non-OADS,/arxiv_data1/oa_pdf/8a/25/kjs-11-258.PMC4303281.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.252 Korean J Spine  11(4):252-4, 2014 www.e-kjs.org 252   Copyright © 2014 The Korean Spinal Neurosurgery SocietySpinal Paraganglioma Adherent to the Cauda Equina Han San Oh, Tae Wan Kim, Kwan Ho Park Department of Neurosurgery, VHS Medical Center, Seoul, Korea Paragangliomas are rare among intradural spinal tumors.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/kjs-11-252.PMC4303282.pdf
"Key Words : Paraganglioma ㆍCauda equina ㆍOperation ●Received: October 8, 2014  ●Revised: November 8, 2014 ●Accepted: November 10, 2014 Corresponding Author:  Tae Wan Kim , MD Department of Neurosurgery, VHS medical center, 53 Jinhwangdo-ro, 61-gil, Gangdong-gu, Seoul 134-791, KoreaTel: +82-2-2225-1363, Fax: +82-2-2225-4152E-mail: euro3399@naver.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Paragangliomas are rare among intradural spinal tumors.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/kjs-11-252.PMC4303282.pdf
"LETTER TO EDITORpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.255 Korean J Spine 11(4):255-7, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  255Lumbar Disc Herniations ‘To Operate or Not ’ Patient Selection and  Timing of Surgery Gazanfar Rahmathulla1, Kambiz Kamian2 1Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida, 2Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio, USA At times lumbar disc herniations present a quandary to the spine surgeon in regards to the most appropriate intervention  and a need to optimize medical and surgical therapies.",Non-OADS,/arxiv_data1/oa_pdf/b6/51/kjs-11-255.PMC4303283.pdf
"( C) Axial T2 WI at the level of the L2/3 disk space revealing the extruded fragment almost  encroaching the foramen.●Received: June 1, 2014  ●Revised: June 22, 2014 ●Accepted: June 25, 2014 Corresponding Author:  Gazanfar Rahmathulla , MD Department of Neurosurgery, Mayo Clinic, 4500 San Pablo Rd, Cannaday 2E, Jacksonville, Florida 32224, USATel: +1-904-953-2000, Fax: +1-888-9394093E-mail: drgazanfar@gmail.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.W e w ould like to elaborate on som e of the issues brought  up by K im  et al.15) in their article in Korean Journal of Spine  regarding spontaneous disk regression in a recent publication  entitled ‘Spontaneous regression of extruded lumbar disc herniation: three cases report.’ 2013 Jun;10(2):78-81.",Non-OADS,/arxiv_data1/oa_pdf/b6/51/kjs-11-255.PMC4303283.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.249 Korean J Spine 11(4):249-51, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  249Aneurysmal Bone Cysts of the Spine : Two Case Reports Seymen Ozdemir1, Can Yaldiz2, Ferhat Ozden4, Ozlem Kitiki Kacira3, Tibet Kacira2 1Department of Neurosurgery, Van Training and Research Hospital Van, 2Department of Neurosurgery, Sakarya Training  and Research Hospital, Sakarya, 3Department of Radiology, Sakarya Training and Research Hospital, Sakarya,  4Department of Pathology, Van Training and Research Hospital Van, Turkey Aneurysmal bone cysts are rare entities which causes expansile and destructive bone lesions characterized by reactive  proliferation of connective tissue.",Non-OADS,/arxiv_data1/oa_pdf/18/4f/kjs-11-249.PMC4303284.pdf
"Key Words : Aneurysmal bone cysts ㆍSpineㆍSacrum ●Received: October 31, 2014  ●Revised: November 6, 2014 ●Accepted: November 10, 2014 Corresponding Author:  Can Yaldiz , MD Department of Neurosurgery, Sakarya Training and Research Hospital, Sakarya, Turkey 54010Tel: +900503572222, Fax: +902643460101E-mail: drcanyaldiz@yahoo.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/4f/kjs-11-249.PMC4303284.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.238 Korean J Spine  11(4):238-40, 2014 www.e-kjs.org 238   Copyright © 2014 The Korean Spinal Neurosurgery SocietyFatal Rhabdomyolysis following Spine Surgery in a Morbidly Obes e    Patient: A Case Report Se Ho Jung1, Seok Won Kim1, Dong Min Kim2, Chang Il Ju1 Departments of 1Neurosurgery, 2Internal Medicine, Chosun University College of Medicine, Gwangju, Korea We generally believe that obese patients are faced on higher risk of developing perioperative complications.",Non-OADS,/arxiv_data1/oa_pdf/17/61/kjs-11-238.PMC4303285.pdf
"Key Words : Spine ㆍRhabdomyolysis ㆍObesity ●Received: June 20, 2014  ●Revised: July 28, 2014 ●Accepted: August 11, 2014 Corresponding Author:  Seok Won Kim , MD, PhD Department of Neurosurgery, Chosun University College of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju-city 501-717, KoreaTel: +82-62-220-3126, Fax: +82-62-227-4575E-mail: ns64902@hanmail.net/chosunns@chosun.ac.kr ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Rhabdomyolysis causes muscle breakdown and the leakage  of intracellular muscle constituents, such as enzymes, electroly- tes, and myoglobin into the circulation and extracellular fluid 3,6,8).",Non-OADS,/arxiv_data1/oa_pdf/17/61/kjs-11-238.PMC4303285.pdf
"LETTER TO EDITORpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.259 Korean J Spine 11(4):259, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  259Noncontiguous Multiple Spinal Tuberculosis Sim Sai Tin1, Viroj Wiwanitkit2 1Medical Science, Medical Center, Shantou, China, 2Visiting Professor, Hainan Medical University, China ●Received: September 5, 2014  ●Revised: November 2, 2014 ●Accepted: November 4, 2014 Corresponding Author:  Sim Sai Tin , MD Medical Center, Shantou, ChinaTel: +866624132436, Fax: +866624132436E-mail: simsaitin@gmail.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dear Editor, we would like to discuss on the publication  on “noncontiguous multiple spinal tuberculosis1).” Kim et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/25/kjs-11-259.PMC4303286.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.232 Korean J Spine 11(4):232-4, 2014 www.e-kjs.org 232   Copyright © 2014 The Korean Spinal Neurosurgery SocietyEffectiveness of Repeated Radiofrequency Neurotomy for Facet  joint Syndrome after Microscopic Discectomy Myung Hoon Kim1, Seok Won Kim1, Chang Il Ju1, Ki Hwan Chae1, Dong Min Kim2 Departments of 1Neurosurgery, 2Internal Medicine, Chosun University College of Medicine, Gwangju, Korea Objective:  Postoperative facet joint syndrome requiring radiofrequency neurotomy (RFN) is a relatively common problem  following microscopic discectomy.",Non-OADS,/arxiv_data1/oa_pdf/15/ea/kjs-11-232.PMC4303287.pdf
"Key Words : Facet syndrome ㆍRadiofrequency ㆍNeurotomy ㆍDiscectomy ●Received: July 3, 2014  ●Revised: November 17, 2014 ●Accepted: December 1, 2014 Corresponding Author: Ki Hwan Chae , MD Department of Neurosurgery, Chosun University College of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju-city 501-717, KoreaTel: +82-62-220-3126, Fax: +82-62-227-4575E-mail: ns64902@hanmail.net/chosunns@chosun.ac.kr ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Microscopic discectomy is a standard surgical procedure for  lumbar disc herniation and has been approved as a safe method  to alleviate radiating pain and other neurological symptoms.",Non-OADS,/arxiv_data1/oa_pdf/15/ea/kjs-11-232.PMC4303287.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2014.11.4.245 Korean J Spine 11(4):245-8, 2014 www.e-kjs.org Copyright © 2014 The Korean Spinal Neurosurgery Society  245Lumbar Disc Herniation in a Patient With Congenital Vertebral  Body Anomaly: A Case Report Cem Atabey1, Ahmet Ero ğlu2, Ali Kivanc Topuz3, Murat Velio ğlu4, Mehmet Nusret Demircan1 1Department of Neurosurgery, GATA Haydarpasa Training Hospital, Istanbul, 2Department of Neurosurgery, Van Military  Hospital, Van, 3Department of Neurosurgery, Kas ımpaşa Military Hospital, Istanbul, 4Department of Radiology, GATA  Haydarpasa Training Hospital, Istanbul, Turkey Lumbar disc herniation is characterized with low back and leg pain resulting from the degenerated lumbar disc compressing  the spinal nerve root.",Non-OADS,/arxiv_data1/oa_pdf/b8/f3/kjs-11-245.PMC4303288.pdf
"Key Words : Fusion anomaly ㆍDisc hernia ㆍTraumaㆍNervous system ●Received: July 2, 2014  ●Revised: August 2, 2014 ●Accepted: August 11, 2014 Corresponding Author:  Ahmet Ero ğlu, MD Department of Neurosurgery, Van Military Hospital, Clinic of Neurosur- gery, Van, TurkeyTel: +90-506-203-6231, Fax: +90-432-222-0244E-mail: drahmeteroglu@gmail.com ◯∝This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/f3/kjs-11-245.PMC4303288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 85–93ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  85ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7532 3Economic evaluation of anti-TnF agents   for patients with rheumatoid arthritis in greece Vasilis Fragoulakis1 Elli Vitsou2 ana Cristina hernandez2 nikolaos Maniadakis1 1national school of Public health,   2Pfizer hellas, athens, greece Correspondence: V Fragoulakis   Department of health services  Management, national school of Public  health, 196 alexandras avenue,   athens 11521, greece   Tel +30 210 646 7097   Fax +30 213 201 0194   Email vfragoulakis@esdy.edu.g rObjectives:  We aimed to estimate the total mean annual treatment cost of different therapy  options for patients with moderate-to-severe rheumatoid arthritis (RA) in Greece.",Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
London: European Medicines Agency; Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/ceor-7-085.PMC4303331.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/bd/bctt-7-021.PMC4303336.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 21–35Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  21Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4722 7Cardiac risk in the treatment of breast cancer:  assessment and management Antonis valachis1 Cecilia Nilsson2 1Centre for Clinical Research  Sörmland, Uppsala University,   eskilstuna, Sweden; 2Center for  Clinical Research, västmanlands  County Hospital, västerås, Sweden Correspondence: Antonis valachis   Department of Oncology,   63188 Mälarsjukhuset,   eskilstuna, Sweden   Tel +46 735 617 691   Fax +46 16 104 035   email valachis@hotmail.co m; antonis.",Non-OADS,/arxiv_data1/oa_pdf/d4/bd/bctt-7-021.PMC4303336.pdf
"Available from:  http://globocan.iarc.fr/Pages/fact_sheets_cancer.asp x. Accessed   October 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d4/bd/bctt-7-021.PMC4303336.pdf
18. http://www.dbcg.dk  [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/d4/bd/bctt-7-021.PMC4303336.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d4/bd/bctt-7-021.PMC4303336.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 35–43Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  35OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6841 3T eaching pediatric communication skills   to medical students Katherine A Frost1,2 Elizabeth P Metcalf3 rachel Brooks2,3 Paul Kinnersley3 stephen r greenwood3 colin VE Powell1,2,4 1noah’s Ark children’s hospital for  Wales, 2Department of Pediatrics,   3institute of Medical Education,   4Molecular and Experimental  Medicine, school of Medicine, cardiff  University, cardiff, Wales correspondence: KA Frost   University hospital of Wales, heath Park,  cardiff, cF14 4XW, United Kingdom   Tel +29 2074 7747   Email k atherine.",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
Available from: http://www.nhssurveys.,Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
"Available from: http://www.gov.uk/child-employment/ restrictions - on-child-employmen t. Accessed January 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/6b/amep-6-035.PMC4303365.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/da/cia-10-277.PMC4303366.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 277–286Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  277OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7410 2Multicenter, prospective, comparative cohort  study evaluating the efficacy and safety of  alfuzosin 10 mg with regard to blood pressure  in men with lower urinary tract symptoms  suggestive of benign prostatic hyperplasia with  or without antihypertensive medications li Tao Zhang1 sung Won lee2 Kwangsung Park3 Woo sik Chung4 sae Woong Kim5 Jae seog hyun6 Doo geon Moon7 sang-Kuk Yang8  Ji Kan ryu9 Dae Yul Yang10 Ki hak Moon11 Kweon sik Min12 Jong Kwan Park1 1Department of Urology, Chonbuk national  University, Medical school and Biomedical  research Institute and Clinical Trial Center for  Medical Devices of Chonbuk national University  hospital, Jeonju; 2Department of Urology, College  of Medicine, sungkyunkwan University, seoul;  3Department of Urology, College of Medicine,   Chonnam national University, gwangju;  4Department of Urology, College of Medicine,   ewha Woman’s University, seoul; 5Department of  Urology, College of Medicine, Catholic University,   seoul; 6Department of Urology, College of  Medicine, Kyungsang national University, Jinju;  7Department of Urology, College of Medicine,   Korea University, seoul; 8Department of Urology,   Chungju hospital, College of Medicine, Konkuk  University, Chungju; 9Department of Urology,   College of Medicine, Inha University, Incheon;  10Department of Urology, College of Medicine,   hallym University, seoul; 11Department of Urology,   College of Medicine, Y oungnam University, Daegu;  12Department of Urology, College of Medicine, Inje  University, Busan, republic of KoreaBackground:  The objective of this study was  to assess the efficacy and safety of alfuzosin  10 mg monotherapy or combined antihypertensive medication on blood pressure (BP) in patients  with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS) with  or without antihypertensive medication.",Non-OADS,/arxiv_data1/oa_pdf/62/da/cia-10-277.PMC4303366.pdf
"Keywords:  alfuzosin, lower urinary tract symptoms, benign prostatic hyperplasia, antihyper - tensive medication, blood pressureJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: Alfuzosin in hypertensive patients with BPH DOI: http://dx.doi.org/10.2147/CIA.S74102 Correspondence: Jong Kwan Park  Department of Urology, Chonbuk national University,  Medical school and Biomedical research Institute  and Clinical Trial Center for Medical Devices  of Chonbuk national University hospital,   Jeonju 561-712, republic of Korea Tel +82 063 250 1510 Fax +82 063 250 1564 email rain@chonbuk.ac.k r",Non-OADS,/arxiv_data1/oa_pdf/62/da/cia-10-277.PMC4303366.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/62/da/cia-10-277.PMC4303366.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/62/da/cia-10-277.PMC4303366.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/ca/clep-7-091.PMC4303367.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 91–106Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  91MEthodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CLEP .S7224 7Using multiple imputation to deal with missing  data and attrition in longitudinal studies with  repeated measures of patient-reported outcomes Karin Biering1 Niels henrik hjollund2,3 Morten Frydenberg4 1danish Ramazzini Centre,   department of occupational Medicine  – University Research Clinic, hospital  West Jutland, herning, denmark;   2WestChronic, Regional hospital  West Jutland, herning, denmark;   3department of Clinical Epidemiology,   Aarhus University hospital, Aarhus,   denmark; 4Section of Biostatistics,   department of Public health, Aarhus  University, Aarhus, denmark Correspondence: Karin Biering   department of occupational Medicine,  Regional hospital West Jutland,   dK-7400 herning, denmark   tel +45 7843 3500   Email k arin.biering@vest.rm.d kObjective:  Missing data is a ubiquitous problem in studies using patient-reported measures,  decreasing sample sizes and causing possible bias.",Non-OADS,/arxiv_data1/oa_pdf/86/ca/clep-7-091.PMC4303367.pdf
"Clinical Epidemiology 2015:7submit your manuscript | www.dovepress.co m Dove press Dove press 103Multiple imputation in longitudinal studies § 14.2, available from: http://www.cvk.sum.dk/English/ actonabiomedicalresearch.asp x.",Non-OADS,/arxiv_data1/oa_pdf/86/ca/clep-7-091.PMC4303367.pdf
Available  from: http://www.missingdata.org.uk /.,Non-OADS,/arxiv_data1/oa_pdf/86/ca/clep-7-091.PMC4303367.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/86/ca/clep-7-091.PMC4303367.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/de/jpr-8-039.PMC4303394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 39–45Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  39ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6951 1Postoperative pain management with transdermal  fentanyl after forefoot surgery: a randomized,  placebo-controlled study Riika Merivirta1 Mikko Pitkänen2 Jouko alanen3 elina haapoja1 Mari Koivisto4 Kristiina Kuusniemi1 1Department of anaesthesiology,   intensive care, emergency care and  Pain Medicine of T urku University  hospital and University of T urku,   T urku, 2Department of anaesthesia,   hospital Orton, invalid Foundation,   helsinki, 3T erveystalo clinic hospital,   helsinki, 4Department of Biostatistics,   University of T urku, T urku, Finland correspondence: Riika Merivirta   TYKs, Pl 52, Fi-20521 Turku, Finland   Tel +358 2313 0704   Fax +358 2313 9254   email riika.merivirta@tyks.fiBackground:  Quality of life is decreased in patients with hallux valgus deformity, mainly  because of pain.",Non-OADS,/arxiv_data1/oa_pdf/a7/de/jpr-8-039.PMC4303394.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/a7/de/jpr-8-039.PMC4303394.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/de/jpr-8-039.PMC4303394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/1f/jir-8-015.PMC4303395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 15–27Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  15RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S5125 0Targeting the NLRP3 inflammasome in chronic  inflammatory diseases: current perspectives ema Ozaki1 Matthew Campbell1 Sarah L Doyle2,3 1Department of Genetics,   2Department of Clinical Medicine,   School of Medicine, Trinity College  Dublin,  3National Children’s Research  Centre, Our Lady’s Children’s  Hospital Crumlin, Dublin, Ireland Correspondence: Sarah Doyle   Gate 5, National Children’s Research  Centre, Our Lady’s Children’s Hospital,  Cooley Road, Crumlin, Dublin  12, Ireland   Tel +353 1 409 8496  Fax +353 1 455 0201  email sarah.doyle@tcd.i eAbstract:  The inflammasome is a molecular platform formed by activation of an innate immune  pattern recognition receptor seed, such as NLRP3.",Non-OADS,/arxiv_data1/oa_pdf/81/1f/jir-8-015.PMC4303395.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/81/1f/jir-8-015.PMC4303395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/7d/jmdh-8-039.PMC4303396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 39–45Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  39Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7776 6role of betaine in improving the antidepressant  effect of S-adenosyl-methionine in patients   with mild-to-moderate depression Francesco Di Pierro1 rossana Orsi2 roberto settembre3 1scientific Department, Velleja  research, Milan, italy; 2asl TO1, T urin,   italy; 3neurosurgery Department, asl  Ba, Di Venere Hospital, Bari, italy correspondence: Francesco Di Pierro   Scientific Department, Velleja Research,  Viale lunigiana  23, Milan  20125, italy   Tel +39 349 552 7663   Fax +39 0523 511 894   email f.dipierro@vellejaresearch.co mBackground:  S-adenosyl-methionine (SAMe) is a common add-on treatment used to counteract  depressive symptoms in subjects with mild-to-moderate depression, who are low responders to  other antidepressant drugs.",Non-OADS,/arxiv_data1/oa_pdf/e2/7d/jmdh-8-039.PMC4303396.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/e2/7d/jmdh-8-039.PMC4303396.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/7d/jmdh-8-039.PMC4303396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/78/imcrj-8-029.PMC4303397.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 29–31International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  29Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6109 4Radical cystectomy and pelvic lymphadenectomy  with ileal conduit urinary diversion and abdominal  wall reconstruction: an interesting case   of multidisciplinary management stratos s sofos1  Ciaran J Walsh2  Nigel J parr2  Kevin Hancock1 1Whiston Hospital, p rescot,  2arrowe  park Hospital, Wirral, Merseyside, UK Correspondence: stratos s sofos   Whistion Hospital, Warrington Rd,  prescot L34  5Nt, Merseyside, UK   tel +01 51 426 1600  Fax +01 51 426 3950  email tsofos@hotmail.co mAbstract:  The ileal conduit for urinary diversion after radical cystectomy is a well-described  procedure.",Non-OADS,/arxiv_data1/oa_pdf/09/78/imcrj-8-029.PMC4303397.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/09/78/imcrj-8-029.PMC4303397.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/78/imcrj-8-029.PMC4303397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/vhrm-11-055.PMC4303398.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 55–70Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  55ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4875 3Adiponectin as a potential biomarker   of vascular disease Mehrangiz ebrahimi- Mamaeghani1 Somayeh Mohammadi2 Seyed Rafie Arefhosseini3 Parviz Fallah4 Zahra Bazi5 1Nutrition Research Center,   2Department of Nutrition,   3Department of Food T echnology,   Faculty of Nutrition Sciences, Tabriz  University of Medical Sciences, Tabriz,   4Department of Molecular Biology  and Genetic engineering, Stem Cell  T echnology Research Center,  T ehran,   5Department of Biotechnology,   Faculty of Medicine, Shahid Beheshti  University of Medical Sciences, T ehran,   iran Correspondence: Somayeh Mohammadi   Department of Nutrition, Faculty of  Nutrition Sciences, Tabriz University of  Medical Sciences, Attar Neishaboori Ave,  PO Box 5166614711, Tabriz, iran   Tel +98 411 335 7580   Fax +98 411 334 0634   email m ohammadis.phd@gmail.co mAbstract:  The increasing prevalence of diabetes and its complications heralds an alarming   situation worldwide.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/vhrm-11-055.PMC4303398.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/95/9e/vhrm-11-055.PMC4303398.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/9e/vhrm-11-055.PMC4303398.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 165–175Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  165REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5884 1Anxiety disorders and GABA neurotransmission:  a disturbance of modulation Philippe Nuss1,2 1Department of Psychiatry, Hôpital St  Antoine, AP-HP , 2UMR 7203, INSERM  ERL 1057 – Bioactive Molecules  Laboratory, Pierre and Marie Curie  University, Paris, FranceAbstract:  Lines of evidence coming from many branches of neuroscience indicate that anxiety  disorders arise from a dysfunction in the modulation of brain circuits which regulate emotional  responses to potentially threatening stimuli.",Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
"Anxiety disorders: definitions, presentation,  and classification Anxiety is a frequent negative emotional state characterized by feelings of worry  and apprehension, and accompanied by specific somatic, cognitive, and behavioral Correspondence: Philippe Nuss Department of Psychiatry, Hôpital  St Antoine, 184 rue du Faubourg  St Antoine, Paris 75012, France Tel +33 1 4928 2655 Email philippe.nuss@sat.aphp.f r Journal name: Neuropsychiatric Disease and Treatment Article Designation: REVIEW Y ear: 2015 Volume: 11 Running head verso: Nuss Running head recto: Anxiety and modulation DOI: http://dx.doi.org/10.2147/NDT.S58841",Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
Available from: http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/23/ndt-11-165.PMC4303399.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/ff/dmso-8-049.PMC4303400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 49–56Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  49Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S7192 3Recognition of and steps to mitigate anxiety   and fear of pain in injec table diabetes treatment Davida F Kruger1 Susan LaRue2,3  Phil estepa3 1Henry Ford Health System, Detroit,   Mi, USA; 2Amylin Pharmaceuticals,    San Diego, CA, USA; 3AstraZeneca,   San Diego, CA, USA Correspondence: Davida F Kruger   Henry Ford Health System, Division   of endocrinology, Diabetes, Bone   and Mineral Disease, New Center One,   3031 west Grand Blvd, Suite 800,  Detroit, Mi 48202, USA   Tel +1 313 916 3906   Fax +1 313 916 3907   email d kruger1@hfhs.or gAbstract:  Injec table  treatments, such as glucagon-like peptide-1 receptor agonists and insu - lin, are options for the pharmacologic treatment of type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d6/ff/dmso-8-049.PMC4303400.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/d6/ff/dmso-8-049.PMC4303400.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/ff/dmso-8-049.PMC4303400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 79–93Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  79REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S3969 1New developments in bone-conduction hearing  implants: a review Sabine Reinfeldt1 Bo Håkansson1 Hamidreza Taghavi1 Måns Eeg-Olofsson2 1Department of Signals and Systems,   Chalmers University of T echnology,   Gothenburg, Sweden;  2Department  of Otorhinolaryngology, Head  and Neck Surgery, Sahlgrenska  University Hospital, Sahlgrenska  Academy, University of Gothenburg,   Gothenburg, Sweden Correspondence: Sabine Reinfeldt   Department of Signals and Systems,  Chalmers University of Technology,  SE-412  96 Gothenburg, Sweden   Tel +46 31 772 8063  Fax +46 31 772 1782  Email sabine.reinfeldt@chalmers.s eAbstract:  The different kinds of bone-conduction devices (BCDs) available for hearing  rehabilitation are growing.",Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
Available from: http://www.cochlear.com/wps/ wcm/connect/0a7aa3b7-8ad8-40ab-b288-20054c04e3e2/en-Baha-Os - seo-Press-Release-2013-June-11.pdf?MOD=AJPERES&CONVERT_ TO=url&CACHEID=0a7aa3b7-8ad8-40ab-b288-20054c04e3e2.,Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
A vailable from:  http://www.oticonmedical.com/ ∼asset/cache.ashx?id =7229 &type =  14&format =web.,Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
"Available from  https://www.google.com/glass/star t. Accessed November 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 93Bone-conduction hearing implants  67.,Non-OADS,/arxiv_data1/oa_pdf/fd/12/mder-8-079.PMC4303401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 107–114Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  107ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7486 7Target-controlled infusion and population  pharmacokinetics of landiolol hydrochloride  in patients with peripheral arterial disease Takayuki Kunisawa1 akio Yamagishi2 Manabu suno3 susumu nakade4 naoki honda4 atsushi Kurosawa2 ami sugawara2 Y oshikazu Tasaki5 hiroshi iwasaki2 1surgical Operation Department,   asahikawa Medical University  hospital, asahikawa, Japan;   2Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, asahikawa,   Japan; 3Department of Oncology  Pharmaceutical Care and sciences,   Okayama University, Okayama,   Japan; 4Pharmacokinetic Research  laboratories, Ono Pharmaceutical  Co., ltd., Osaka, Japan; 5Department  of hospital Pharmacy and  Pharmacology, asahikawa Medical  University, asahikawa, JapanPurpose:  We previously determined the pharmacokinetic (PK) parameters of landiolol in  healthy male volunteers and gynecological patients.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
"Recently, we determined that PK parameters of landiolol in Correspondence: Takayuki Kunisawa Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, 2-1-1-1 Midorigaoka  higashi, asahikawa, hokkaido 0788510,  Japan Tel +81 166 68 2583 Fax +81 166 68 2589 email taka.kunisawa@nifty.ne.jpJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kunisawa et al Running head recto: TCI and PPK of landiolol with PAD DOI: http://dx.doi.org/10.2147/TCRM.S74867",OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
"STANPUMP  software ( http://opentci.org/doku.ph p) was used to run the  infusion pump (Graseby™ 3500 Syringe Pump; Smiths  Medical, London, UK) with the Minto’s parameter setting.5  Rocuronium (0.6 mg/kg) was administered for intubation,  and supplemental 10 mg doses were administered as neces - sary.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/d0/tcrm-11-107.PMC4303402.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/20/ppa-9-105.PMC4303403.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 105–111Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  105OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7656 3systematic review and meta-analysis of  prospective studies for ecP treatment in patients  with steroid-refractory acute gVhD hongming Zhang runzhe chen Jian cheng nan Jin Baoan chen Department of hematology and  Oncology (Key Department of Jiangsu  Medicine), Zhongda hospital, Medical  school, southeast University, nanjing,   Jiangsu Province, People’s republic  of chinaPurpose:  The aim of this systematic review was to evaluate the efficacy and safety of  extracorporeal photopheresis (ECP) treatment in patients with steroid-refractory acute graft- versus-host disease (SR-aGVHD).",Non-OADS,/arxiv_data1/oa_pdf/f2/20/ppa-9-105.PMC4303403.pdf
"At present,  the results of ECP treatment have been reported only in a small number of patients correspondence: Baoan chen Department of hematology and  Oncology (Key Department of Jiangsu  Medicine), Zhongda hospital, Medical  school, southeast University, Dingjiaqiao  87, gulou District, nanjing, Jiangsu  Province, People’s republic of china Tel +86 25 8327 2006 Fax +86 25 8327 2011 email cba8888@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: ECP treatment in steroid-refractory acute GVHD patients DOI: http://dx.doi.org/10.2147/PPA.S76563",Non-OADS,/arxiv_data1/oa_pdf/f2/20/ppa-9-105.PMC4303403.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f2/20/ppa-9-105.PMC4303403.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/8d/ppa-9-095.PMC4303404.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 95–104Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  95Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5500 9Patient-reported outcomes and considerations  in the management of COPD: focus on aclidinium Jose Luis Lopez-Campos1,2 Carmen Calero1,2 Cecilia Lopez-Ramirez1 Maria isabel Asensio-Cruz1 eduardo Márquez-Martín1 Francisco Ortega-Ruiz1,2 1Unidad Médico-Quirúrgica de  enfermedades Respiratorias,   instituto de Biomedicina de Sevilla  (iBiS), Hospital Universitario virgen  del Rocío/Universidad de Sevilla,   Sevilla, 2CiBeR de enfermedades  Respiratorias (CiBeReS), instituto de  Salud Carlos iii, Madrid, SpainAbstract:  Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disease,  in which several factors combine to give the final clinical expression.",Non-OADS,/arxiv_data1/oa_pdf/d7/8d/ppa-9-095.PMC4303404.pdf
"As a result, traditional clinical trials have focused  on demonstrating improvement in FEV1 either as an isolated measurement or as a  declining trend over time.5 Accordingly, previous guidelines focused on establishing  treatment strategies according to the degree of FEV1 impairment.6Correspondence: Jose Luis Lopez- Campos Unidad Médico-Quirúrgica de  enfermedades Respiratorias, instituto  de Biomedicina de Sevilla (iBiS),  Hospital Universitario virgen del Rocío/ Universidad de Sevilla, Avda Manuel  Siurot, s/n, 41012 Sevilla, Spain email lcampos@separ.e s Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lopez-Campos et al Running head recto: Aclidinium and patient-reported outcomes DOI: http://dx.doi.org/10.2147/PPA.S55009",Non-OADS,/arxiv_data1/oa_pdf/d7/8d/ppa-9-095.PMC4303404.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d7/8d/ppa-9-095.PMC4303404.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 113–126International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  113RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6712 4Non-invasive prenatal testing: a review   of international implementation and challenges Megan Allyse1 Mollie A Minear2 elisa Berson3 Shilpa Sridhar3 Margaret Rote3 Anthony Hung3 Subhashini  Chandrasekharan4 1Institute for Health and Aging,   University of California San Francisco,   San Francisco, California, USA, 2Duke  Science & Society, Duke University,   Durham, NC, USA, 3Trinity College of  Arts and Sciences, Duke University,   Durham, NC, USA;  4Duke Global  Health Institute, Duke University,    Durham, NC, USA Correspondence: Megan Allyse   University of California San Francisco,  Box 0646, 333 California St, Laurel  Heights, Room 340, San Francisco, CA  94143, USA   email megan.allyse@ucsf.ed uAbstract:  Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal  chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available  from: http://www.acog.org/Resources-And-Publications/Committee- Opinions/Committee-on-Genetics/Noninvasive-Prenatal-Testing-for- Fetal-Aneuploid y. Accessed July  28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://www.verifitest.com/clinical-data /.,OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://sequenom.uber - flip.com/i/21203 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available  from: http://www.sequenom.com/press/sequenom-laboratories- launches-enhanced-sequencing-series-maternit21-plus-tes t. Accessed  July 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from:  http://www.sequenom.com/press/sequenom- laboratories -presents-new- data-enhanced-sequencing-series-maternit21-plus-laborator y. Accessed  August 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from:  http://www.transparencymarketresearch.com/ noninvasive-prenatal- diagnostics-market.html 2014.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://www.ariosadx.com/review-clinical- data/clinical-data /.,OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from: https://www.labcorp.com/wps/wcm/connect/IntGen - eticsLib/integratedgenetics/home/our+services/reproductive+testing/ informaseq+prenatal+tes t. Accessed September 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available  from: http://www.genomeweb.com/sequencing/maternit21-drives- spike-diagnostic-revenue-sequenom-predicts-25k-tests-sold-201 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from: http://www.genomeweb.com/sequencing/rivals-vie- share- noninvasive -trisomy-testing-market-physicians-see-value-screen i.  Accessed August 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://www.genomeweb.com/sequencing/sequencing- based-fetal-testing-market-heats-verinata-plans-2012-launch-down- synd.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from: http://www.rapid.nhs.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from: http://www.genomeweb.com/clinical-genomics/ amid-chaos-fdas-gutierrez-offers-insights-agencys-regulatory-stance- molecular-t e. Accessed August 29, 2014.",OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from http://www.forbes.com/sites/shuchingjeanchen/2014/   03/03/china-cracks-down-on-dna-testing-2 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"March  4, 2014. http://www.genomeweb.",OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from: http://www.genomeweb.com/ sequencing/china-fda-approves-bgis-ngs-product s. Accessed August,  29 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Avail - able from: http://www.hsph.harvard.edu/pgda/wp-content/uploads/ sites/1288/2013/10/PGDA_WP_96.pd f. Accessed August 25, 2104.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Available from http://www.who.int/ reproductivehealth/publications/unsafe_abortion/9789241501118/en /.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
"Available from: http://india.unfpa.org/drive/ IMPLEMENTATIONOFTHEPCPNDTACTININDIAPerspective - sandChallenges.pd f. Accessed June  15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/29/ijwh-7-113.PMC4303457.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/ott-8-157.PMC4303458.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 157–168OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  157Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3909 6BRAF-mutant melanoma: treatment approaches,  resistance mechanisms, and diagnostic strategies Francesco Spagnolo1 Paola Ghiorzo2,3 Laura Orgiano4 Lorenza Pastorino2,3 virginia Picasso4 elena T ornari4 vincenzo Ottaviano4 Paola Queirolo4 1Department of Plastic and  Reconstructive Surgery, iRCCS  Azienda Ospedaliera Universitaria San  Martino, iST istituto Nazionale per  la Ricerca sul Cancro, Genova, italy;  2Department of internal Medicine  and Medical Specialties (DiM i),   University of Genoa, Genova, italy;  3Genetics of Rare Cancers, iRCCS  Azienda Ospedaliera Universitaria  San Martino, iST istituto Nazionale  per la Ricerca sul Cancro, Genova,   italy; 4Department of Medical  Oncology, iRCCS Azienda Ospedaliera  Universitaria San Martino, iST istituto  Nazionale per la Ricerca sul Cancro,   Genova, italy Correspondence: Francesco Spagnolo   iRCCS San Martino, iST istituto  Nazionale per la Ricerca sul Cancro,  Largo R Benzi,  10, Genova  16132, italy   Tel +39 010 5600 384  Fax +39 010 5600 8 50  email francesco.spagnolo85@gmail.co mAbstract:  BRAF inhibitors vemurafenib and dabrafenib achieved improved overall survival over  chemotherapy and have been approved for the treatment of BRAF-mutated metastatic melanoma.",Non-OADS,/arxiv_data1/oa_pdf/c0/06/ott-8-157.PMC4303458.pdf
"Available at: http://journals.lww.com/molecularpathology/Full - text/2012/03000/Analytical_Performance_of_a_Real_time_PCR_   based.1.asp x. Accessed September 1, 2014.",OADS,/arxiv_data1/oa_pdf/c0/06/ott-8-157.PMC4303458.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c0/06/ott-8-157.PMC4303458.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/06/ott-8-157.PMC4303458.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 177–193OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  177Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6767 3Triple-negative breast cancer: new perspectives  for targeted therapies Federica T omao1 Anselmo Papa2 eleonora Zaccarelli2 Luigi Rossi2 Davide Caruso2 Marina Minozzi2 Patrizia vici3 Luigi Frati4 Silverio T omao2 1Department of Gynecology and  Obstetrics, “Sapienza” University  of Rome, Policlinico “Umberto i”,   Rome, 2Department of Medico- Surgical Sciences and Biotechnologies,   “Sapienza” University of Rome,   Oncology Unit, istituto Chirurgico  Ortopedico Traumatologico, Latina,   3Division of Medical Oncology B,   Regina elena National Cancer  institute, Rome, italy; 4Department  of Molecular Medicine, “Sapienza”  University of Rome, Policlinico  “Umberto i”, Rome, italy Correspondence: Anselmo Papa   Department of Medico-Surgical  Sciences and Biotechnologies, “Sapienza”  University of Rome, Oncology Unit,   iCOT, Latina, italy   email anselmo.papa@libero.i tAbstract:  Breast cancer is a heterogeneous disease, encompassing a large number of entities  showing different morphological features and having clinical behaviors.",Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/NCT0046871 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/NCT0078257 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/ NCT0104530 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/NCT0120412 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Avail - able from: http://clinicaltrials.gov/show/NCT0107497 0.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/ show/NCT0109764 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/ NCT0063346 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/ show/NCT0070332 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Available from: http://clinicaltrials.gov/show/ NCT0117666 9.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/13/ott-8-177.PMC4303459.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/ijn-10-697.PMC4303460.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 697–709International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  697OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7402 5Physicochemical and biological properties  of a novel injectable polyurethane system  for root canal filling Jian Wang1 Yi Zuo1 Minghui Zhao1 Jiaxing Jiang1 Yi Man2 Jun Wu3 Yunjiu hu3 changlei liu4 Yubao li1 Jidong li1 1research center for Nano- Biomaterials, analytical and Testing  center, sichuan University, chengdu,   sichuan, People’s republic of  china; 2college of stomatology,   sichuan University, chengdu,   sichuan, People’s republic of china;  3Department of Orthopedics,   chongqing Medical University,   chongqing, People’s republic  of china; 4college of chemistry,   sichuan University, chengdu, sichuan,   People’s republic of chinaAbstract:  A root canal sealer with antibacterial activity can be efficacious in preventing  reinfection that results from residual microorganisms and/or the leakage of microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/8e/42/ijn-10-697.PMC4303460.pdf
"Keywords:  root canal sealer, polyurethane, silver phosphate, antibacterial properties, direct  contact test Introduction The ultimate goal of root canal therapy is to eliminate microorganisms thoroughly  while avoiding reinfection via good three-dimensional root canal obturation.1 The  application of endodontic sealers after biomechanical cleaning, which is a common  procedure, has been used to prevent and cure periapical periodontitis.2 However, it  has been reported that even after rigid chemomechanical preparation, microorganisms  in the lateral canals, dentinal tubules, and apical ramifications still cannot be cleaned  thoroughly.3,4 If the access cavity is sealed incompletely, passages for bacteria, fluid,  and chemical substance penetration are apt to be created when the root canals are not  well obturated.5,6 This situation commonly occurs because the currently available  sealers, such as the most widely used root filling material (thermoplastisized Gutta- percha), exhibit volume shrinkage after cooling.7 The residual organisms and bacteria  from the oral cavity could rapidly reenter and proliferate in the empty canals and can  subsequently induce or sustain periapical periodontitis.8,9 To overcome these drawbacks, it is best that root canal materials with antibacterial prop - erties be used,10 as they may be efficacious for preventing the leakage of microorganisms correspondence: Jidong li research center for Nano-Biomaterials,  analytical and Testing center, sichuan  University, chengdu, sichuan, People’s  republic of china 610064 Tel +86 28 8541 8178 Fax +86 28 8541 8178 email nic1979@scu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Physicochemical and biological properties of a novel PU sealer DOI: http://dx.doi.org/10.2147/IJN.S74025",Non-OADS,/arxiv_data1/oa_pdf/8e/42/ijn-10-697.PMC4303460.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8e/42/ijn-10-697.PMC4303460.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/ijn-10-697.PMC4303460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ott-8-169.PMC4303461.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 169–176OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7439 7hMga2 is associated with epithelial– mesenchymal transition and can predict poor  prognosis in nasopharyngeal carcinoma Objective:  High-mobility group protein 2 (HMGA2) and epithelial–mesenchymal transition  (EMT)-associated proteins play key roles in cancer progression and metastasis.,Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ott-8-169.PMC4303461.pdf
"Keywords:  EMT, NPC, high-mobility group protein 2 Introduction Nasopharyngeal carcinoma (NPC) is a common malignancy with remarkably  distinctive ethnic and geographic distributions: it is highly prevalent in Southern  China and Southeast Asia.1 Among head and neck cancers, most NPC cases are lowly  differentiated or undifferentiated squamous cell carcinomas with a high tendency to  metastasize to regional lymph nodes.2,3 In addition, early metastasis to the neck is  common, with about 74.5% of patients presenting with regional lymph node metastasis  at the time of diagnosis.4 Though NPC is sensitive to radiotherapy and/or chemotherapy,  treatment failure remains high due to the development of local recurrence, lymph  nodes, and distant metastasis.5correspondence: Xia he Department of radiation Oncology,  The Affiliated Jiangsu Cancer Hospital of  nanjing Medical University, 42 Bai Zi Ting  Road, Nanjing, Jiangsu, People’s Republic  of china email hexia2003@tom.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xia et al  Running head recto: HMGA2 and EMT: prognosis in nasopharyngeal carcinoma DOI: http://dx.doi.org/10.2147/OTT.S74397 Y ou-Y ou Xia1,* li Yin2,* hao Tian1 Wen-Jie Guo2 Ning Jiang2 Xue-Song Jiang2 Jing Wu1 Meng chen1 Jian-Zhong Wu3 Xia he2 1The Fourth clinical Medical college  of nanjing Medical University,  2Department of radiation Oncology,   3research center of clinical  Oncology, The Affiliated Jiangsu  cancer hospital of nanjing Medical  University, Nanjing, Jiangsu, People’s  Republic of China *These authors contributed equally  to this paper",Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ott-8-169.PMC4303461.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ott-8-169.PMC4303461.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/e7/ott-8-169.PMC4303461.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/ijn-10-665.PMC4303462.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 665–675International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  665OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7630 7Specific targeting of A54 homing peptide- functionalized dextran- g-poly(lactic- co-glycolic  acid) micelles to tumor cells Jun-Qing Situ1 Yi-Qing Ye2 Xiu-Liang Zhu3 Ri-Sheng Yu3 Jian Y ou1 Hong Yuan1 Fu-Qiang Hu1 Y ong-Zhong Du1 1College of Pharmaceutical Sciences,   2Women’s Hospital, 3Department  of Radiology, Second Affiliated  Hospital, School of Medicine, Zhejiang  University, Hangzhou, People’s  Republic of ChinaAbstract:  The delivery of chemotherapeutics into tumor cells is a fundamental knot for  tumor-target therapy to improve the curative effect and avoid side effects.",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/ijn-10-665.PMC4303462.pdf
"Polymeric micelles possess a nano-order size distribution  varying from 20 to 100 nm.7,8 Based on their size and surface properties, micelles  have many advantages, such as the accumulation in tumors via the passive enhanced- permeability-and-retention (EPR) effect9–11 and the prolongation of circulation time  by avoiding recognition and phagocytosis by the reticuloendothelial system.12,13  However, nonspecific cellular targeting and poor cellular internalization of carriers Correspondence: Yong-Zhong Du College of Pharmaceutical Sciences,  Zhejiang University, 866 Yuhangtang  Road, Hangzhou, Zhejiang 310058,  People’s Republic of China Tel/fax +86 571 8820 8439 email duyongzhong@zju.edu.c n Ri-Sheng Yu Department of Radiology, Second  Affiliated Hospital, School of Medicine,  Zhejiang University, 80 Jiefang Road,  Hangzhou, Zhejiang 310009, People’s  Republic of China Tel/fax +86 571 8778 4556 email yurisheng2003@aliyun.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Situ et al Running head recto: A54-Dex-PLGA micelle drug delivery DOI: http://dx.doi.org/10.2147/IJN.S76307",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/ijn-10-665.PMC4303462.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4b/9c/ijn-10-665.PMC4303462.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/9c/ijn-10-665.PMC4303462.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/78/ott-8-195.PMC4303463.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 195–209OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7124 2Oncogenic mutation profiling in new lung cancer  and mesothelioma cell lines David cl lam1 susan Y luo1 Wen Deng2 Johnny sh Kwan3 Jaime rodriguez-canales4 annie lM cheung5 grace hW cheng6 chi-ho lin6 ignacio i Wistuba4 Pak c sham6 Thomas sK Wan7 sai-Wah Tsao5 1Department of Medicine, 2school of  nursing, 3Department of Psychiatry,   University of hong Kong, hong  Kong sar, People’s republic of  china; 4Department of Translational  Molecular Pathology, MD anderson  cancer center, University of Texas  at houston, houston, TX, Usa;   5Department of anatomy, 6center for  genome sciences, 7Department of  Pathology, University of hong Kong,   hong Kong sar, People’s republic of  china correspondence: David cl lam   Department of Medicine, University   of hong Kong, Queen Mary hospital,   102 Pokfulam road, hong Kong,   People’s republic of china   Tel +852 2255 4455   Fax +852 2816 2863   email dcllam@hku.h kBackground:  Thoracic tumor, especially lung cancer, ranks as the top cancer mortality in most  parts of the world.",Non-OADS,/arxiv_data1/oa_pdf/e1/78/ott-8-195.PMC4303463.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e1/78/ott-8-195.PMC4303463.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/78/ott-8-195.PMC4303463.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cb/f3/jgenv03p0001.PMC4303597.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/jgenv03p0020.PMC4303598.pdf
"A reference transcriptome of C. mac ulata   has been published to the internet (http://2ei.univ -perp.fr/?page_id=89, accessed 22  July 2014).",OADS,/arxiv_data1/oa_pdf/4c/ea/jgenv03p0020.PMC4303598.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3a/65/jgenv03p0029.PMC4303599.pdf
"1–3Here, we prefer to use the term ‘‘psychogenic’’, but a discussion of which term is more appropriate is beyond the scope of this review.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Therefore, other conditions with normal DaT-SPECT should be considered in the differential diagnosisBaizabal-Carvallo JF, Fekete R Uncommon Psychogenic Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"L-dopa-induced dyskinesias Dystonia, chorea, athetosis Hyperkinetic bizarre movements 1Tremor frequency (Hz) measured simultaneously in two different body parts.Uncommon Psychogenic Movement Disorders Baizabal-Carvallo JF, Fekete R Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Table 2.Differential Diagnosis of Conditions with Normal Dopamine Transporter Imaging with Photon Emission Tomography Psychogenic Parkinsonism Vascular parkinsonism Drug-induced parkinsonism Dystonic tremorEssential tremorOrthostatic tremor Dopa-responsive dystonia Healthy subjectsBaizabal-Carvallo JF, Fekete R Uncommon Psychogenic Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"68The mean age of onset varies between 11.5 and 14.2 years in published case series focused on this populationUncommon Psychogenic Movement Disorders Baizabal-Carvallo JF, Fekete R Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"of Patients Female–Male Mean Age or Range of Onset (years)Most Common PMDs1 Ferrara and Jankovic6854 42:12 14.2 Tremor n 535, dystonia n 529, myoclonus n 520, gait disorders n512, other n 512 Ahmed et al.3411 4:7 6.11–15.11 Tics n 56, tremor n 54, clonus n51 Schwingenschuh et al.7415 12:3 12.3 Dystonia n 57, tremor n 56, gait disorder n 52 Dale et al.6912 10:2 12.7 Tremor n 510, myoclonus n 55, dystonia n 54, tics n 51 Faust and Soman3614 11:3 13.1 Dystonia n 56, myoclonus n 53, tremor n 53, chorea n 52 Canavese et al.7114 8:6 11.5 Tremor n 55, myoclonus n 56, dystonia n 56, gait disorder n 52 1Some patients present with more than one movement disorder; therefore, frequencies may exceed the total number of studied subjects.Baizabal-Carvallo JF, Fekete R Uncommon Psychogenic Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2014;29:853–856, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 1995; 59:406–412, doi: http://dx.doi.org/10.1136/jnnp.59.4.406.3.Edwards MJ, Bhatia KP.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Lancet Neurol 2012;50:250–260, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"CNS Drugs 2004;18:437–452, doi: http://dx.doi.org/10.2165/ 00023210-200418070-00003.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Arch Neurol 1995; 52:802–810, doi: http://dx.doi.org/10.1001/archneur.1995.00540320078015.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Psychol Rep 1988;62:979–985, doi: http://dx.doi.org/10.2466/pr0.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2009;24:759–762, doi: http://dx.doi.org/10.1002/mds.22114.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Sci 2011;310:163–165, doi: http://dx.doi.org/10.1016/j.jns.2011.03.019.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2011;82:1300–1303, doi: http://dx.doi.org/10.1136/jnnp- 2011-300876.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Sci 2007;263:94–99, doi: http://dx.doi.org/10.1016/j.jns.2007.06.008.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"12.Hellmann MA, Melamed E, Steinmetz AP, Djaldetti R. Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson’s disease.Mov Disord 2010;25:924–927, doi: http://dx.doi.org/10.1002/mds.23030.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Neurology 2014;82:945–955, doi: http://dx.doi.org/10.1212/WNL.0000000000000212.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2003;18:S28–S33, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2006;21:1994– 1998, doi: http://dx.doi.org/10.1002/mds.21062.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Eur J Nucl Med 2001;28:266–272, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2010;25:560–569, doi: http://dx.doi.org/10.1002/mds.23019.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2006; 21:310–317, doi: http://dx.doi.org/10.1002/mds.20720.Uncommon Psychogenic Movement Disorders Baizabal-Carvallo JF, Fekete R Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Clin Neurol Neurosurg 2010;112:282–285, doi: http://dx.doi.org/10.1016/j.clineuro.2009.12.010.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"23.Onofrj M, Bonanni L, Manzoli L, Thomas A. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.Neurology 2010;74:1598–1606, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurosurg 2012;116:114–118, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Nat Rev Neurol 2011;7:667–676, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Handb Clin Neurol 2010;95:501–546, doi: http://dx.doi.org/10.1016/S0072-9752(08)02133-7.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2011;26:1149–1156, doi: http://dx.doi.org/10.1002/mds.23618.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"JN e u r o l 2010;257:1349–1355, doi: http://dx.doi.org/10.1007/s00415-010-5531-6.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2014;85:573– 575, doi: http://dx.doi.org/10.1136/jnnp-2013-305594.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Rev Bras Psiquiatr 2005;27:11–17, doi: http://dx.doi.org/10.1590/S1516-44462005000100006.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Dev Med Child Neurol 2008;50:300–304, doi: http://dx.doi.org/10.1111/j.1469-8749.2008.02043.x.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Child Neurol 1994;9:50–51, doi: http://dx.doi.org/10.1177/088307389400900112.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Child Neurol 2012;27:610–614, doi: http://dx.doi.org/10.1177/0883073811422753.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Child Neurol 2004;19:976–977, doi: http://dx.doi.org/10.1177/088307380401900813.38.Heintz CE, van Tricht MJ, van der Salm SM, et al.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2013;84:862–867, doi: http://dx.doi.org/10.1136/jnnp-2012- 304397.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Clin Neurophysiol 2006;117:2341–2356, doi: http://dx.doi.org/10.1016/j.clinph.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Clin Neurosci 2010;17:959–965, doi: http://dx.doi.org/10.1016/j.jocn.2009.11.021.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 1981;44:735–738, doi: http://dx.doi.org/ 10.1136/jnnp.44.8.735.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2012;83:1162–1167, doi: http://dx.doi.org/10.1136/jnnp-2012-303081.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2010;25:503–504, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2012;27:1544– 1551, doi: http://dx.doi.org/10.1002/mds.25190.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2011;26:1582–1592, doi: http://dx.doi.org/10.1002/mds.23692.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Neurology 2007;69:402–404, doi: http://dx.doi.org/10.1212/01.wnl.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Neurology 2011;76:610–614, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2012;83:202–204, doi: http://dx.doi.org/10.1136/jnnp-2011-300733.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Indian J Psychol Med 2014;36:332–334, doi: http://dx.doi.org/10.4103/ 0253-7176.127262.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Eur J Neurol 2013;20: e107–8, doi: http://dx.doi.org/10.1111/ene.12181.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Neurology 2012;78:681–682, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"org/10.1212/WNL.0b013e318248df04.Baizabal-Carvallo JF, Fekete R Uncommon Psychogenic Movement Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"AMA Archives of Ophthalmology 1959;62:864–867, doi: http://dx.doi.org/10.1001/ archopht.1959.04220050124020.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 1994;9:676–678, doi: http://dx.doi.org/10.1002/mds.870090615.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2006;21:274–276, doi: http://dx.doi.org/10.1002/ mds.20731.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2004;19:333–335, doi: http://dx.doi.org/10.1002/mds.10632.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"59.Margari F, Giannella G, Lecce PA, Fanizzi P, Toto M, Margari L. A childhood case of symptomatic essential and psychogenic palatal tremor.Neuropsychiatr Dis Treat 2011;7:223–227, doi: http://dx.doi.org/10.2147/NDT.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 1998;13:545–548, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2004;19:717–719, doi: http://dx.doi.org/10.1002/mds.20034.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2012;27:1164–1168, doi: http://dx.doi.org/10.1002/mds.24948.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2001;16:779–782, doi: http://dx.doi.org/10.1002/mds.1132.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol 2006;253:857–860, doi: http://dx.doi.org/10.1007/s00415-006-0039-9.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Am Acad Child Adolesc Psychiatry 2007;46:68–75, doi: http://dx.doi.org/10.1097/01.chi.0000242235.83140.1f.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Ann NY Acad Sci 2013;1304:40–44, doi: http://dx.doi.org/10.1111/ nyas.12298.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2008;23:1875–1881, doi: http://dx.doi.org/10.1002/mds.22220.69.Dale RC, Singh H, Troedson C, Pillai S, Gaikiwari S, Kozlowska K. A prospective study of acute movement disorders in children.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Dev Med Child Neurol 2010;52:739–748, doi: http://dx.doi.org/10.1111/j.1469-8749.2009.03598.x.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2003;18:1395–1397, doi: http://dx.doi.org/10.1002/mds.10539.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2012;27:1153–1157, doi: http://dx.doi.org/10.1002/mds.24947.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Parkinsonism Relat Disord 2014;20: 1287–1289, doi: http://dx.doi.org/10.1016/j.parkreldis.2014.09.017.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Neurologist 2007;13:87–91, doi: http://dx.doi.org/10.1097/01.nrl.0000256358.52613.cc.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2008;23:1882–1888, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"J Neurol Neurosurg Psychiatry 2014;85:220–226, doi: http://dx.doi.org/10.1136/jnnp-2013-305321.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2013;28:540–543, doi: http://dx.doi.org/10.1002/mds.25350.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2007;22:395–399, doi: http://dx.doi.org/10.1002/mds.21283.",OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Curr Opin Psychiatry 2006;19:171–174, doi: http://dx.doi.org/10.1097/01.yco.0000214343.59872.7a.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Ann Behav Med 2007;33:112–116, doi: http://dx.doi.org/10.1207/s15324796abm3301_ 13.",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Mov Disord 2013;28:1295–1298, doi: http://dx.doi.org/ 10.1002/mds.25463.Uncommon Psychogenic Movement Disorders Baizabal-Carvallo JF, Fekete R Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/26/c5/tre-05-279-6411-1.PMC4303603.pdf
"Episodes were triggered by sudden movement after a period ofinactivity such as sitting in a car or watching television on a couch.During attacks, there was dystonia of both arms and trunk with flexionFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
16p11.2 Microdeletion Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
16p11.2 Microdeletion Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Am J Hum Genet 1997;61:889–898, doi: http://dx.doi.org/ 10.1086/514877.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Nat Genet 2011;43:1252–1255, doi: http://dx.doi.org/10.1038/ng.1008.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Med Genet 2013;50: 133–139, doi: http://dx.doi.org/10.1136/jmedgenet-2012-101406.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Neurology 2009;73:479–480, doi: http://dx.doi.org/10.1212/WNL.0b013e3181b16393.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Neurology 2011; 77: 1401–1402, doi: http://dx.doi.org/10.1212/WNL.0b013e31823152d7.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Dev Med Child Neurol 2012;54:618– 623, doi: http://dx.doi.org/10.1111/j.1469-8749.2012.04287.x.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Neurogenetics 2013;14:251–253, doi: http://dx.doi.org/10.1007/s10048-013-0376-7.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"N Engl J Med 2008;358:667–675, doi: http://dx.doi.org/10.1056/NEJMoa075974.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Med Genet 2010;47:195–203, doi: http://dx.doi.org/10.1136/jmg.2009.069369.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Med Genet 2010; 47:332–341, doi: http://dx.doi.org/10.1136/jmg.2009.073015.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Eur J Med Genet 2009;52:77–87, doi: http://dx.doi.org/10.1016/j.ejmg.2009.03.006.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Nature 2009;459:569–573, doi: http://dx.doi.org/10.1038/nature07953.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Dev Behav Pediatr 2010;31: 649–657, doi: http://dx.doi.org/10.1097/DBP.0b013e3181ea50ed.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Med Genet 2012;49:660–668, doi: http://dx.doi.org/10.1136/jmedgenet-2012-101203.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"PLoS One2012;7:e38543, doi: http://dx.doi.org/10.1371/journal.pone.0038543.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Neurology 2012;79:170–174, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Neurol 2013;260:93–99, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Eur J Neurol 2014;21:174–176, doi: http://dx.doi.org/10.1111/ene.12122.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Brain 2011;134:3493–3501, doi: http://dx.doi.org/10.1093/brain/awr289.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Am J Hum Genet 2012;90:152–160, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"J Neurodev Disord 2010;2:26– 38, doi: http://dx.doi.org/10.1007/s11689-009-9037-4.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Am J Hum Genet 2008;82:477–488, doi: http://dx.doi.org/10.1016/j.ajhg.2007.12.009.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Nature 2010;463:671– 675, doi: http://dx.doi.org/10.1038/nature08727.",Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Hum Mol Genet 2013; 22:1625–1631, doi: http://dx.doi.org/10.1093/hmg/ddt012.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
16p11.2 Microdeletion Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Am J Hum Genet 2011;89: 767–772, doi: http://dx.doi.org/10.1016/j.ajhg.2011.10.016.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Am J Hum Genet 2011;89:760–766, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Nucleic Acids Res 2014;42:D986–992, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"Genet Med 2005;7:650–654, doi: http://dx.doi.org/10.1097/01.",OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/34/8b/tre-04-274-6230-1.PMC4303604.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)SAR11 ecotype dynamics in NW Mediterranean I Salter et al 360 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/27/96/ismej2014129a.PMC4303628.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Structure and gene flow in a microbial eukaryote S Knight and MR Goddard 370 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/2f/11/ismej2014132a.PMC4303630.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Early redox perturbation predicts cell fate SG van Creveld et al 395 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/ismej2014136a.PMC4303632.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Physicochemical impacts on subsurface methanogens T Katayama et al 446 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/86/cf/ismej2014140a.PMC4303636.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Single-cell analysis of diazotrophs in mats D Woebken et al 496 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/3f/5a/ismej2014144a.PMC4303640.pdf
"Key Words : Intraoperative neurophysiological monitoring · Somatosensory evoked potentials · Slope-measure · Single trials · Temporary clipping.Laboratory Investigation • Received : July 8, 2014  • Revised : September 15, 2014  • Accepted : September 15, 2014 • Address for reprints : Chun Kee Chung, M.D., Ph.D.  Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel : +82-2-2072-2352,  Fax : +82-2-744-8459,  E-mail : chungc@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 455-462, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.455 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/7f/3d/jkns-56-455.PMC4303719.pdf
"Department of Diagnostic Radiology, Busan Paik Hospital, Inje University, 75 Bokji-ro, Busanjin-gu, Busan 614-734, Korea  Tel : +82-51-890-6547,  Fax : +82-51-896-1085,  E-mail : hwjeong2000@lycos.co.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 463-468, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.463 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/a8/cd/jkns-56-463.PMC4303720.pdf
"Key Words : Transforaminal lumbar interbody fusion · Direct lumbar interbody fusion · Segmental balance · Coronal balance · Fusion rate.Clinical Article • Received : March 26, 2014  • Revised : June 19, 2014  • Accepted : July 7, 2014 • Address for reprints : Young Baeg Kim, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea  Tel : +82-2-6299-1607,  Fax : +82-2-6299-2069,  E-mail : ybkim1218@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 469-474, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.469 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/8f/63/jkns-56-469.PMC4303721.pdf
"Department of Neurosurgery, St. Vincent’s Hospital, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea  Tel : +82-31-249-7196,  Fax : +82-31-249-5208,  E-mail : jatagi15@paran.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 475-481, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.475 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/0c/80/jkns-56-475.PMC4303722.pdf
"Key Words : Chronic low back pain · Public health · Quality of life · Health surveys.Clinical Article • Received : June 7, 2014  • Revised : August 25, 2014  • Accepted : September 9, 2014 • Address for reprints : Kyeong-Seok Lee, M.D., Ph.D.  Department of Neurosurgery, Soonchunhyang University Cheonan Hospital, 50 Suncheonhyang 4-gil, Dongnam-gu, Cheonan 330-930, Korea  Tel : +82-41-570-3652,  Fax : +82-41-572-9297,  E-mail : ksleens@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 482-487, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.482 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/69/42/jkns-56-482.PMC4303723.pdf
"Clinical Article • Received : November 13, 2013  • Revised : January 2, 2014  • Accepted : March 31, 2014 • Address for reprints : Seok Won Kim, M.D., Ph.D.  Department of Neurosurgery, School of Medicine, Chosun University, 365 Pilmun-daero, Dong-gu, Gwangju 501-717, Korea  Tel : +82-62-220-3126,  Fax : +82-62-227-4575,  E-mail : chosunns@chosun.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 488-491, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.488 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/jkns-56-488.PMC4303724.pdf
"Key Words : Moyamoya disease · Cerebral hemorrhage · Therapeutic embolization.Case Report • Received : January 18, 2014  • Revised : March 14, 2014  • Accepted : March 19, 2014 • Address for reprints : Gyojun Hwang, M.D., Ph.D.  Department of Neurosurgery, Seoul National University Bundang Hospital, 82 Gumi-ro 173-gil, Bundang-gu, Seongnam 463-707, Korea  Tel : +82-31-787-7168,  Fax : +82-31-787-4097,  E-mail : storynlemon@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 492-495, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.492 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/1f/20/jkns-56-492.PMC4303725.pdf
"Department of Neurosurgery, Daegu Catholic University Hospital, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea  Tel : +82-53-650-4258,  Fax : +82-53-650-4932,  E-mail : fhjhcho@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 496-499, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.496 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/4c/5e/jkns-56-496.PMC4303726.pdf
"Key Words : Anterior choroidal artery · Blood blister-like aneurysm · Surgical technique.Case Report • Received : June 7, 2014  • Revised : August 11, 2014  • Accepted : August 31, 2014 • Address for reprints : Jaechan Park, M.D., Ph.D.  Department of Neurosurgery, Kyungpook National University Hospital, 50 Samdeok 2-ga, Jung-gu, Daegu 700-721, Korea  Tel : +82-53-200-5647,  Fax : +82-53-423-0504,  E-mail : jparkmd@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 500-503, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.500 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/91/cf/jkns-56-500.PMC4303727.pdf
"Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-6353,  Fax : +82-2-594-4248,  E-mail : jhyun@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 504-508, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.504 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/1b/8d/jkns-56-504.PMC4303728.pdf
"Key Words : Atypical · Intraosseous · Meningioma · Osteolysis.Case Report • Received : June 19, 2014  • Revised : July 1, 2014  • Accepted : October 28, 2014 • Address for reprints : Sang-Koo Lee, M.D., Ph.D.  Department of Neurosurgery, Dankook University College of Medicine, 201 Manghyang-ro, Dongnam-gu, Cheonan 330-715, Korea  Tel : +82-41-550-6280,  Fax : +82-41-552-6870,  E-mail : lsk999999@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 509-512, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.509 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/6f/31/jkns-56-509.PMC4303729.pdf
"Department of Neurosurgery, Busan Paik Hospital, Inje University School of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 614-735, Korea  Tel : +82-51-890-6144,  Fax : +82-51-898-4244,  E-mail : 106304@paik.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 513-516, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.513 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/9f/51/jkns-56-513.PMC4303730.pdf
"Key Words : Ankylosing spondylitis · Cauda equina syndrome · Dural ectasia · Filum terminale.Case Report • Received : June 5, 2014  • Revised : August 15, 2014  • Accepted : August 31, 2014 • Address for reprints : Byung-chul Son, M.D., Ph.D.  Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, 222 Banpo-daero,    Seocho-gu,  Seoul 137-701, Korea  Tel : +82-2-2258-6122,  Fax : +82-2-594-4248,  E-mail : sbc@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 517-520, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.517 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/02/1e/jkns-56-517.PMC4303731.pdf
"Key Words : Epidural gas · Vacuum phenomenon · Lumbar spine · Recurrent radiculopathy · Spinal surgery.Case Report • Received : April 14, 2014  • Revised : July 7, 2014  • Accepted : July 10, 2014 • Address for reprints : Chul-Woo Lee, M.D., Ph.D.  Department of Neurosurgery, St. Peter’s Hospital, 2633 Nambusunhwan-ro, Gangnam-gu, Seoul 135-859, Korea  Tel : +82-2-1544-7522,  Fax : +82-2-574-9414,  E-mail : mannitol240@gmail.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 521-526, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.521 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/jkns-56-521.PMC4303732.pdf
"Department of Neurosurgery and Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, 305 Gudeok-ro, Seo-gu,    Busan 602-739,  Korea  Tel : +82-51-240-7257,  Fax : +82-51-244-0282,  E-mail : farlateral@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 527-530, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.527 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/25/5d/jkns-56-527.PMC4303733.pdf
"Key Words : Traumatic subarachnoid hemorrhage · Anterior choroidal artery · Transection · Angiography · Cadaver.Case Report • Received : May 22, 2014  • Revised : August 14, 2014  • Accepted : August 21, 2014 • Address for reprints : Sukh Que Park, M.D., Ph.D.  Department of Neurosurgery, Soonchunhyang University Hospital Seoul, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743,    Korea  Tel : +82-2-709-9088,  Fax : +82-2-792-5976,  E-mail : drcolor@schmc.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 531-533, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.531 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/0f/aa/jkns-56-531.PMC4303734.pdf
"Key Words : Trauma · Resuscitation · Heart arrest · Fracture.Case Report • Received : April 23, 2014  • Revised : September 8, 2014  • Accepted : September 9, 2014 • Address for reprints : Jung Soo Kim, M.D., Ph.D.  Department of Neurosurgery, Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeun-daero, Haeundae-gu, Busan 612-896, Korea  Tel : +82-51-797-0628,  Fax : +82-51-787-0841,  E-mail : jheaj@paik.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 534-536, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.534 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/0a/45/jkns-56-534.PMC4303735.pdf
"Key Words : Head · Injury · Penetrating.Case Report • Received : December 16, 2013  • Revised : January 10, 2014  • Accepted : February 1, 2014 • Address for reprints : Seok Won Kim, M.D., Ph.D.  Department of Neurosurgery, School of Medicine, Chosun University, 365 Pilmun-daero, Dong-gu, Gwangju 501-717, Korea  Tel : +82-62-220-3126,  Fax : +82-62-227-4575,  E-mail : chosunns@chosun.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 )     which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 56  (6) : 537-539, 2014http://dx.doi.org/10.3340/jkns.2014.56.6.537 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/e1/4f/jkns-56-537.PMC4303736.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Review Obstet Gynecol Sci 2015;58(1):1-9 http://dx.doi.org/10.5468/ogs.2015.58.1.1pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 1Introduction A first-trimester ultrasound scan has become an essential part  of antenatal care.,Non-OADS,/arxiv_data1/oa_pdf/33/07/ogs-58-1.PMC4303746.pdf
Available from: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/Patien - tAlerts/ucm064756.htm.,Non-OADS,/arxiv_data1/oa_pdf/33/07/ogs-58-1.PMC4303746.pdf
Available from: http://fetalanomaly.screen - ing.nhs.uk/fetalanomalyresource/images/stories/Down -loads/2.5.1_safe_environment/bmus-safety-guidelines-2009-revision-final-nov-2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/07/ogs-58-1.PMC4303746.pdf
Original Article Obstet Gynecol Sci 2015;58(1):10-16 http://dx.doi.org/10.5468/ogs.2015.58.1.10pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 10Introduction Preeclampsia complicates approximately 5% of pregnancies and  constitutes a major cause of maternal and neonatal morbidity and mortality.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ogs-58-10.PMC4303747.pdf
Original Article Obstet Gynecol Sci 2015;58(1):17-23 http://dx.doi.org/10.5468/ogs.2015.58.1.17pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 17Introduction The aortic isthmus (AoI) is the vascular segment located between  the origin of the left subclavian artery and the aortic end of the ductus arteriosus.,Non-OADS,/arxiv_data1/oa_pdf/80/05/ogs-58-17.PMC4303748.pdf
Original Article Obstet Gynecol Sci 2015;58(1):24-31 http://dx.doi.org/10.5468/ogs.2015.58.1.24pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 24Introduction Meconium aspiration syndrome (MAS) is a life-threatening dis - ease that affects some neonates born with meconium staining  [1-6].,Non-OADS,/arxiv_data1/oa_pdf/6d/d4/ogs-58-24.PMC4303749.pdf
Original Article Obstet Gynecol Sci 2015;58(1):32-39 http://dx.doi.org/10.5468/ogs.2015.58.1.32pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 32Introduction Krukenberg tumor (KT) refers to a malignancy in the ovary  that metastasized from a primay site.,Non-OADS,/arxiv_data1/oa_pdf/39/95/ogs-58-32.PMC4303750.pdf
"Original Article Obstet Gynecol Sci 2015;58(1):40-45 http://dx.doi.org/10.5468/ogs.2015.58.1.40pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 40Introduction Cervical cancer is the second most common cancer in women  worldwide, and 80% of cases occur in developing countries [1].",Non-OADS,/arxiv_data1/oa_pdf/6b/a5/ogs-58-40.PMC4303751.pdf
Original Article Obstet Gynecol Sci 2015;58(1):46-52 http://dx.doi.org/10.5468/ogs.2015.58.1.46pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 46Introduction Osteoporosis is an important health problem and a major pre - disposing factor for fracture.,Non-OADS,/arxiv_data1/oa_pdf/d9/0b/ogs-58-46.PMC4303752.pdf
Original Article Obstet Gynecol Sci 2015;58(1):53-58 http://dx.doi.org/10.5468/ogs.2015.58.1.53pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 53Introduction Endometriosis is a common gynecologic condition occurring in  10% to 15% of women of reproductive age and is associated with decreased fecundity [1].,Non-OADS,/arxiv_data1/oa_pdf/c6/45/ogs-58-53.PMC4303753.pdf
Original Article Obstet Gynecol Sci 2015;58(1):59-64 http://dx.doi.org/10.5468/ogs.2015.58.1.59pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 59Introduction Korea is one of the most rapidly aging countries in the world.,Non-OADS,/arxiv_data1/oa_pdf/7b/0d/ogs-58-59.PMC4303754.pdf
"Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(1):65-68 http://dx.doi.org/10.5468/ogs.2015.58.1.65pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 65Introduction Epignathus or oral teratoma is an extremely rare congenital  tumor, which arises in the sphenoid region of the palate or pharynx, occurring in 1 in 35,000 to 1 in 200,000 live births [1].",Non-OADS,/arxiv_data1/oa_pdf/88/db/ogs-58-65.PMC4303755.pdf
"Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(1):69-72 http://dx.doi.org/10.5468/ogs.2015.58.1.69pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 69Introduction Peritoneal carcinoma is a rare disease with nonspecific symp - toms which were pelvic pain, abdominal pain, constipation,  bloating, indigestion and abdominal distention.",Non-OADS,/arxiv_data1/oa_pdf/c4/e3/ogs-58-69.PMC4303756.pdf
Available from: http://www.foundationfor - womenscancer.org/wp-content/uploads/CA125levels.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/e3/ogs-58-69.PMC4303756.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(1):73-76 http://dx.doi.org/10.5468/ogs.2015.58.1.73pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 73Introduction Solitary fibrous tumors (SFTs) are uncommon soft-tissue tu - mors.,Non-OADS,/arxiv_data1/oa_pdf/b1/03/ogs-58-73.PMC4303757.pdf
Copyright © 2015 Korean Society of Obstetrics and Gynecology Case Report Obstet Gynecol Sci 2015;58(1):77-79 http://dx.doi.org/10.5468/ogs.2015.58.1.77pISSN 2287-8572 · eISSN 2287-8580www.ogscience.org 77Introduction Carvenous lymphangioma (CL) is extremely rare benign tumor  of the vulva.,Non-OADS,/arxiv_data1/oa_pdf/d9/87/ogs-58-77.PMC4303758.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/5e/srep07997.PMC4303864.pdf
Methods Data .We used the USDA Forest Service Forest Inventory and Analysis data for our analysis (http://apps.fs.fed.us/fiadb-downloads/datamart.html).,OADS,/arxiv_data1/oa_pdf/7e/fb/srep08002.PMC4303866.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7e/fb/srep08002.PMC4303866.pdf
"Discussion In humans, meta-analyses of gene expression (NCBI GeneExpression Omnibus, http://lifesciencedb.jp/geo/) show that thenegative Rap regulator SIPA1 is one of the most prominently under-expressed genes in T-ALL (Figure S5).",Non-OADS,/arxiv_data1/oa_pdf/21/9a/srep07978.PMC4303867.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/9a/srep07978.PMC4303867.pdf
"The well-knownpowerful inhibitor, EGCG, which is in Phase III clinical trial for treating AD (http://www.clinicaltrials.gov), was chosen to comparewith brazilin for their inhibitory capacities.",Non-OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
The snapshot is plotted by visua l molecular dynamics (VMD) software (http://www.ks.uiuc.edu/Research/vmd/).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7992 | DOI: 10.1038/srep07992 4,OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
The snapshots are plotted by visual molecular dynamics (VMD) software (http://www.ks.uiuc.edu/Research/vmd/).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7992 | DOI: 10.1038/srep07992 6,OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
The initial structure of brazilin was taken fromthe PubChem Compound Database (http://www.ncbi.nlm.nih.gov/pccompound).,OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
The snapshots of simulation trajectories were visualized using visual molecular dynamics (VMD) software (http://www.ks.uiuc.edu/Research/vmd/)61.,OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7992 | DOI: 10.1038/srep07992 10",Non-OADS,/arxiv_data1/oa_pdf/70/e0/srep07992.PMC4303869.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/21/srep07999.PMC4303870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7999 | DOI: 10.1038/srep07999 10",Non-OADS,/arxiv_data1/oa_pdf/d3/21/srep07999.PMC4303870.pdf
(http://www.pymol.org).,Non-OADS,/arxiv_data1/oa_pdf/96/9c/srep07995.PMC4303873.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/9c/srep07995.PMC4303873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7995 | DOI: 10.1038/srep07995 8",Non-OADS,/arxiv_data1/oa_pdf/96/9c/srep07995.PMC4303873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7976 | DOI: 10.1038/srep07976 8",Non-OADS,/arxiv_data1/oa_pdf/5a/47/srep07976.PMC4303874.pdf
Additional information Data Accession Microarray data have been deposited to GEO databases (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/5b/7c/srep07994.PMC4303876.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/7c/srep07994.PMC4303876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7994 | DOI: 10.1038/srep07994 10",Non-OADS,/arxiv_data1/oa_pdf/5b/7c/srep07994.PMC4303876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8000 | DOI: 10.1038/srep08000 7",Non-OADS,/arxiv_data1/oa_pdf/8c/8f/srep08000.PMC4303878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7988 | DOI: 10.1038/srep07988 8",Non-OADS,/arxiv_data1/oa_pdf/71/7f/srep07988.PMC4303881.pdf
wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a2/dc/srep07984.PMC4303883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7984 | DOI: 10.1038/srep07984 11",Non-OADS,/arxiv_data1/oa_pdf/a2/dc/srep07984.PMC4303883.pdf
http://www.who.int/influenza/ vaccines/use/en/ (2014) 15/05/2014.,Non-OADS,/arxiv_data1/oa_pdf/f2/ba/srep07648.PMC4303884.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/ba/srep07648.PMC4303884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7991 | DOI: 10.1038/srep07991 4",Non-OADS,/arxiv_data1/oa_pdf/03/b1/srep07991.PMC4303895.pdf
All authors commented on the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/21/srep07996.PMC4303896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7996 | DOI: 10.1038/srep07996 7",Non-OADS,/arxiv_data1/oa_pdf/5b/21/srep07996.PMC4303896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7977 | DOI: 10.1038/srep07977 8",Non-OADS,/arxiv_data1/oa_pdf/b5/9f/srep07977.PMC4303898.pdf
"Retrieved February 20, 2013 from http://www.google.no/books.",Non-OADS,/arxiv_data1/oa_pdf/5c/37/dys0020-0146.PMC4303915.pdf
"Journal of Experimental Child Psychology ,35(2), 345 – 367. doi: http://dx.doi.org/10.1016/ 0022-0965(83)90087-5162 A. Farukh and M. Vulchanova © 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5c/37/dys0020-0146.PMC4303915.pdf
"doi: http://dx.doi.org/10.1016/0749-596X(89)90044-2 Georgiou, G. K., Parrila, R., & Kirby, J. R. (2009).",OADS,/arxiv_data1/oa_pdf/5c/37/dys0020-0146.PMC4303915.pdf
cAMP regulates lipolysis in adipocytes by activating protein kinase A that phos- Correspondence to : Soﬁa Tapani (Telephone: +46-31-7762670; Fax: +46-31- 7724260; E-mail: Soﬁa.Tapani@astrazeneca.com) This article contains supplementary material available from the authors upon request or via the Internet at http://onlinelibrary.wiley.com/.,Non-OADS,/arxiv_data1/oa_pdf/33/51/jps0103-2571.PMC4303919.pdf
"2012a) from the interactive website, the UK’s Communication T rust (see http://www.thecommunicationtrust.org.uk/schools/ what-works).",Non-OADS,/arxiv_data1/oa_pdf/ea/3e/jlcd0049-0416.PMC4303922.pdf
"Science Daily ,2A p r i l (available at: http://www.sciencedaily.com/ releases/2013/04/130402182454.htm).",Non-OADS,/arxiv_data1/oa_pdf/ea/3e/jlcd0049-0416.PMC4303922.pdf
Edn) (Geneva: World Health Or- ganization) (available at: http://apps.who.int/classiﬁcations/ icd10/browse/2010/en).,Non-OADS,/arxiv_data1/oa_pdf/ea/3e/jlcd0049-0416.PMC4303922.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/24/srep07983.PMC4303926.pdf
"The MODIS data were obtained from the NASA Land Processes DistributedActive Archive Center (LP DAAC),located at the USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, SD, USA (http://lpdaac.usgs.gov).",OADS,/arxiv_data1/oa_pdf/95/ac/wrcr0050-8791.PMC4303930.pdf
[Available at http://www.R-project.org.],Non-OADS,/arxiv_data1/oa_pdf/95/ac/wrcr0050-8791.PMC4303930.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/06/srep07974.PMC4303938.pdf
"The DICOM images were converted to the NIfTI image format using the dcm2nii software(McCausland Centre, Columbia, SC, http://www.mccauslandcenter.sc.",OADS,/arxiv_data1/oa_pdf/23/6a/sjop0056-0001.PMC4303944.pdf
Available at: http://www.socialst yrelsen.se/publikationer2013/2013  -5-32.,Non-OADS,/arxiv_data1/oa_pdf/78/c7/TONURSJ-8-71.PMC4303953.pdf
Availiable at: http://www.socialst yrelsen.se/publikationer2009/200  9-12-6.,Non-OADS,/arxiv_data1/oa_pdf/78/c7/TONURSJ-8-71.PMC4303953.pdf
Availiable at: http://www.fo unu.nu/publicera t/rapporter/523- slutrapport-palliativ-v-i-so-pvis.,Non-OADS,/arxiv_data1/oa_pdf/78/c7/TONURSJ-8-71.PMC4303953.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/87/TONEUJ-8-22.PMC4303956.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/7f/92/jcph0055-0230.PMC4303958.pdf
"http://www.fda.gov/down- loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidan- ces/ucm072109.pdf Accessed August 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/92/jcph0055-0230.PMC4303958.pdf
"Analysis was using an in-house pipeline, where FASTQ ﬁles were aligned using Burrows – Wheeler Aligner 1and indexed with SAMtools (http://sam- tools.sourceforge.net/).2Variant calling was performed with VarScan (http://varscan.sourceforge.net/),3,4and VCF ﬁles were annotated with Variant Effect Predictor (http://www.ensembl.org).",OADS,/arxiv_data1/oa_pdf/7c/36/bjd0172-0262.PMC4303979.pdf
predicted in silico as possibly damaging (Polyphen score 0.799; http://genetics.bwh.harvard.edu/pph2/) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/36/bjd0172-0262.PMC4303979.pdf
"Sonis and Musselman  (http://www.ijdr.in/article.asp?issn=0970‑9290;year  =2011;volume=22;issue=3;spage=454;epage=461 ;aulast=Adeyemo ‑ ref57) reported an average of 29.1  bleeding events per year in hemophilia patients, of",OADS,/arxiv_data1/oa_pdf/3c/44/JISPCD-4-147.PMC4304051.pdf
Available from: http://www.sciencecases.org/hemo/hemo.,Non-OADS,/arxiv_data1/oa_pdf/3c/44/JISPCD-4-147.PMC4304051.pdf
Available from:  http://hematology.im.wustl.edu/conferences/presentations  [Last accessed on 2014 Apr 2] 22.,Non-OADS,/arxiv_data1/oa_pdf/3c/44/JISPCD-4-147.PMC4304051.pdf
Available from: <http://www.halimeter.com/kb/ index.php?article=2>.,OADS,/arxiv_data1/oa_pdf/97/f7/JISPCD-4-178.PMC4304056.pdf
"This is an Open Access article distributed under theterms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/35/ciu749.PMC4304363.pdf
Available at: http://www.census.gov/ compendia/statab/2012/tables/12s1103.pdf .,OADS,/arxiv_data1/oa_pdf/15/35/ciu749.PMC4304363.pdf
Available at: http://www.cdc.gov/ ﬂu/professionals/infectioncontrol/healthcaresettings.htm .,Non-OADS,/arxiv_data1/oa_pdf/15/35/ciu749.PMC4304363.pdf
Available at: http://clinicaltrials.gov/show/NCT01249625 .,Non-OADS,/arxiv_data1/oa_pdf/15/35/ciu749.PMC4304363.pdf
Available at: http://www.childrenscolorado.org/File%20Library/ Health-Pros/Publications/Contagious%20Comments/Contagious- Comments-November-December-20 13-14-Respiratory-Season.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/35/ciu749.PMC4304363.pdf
"Copy number analysis using the HumanOmni1-Quad BeadChip (Illumina, San Diego, CA) and Global Parameter Hidden Markov Model (http://bioinformatics.ustc.edu.cn/gphmm/;Li et al., 2011) revealed copy number alterations in chromosome 3 in all 91 clear cell RCCs in the initial and second cohorts (with three exceptions, Supporting Information Tables S1 and S2 and Supporting Information Fig.",OADS,/arxiv_data1/oa_pdf/74/c1/gcc0053-1018.PMC4304365.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2014 |  89  | e51750 | Page 1 of 13Video Article Simultaneous Long-term Recordings at Two Neuronal Processing Stages in Behaving Honeybees Martin Fritz Brill1, Maren Reuter1, Wolfgang Rössler1, Martin Fritz Strube-Bloss1 1Department of Behavioral Physiology and Sociobiology (Zoology II) Biozentrum, University of Würzburg Correspondence to: Martin Fritz Brill at martin.brill@biozentrum.uni-wuerzburg.de , Martin Fritz Strube-Bloss at martin.strube-bloss@uni- wuerzburg.de URL: http://www.jove.com/video/51750 DOI: doi:10.3791/51750 Keywords: Neuroscience, Issue 89, honeybee brain, olfaction, extracellular long term recordings, double recordings, differential wire electrodes, single unit, multi-unit recordings Date Published: 7/21/2014 Citation: Brill, M.F., Reuter, M., Rössler, W., Strube-Bloss, M.F.",Non-OADS,/arxiv_data1/oa_pdf/52/ef/jove-89-51750.PMC4304372.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51750/ Introduction Honeybees as well as most other insects heavily rely on olfaction.,Non-OADS,/arxiv_data1/oa_pdf/52/ef/jove-89-51750.PMC4304372.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/f8/cku086.PMC4304375.pdf
Available at: http://globocan.iarc.fr (12 December 2012 date last accessed).Factors affecting breast cancer treatment delay in Turkey 13,Non-OADS,/arxiv_data1/oa_pdf/2a/f8/cku086.PMC4304375.pdf
"Available at: http://factfinder2.census.gov (18 July 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/2a/f8/cku086.PMC4304375.pdf
Available at: http://www.breastcancer.org (July 2013 date last accessed).,Non-OADS,/arxiv_data1/oa_pdf/2a/f8/cku086.PMC4304375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/c0/mdu459.PMC4304377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/fa/mdu519.PMC4304378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/66/mdu526.PMC4304379.pdf
"http://ctep.cancer.gov/protocol Development/electronic_applications/ctc.htm#ctc_archive:2006 (28 Nov 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/0f/66/mdu526.PMC4304379.pdf
"Geriatric Depression Scale and scoring guide- lines, http://www.stanford.edu/~yesavage/GDS.english.long.",Non-OADS,/arxiv_data1/oa_pdf/4a/6d/10.1177_2050312114546520.PMC4304392.pdf
The invitation e-mail gave both  the survey link (https://www.surveymonkey.com/ politicadevisitaUTI) and the access password.,OADS,/arxiv_data1/oa_pdf/54/67/rbti-26-04-0339.PMC4304460.pdf
http://www.amib.org.br/fileadmin/CensoAMIB2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/67/rbti-26-04-0339.PMC4304460.pdf
Available from: http://www.ihi.org/Engage/Initiatives/ Completed/5MillionLivesCampaign/Pages/default.aspx  11.,Non-OADS,/arxiv_data1/oa_pdf/2d/de/rbti-26-04-0355.PMC4304462.pdf
Retrieved from http://www.clasa-anestesia.org/site/version/docs/SBA.,Non-OADS,/arxiv_data1/oa_pdf/09/bc/rbti-26-04-0373.PMC4304465.pdf
Available from http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/ Ch06_Searching.pdf,OADS,/arxiv_data1/oa_pdf/9e/dc/rbti-26-04-0397.PMC4304469.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs310/en/   2.,Non-OADS,/arxiv_data1/oa_pdf/6d/5e/rbti-26-04-0410.PMC4304471.pdf
Disponível  em: http://www2.datasus.gov.br/DATASUS/index.php?area=02.,OADS,/arxiv_data1/oa_pdf/e3/dc/rbti-26-04-0421.PMC4304473.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/5b/dddt-9-525.PMC4304484.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 525–535Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  525Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7128 9rare sugar d-psicose prevents progression  and development of diabetes in T2DM model  Otsuka long-evans T okushima Fatty rats akram hossain1,2 Fuminori Yamaguchi1 Kayoko hirose1 T oru Matsunaga3 li sui1 Yuko hirata1 chisato noguchi1 ayako Katagi1 Kazuyo Kamitori1 Y ouyi Dong1 ikuko Tsukamoto4 Masaaki T okuda1 1Department of cell Physiology,   Faculty of Medicine, Kagawa  University, ikenobe, Miki, Kagawa,   Japan; 2research and Development,   Matsutani chemical industry co.,   ltd., Kitaitami, itami- shi, hyogo,   Japan; 3Division of hospital Pathology,   Faculty of Medicine, Kagawa  University, ikenobe, Miki, Kagawa,   Japan; 4Department of Pharmaco- Bio-informatics, Faculty of Medicine,   Kagawa University, ikenobe, Miki,   Kagawa, JapanBackground:  The fundamental cause of overweight and obesity is consumption of calorie-dense  foods.",Non-OADS,/arxiv_data1/oa_pdf/3b/5b/dddt-9-525.PMC4304484.pdf
"Following this, type 2 diabetes mellitus (T2DM) inevitably arises, which war - rants attentive consideration of the vital role of food for prevention and treatment.correspondence: akram hossain Department of cell Physiology, Faculty  of Medicine, Kagawa University,  1750-1 ikenobe, Miki, Kagawa,  761-0793, Japan Tel +81 87 891 2095 Fax +81 87 891 2096 email hossain@med.kagawa-u.ac.j p Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hossain et al Running head recto: d-Psicose prevents diabetes development DOI: http://dx.doi.org/10.2147/DDDT.S71289",Non-OADS,/arxiv_data1/oa_pdf/3b/5b/dddt-9-525.PMC4304484.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3b/5b/dddt-9-525.PMC4304484.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/5b/dddt-9-525.PMC4304484.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 561–566Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  561Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7449 7stability of refrigerated miglustat after preparation  in inOrpha® flavored suspending excipient for  compounding of oral solutions and suspensions sofyen riahi Michael ambühl Jürgen stichler Dirk Bandilla actelion Pharmaceuticals ltd,   allschwil, switzerlandBackground:  Miglustat (Zavesca®) is an oral treatment for type 1 Gaucher disease and  Niemann–Pick disease type C. Patients with Niemann–Pick disease type C often have difficul - ties swallowing, and miglustat has an unpleasant taste.",Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
"For NP-C, the standard dose for  adults and adolescents is 200 mg three times a day and for patients under the age of 12   the dose should be adjusted on the basis of body surface area.1correspondence: Dirk Bandilla actelion Pharmaceuticals ltd,  gewerbestrasse 16, 4123 allschwil,  switzerland Tel +41 61 565 6004 email dirk.bandilla@actelion.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Riahi et al Running head recto: Stability of miglustat in InOrpha® suspending excipient DOI: http://dx.doi.org/10.2147/DDDT.S74497",Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
Available from: http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/a2/31/dddt-9-561.PMC4304488.pdf
Patient profiles of hepatic adenosquamous carcinoma ob served in Kormed (http://koreamed.org) search Patient no.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kjhbps-17-38.PMC4304502.pdf
Few primary hepatic ASC cases were observed in  Kormed (http://koreamed.org) search from 2000 to pres-ent; the first case presented cholangiocarcinoma with ab-scess in the liver and was confirmed as ASC postoper-atively.,Non-OADS,/arxiv_data1/oa_pdf/d8/d5/kjhbps-17-38.PMC4304502.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-11-079.PMC4304530.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 79–91Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  79ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S5053 6Scaffolds in vascular regeneration:   current status Neelima Thottappillil Prabha D Nair Division of Tissue engineering   and Regeneration T echnologies,   Biomedical Technology wing, Sree  Chitra Tirunal institute for Medical  Sciences and T echnology, Kerala, india Correspondence: Prabha D Nair   Division of Tissue engineering and  Regeneration T echnologies, Biomedical  T echnology wing, Sree Chitra  Tirunal institute for Medical Sciences  and T echnology, Poojapura, Kerala,  695012, india   email pdnair49@gmail.co mAbstract:  An ideal vascular substitute, especially in ,6 mm diameter applications, is a major  clinical essentiality in blood vessel replacement surgery.",Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-11-079.PMC4304530.pdf
Available from: http://www.who.int /mediacentre/   factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-11-079.PMC4304530.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-11-079.PMC4304530.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-11-079.PMC4304530.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/5f/bctt-7-009.PMC4304531.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 9–19Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  9Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4393 2epithelial-to-mesenchymal transition in breast  cancer: a role for insulin-like growth factor i   and insulin-like growth factor–binding protein 3?,Non-OADS,/arxiv_data1/oa_pdf/0d/5f/bctt-7-009.PMC4304531.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/0d/5f/bctt-7-009.PMC4304531.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/dddt-9-519.PMC4304532.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 519–523Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  519Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7367 0assessment of prescribing, dispensing, and patient  use pattern of antihypertensive drugs for patients  attending outpatient department of hiwot Fana  specialized University hospital, harar,   eastern ethiopia Fedila shukrala1 T esfaye gabriel2 1Dil chora referral hospital, Dire  Dawa, ethiopia; 2Department of  Pharmaceutics and social Pharmacy,   school of Pharmacy, college of health  sciences, addis ababa University,   addis ababa, ethiopiaBackground:  Hypertension is a global concern and is one of the key preventable risk factors  for cardiovascular events, resulting in unnecessary morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/dddt-9-519.PMC4304532.pdf
"Keywords:  hypertension, antihypertensive drugs, monotherapy, combination therapy, fixed  dose combination, compliance Introduction Background information Hypertension is a major global concern and public health problem affecting more than  one billion individuals worldwide and is one of the key preventable risk factors for correspondence: Tesfaye gabriel Department of Pharmaceutics and social  Pharmacy, school of Pharmacy, college of  health sciences, addis ababa University,  PO Box 1176, addis ababa, ethiopia Tel +251 91 204 9154 email tesfu.gabriel@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shukrala and Gabriel Running head recto: Antihypertensive drug use pattern DOI: http://dx.doi.org/10.2147/DDDT.S73670",Non-OADS,/arxiv_data1/oa_pdf/13/ed/dddt-9-519.PMC4304532.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/dddt-9-519.PMC4304532.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/ed/dddt-9-519.PMC4304532.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 113–120Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  113Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S6677 8Using the framework of corporate culture  in “mergers” to support the development  of a cultural basis for integrative medicine –  guidance for building an integrative medicine  department or service Claudia M Witt,1–3 Marion Pérard,2  Brian Berman,3,4 Susan Berman,4  timothy C Birdsall,5 horst defren,6  Sherko Kümmel,7 gary deng,8  gustav dobos,9 Atje drexler,10  Christine holmberg,2 Markus  horneber,11 Robert Jütte,9 lori  Knutson,12 Christopher Kummer,13  Susanne Volpers,14 david Schweiger15 1University hospital Zurich, Institute for  Complementary and Integrative Medicine,  Zurich, Switzerland; 2Institute for Social  Medicine, epidemiology and health economics,  Charité-Universitätsmedizin, Berlin, germany;  3University of Maryland School of Medicine,  Center for Integrative Medicine, Baltimore,  Maryland, USA; 4the Institute for Integrative  health, Baltimore, USA; 5Cancer treatment  Centers of America, goodyear, Arizona, USA,  6Kliniken essen Mitte, evang, huyssen-Stiftung/ Knappschaft gmbh Patientenmanagement,  essen, germany; 7department of Senology,  Breast Center, Kliniken essen-Mitte, evang.",Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
"Complementary medicine is an umbrella term, which represents a heterogeneous  field with disparate beliefs and practices that can vary considerably.9,10 According to  the National Institutes of Health in the US, “complementary” generally refers to using  a non-mainstream approach together with conventional medicine.11Journal name: Patient Preference and Adherence Article Designation: Methodology Y ear: 2015 Volume: 9 Running head verso: Witt et al Running head recto: Translating corporate culture in mergers DOI: http://dx.doi.org/10.2147/PPA.S66778 Correspondence: Claudia M Witt Institute for Complementary and Integrative  Medicine, University hospital Zurich and  University Zurich Sonneggstr 6, Ch-8091 Zurich, Switzerland tel +41 44 255 2396 email claudia.witt@uzh.c h",Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
Available from: http://www.bravewell.org/content/ Downlaods/IMinAm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
Available from: http://nccam.nih.gov/health/whatiscam.,OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
Available from: https://www.aamc.org/newsroom/reporter/ october2011/262456/changingculture.html.,Non-OADS,/arxiv_data1/oa_pdf/c0/b1/ppa-9-113.PMC4304533.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 297–310Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  297OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7407 1effects of cognitive training with additional  physical activity compared to pure cognitive  training in healthy older adults Julia rahe1 Annette Petrelli1 stephanie Kaesberg2 gereon r Fink3 Josef Kessler3 elke Kalbe1 1Psychological gerontology  and Center for neuropsychological  Diagnostics and Interventions,   Institute of gerontology, University  of Vechta, Vechta, germany; 2Cognitive  neurology section, Institute  of neuroscience and Medicine,   research Center Jülich, Jülich,   germany; 3Department of neurology,   University hospital Cologne, Cologne,   germanyIntroduction:  Cognitive training (CT) has been reported to improve cognition in older adults.",Non-OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
"As a result, establishing any specification of the effects  of CT programs remains difficult.1,2 Transfer effects into nontrained domains cannot  yet be clearly supported; therefore, recent studies suggest that multidomain CT seems  more promising than interventions focused on only one domain for inducing lasting  improvement of different cognitive functions in healthy older adults.3,5,6 In addition, many studies suggest a positive effect of physical activity and struc - tured exercise on cognitive functions, with the most consistent findings being reported Correspondence: elke Kalbe Institute of gerontology, Psychological  gerontology and CenDI, University  of Vechta, Driverstrasse 22, 49377  Vechta, germany Tel +49 4441 15204 Fax +49 4441 15621 email elke.kalbe@uni-vechta.d e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rahe et al Running head recto: Cognitive training with physical activity DOI: http://dx.doi.org/10.2147/CIA.S74071",Non-OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
"Referring to Ainsworth et al 1 MET  corresponds to the resting metabolic rate obtained during  quiet sitting.29 Different physical activities can be rated  by multiplying the amount of time spent on the respective  activity by an activity-typical factor in the range between  0.9 for sleeping and 18 for running.29 The total score and  the information from moderate and vigorous activities were  used to build categories indicating whether participants were  highly active, moderately active, or mildly active (for exact  criteria see Scoring Protocol under http://www.ipaq.ki.se/ scoring.pd f).",OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
G*Power ( http://www.gpower.hhu.d e) was used to  estimate the achieved power with a post hoc analysis.37 Cognitive variables Gains from CT from pre- to post-test and to 1 year follow-up  were estimated with analysis of variance (ANOVA) for  repeated measures (rANOVAs) with a significance level  of α=0.05.,OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/08/c4/cia-10-297.PMC4304534.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/bf/cmar-7-047.PMC4304535.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 47–50Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  47Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S7338 9ipilimumab was safe and effective in two patients  with metastatic melanoma and end-stage   renal disease Ludimila Cavalcante1 asim amin2 Jose Lutzky1 1Department of Hematology and  Oncology, Mount sinai Medical  Center, Miami Beach, FL, Usa;  2Levine  Cancer institute, Charlotte, NC, Usa Correspondence: Jose Lutzky   4300 alton Road, Miami Beach, FL, Usa   Tel +1 305 535 3300  Fax +1 305 535 3356  email jose.lutzky@msmc.co mAbstract:  This is a unique report of two cases of patients with end-stage renal disease on  hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity  of safety and efficacy data in this patient subgroup.",Non-OADS,/arxiv_data1/oa_pdf/f9/bf/cmar-7-047.PMC4304535.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f9/bf/cmar-7-047.PMC4304535.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/bf/cmar-7-047.PMC4304535.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/d4/dddt-9-575.PMC4304576.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 575–601Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  575Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7522 1alisertib induces cell cycle arrest and autophagy and  suppresses epithelial-to-mesenchymal transition involving  Pi3K/akt/mTOr and sirtuin 1-mediated signaling pathways  in human pancreatic cancer cells correspondence: shu-Feng Zhou  Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Blvd, MDc 30,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,  The First Affiliated Hospital of Nanchang  University, 17 Yongwai Main st, nanchang 330006,  Jiangxi, People’s republic of china Tel +86 791 8869 5069   Fax +86 791 8869 2745   email qiujiaxuan@163.co mFeng Wang,1,2 hai li,3 Xiao-gang  Yan,4 Zhi-Wei Zhou,2 Zhi-gang  Yi,5 Zhi-Xu he,6 shu-Ting Pan,7  Yin-Xue Yang,3 Zuo-Zheng Wang,1  Xueji Zhang,8 Tianxing Yang,9 Jia- Xuan Qiu,7 shu-Feng Zhou2 1Department of hepatobiliary surgery, general  hospital, ningxia Medical University, Yinchuan,   People’s republic of china; 2Department  of Pharmaceutical sciences, college of  Pharmacy, University of south Florida, Tampa,   Fl, Usa; 3Department of colorectal surgery,   general hospital, ningxia Medical University,   4Department of Oncological surgery, The First  People’s hospital of Yinchuan, 5Department  of general surgery, changqing Yangehu  hospital, Yinchuan, 6guizhou Provincial Key  laboratory for regenerative Medicine, stem  cell and Tissue engineering research center  and sino-U s Joint laboratory for Medical  sciences, guiyang Medical University, guiyang,   7Department of Oral and Maxillofacial surgery,   The First affiliated hospital of nanchang  University, nanchang, 8research center  for Bioengineering and sensing T echnology,   University of science and Technology  Beijing, Beijing, People’s republic of china;   9Department of internal Medicine, University  of Utah and salt lake Veterans affairs Medical  center, salt lake city, UT, UsaAbstract:  Pancreatic cancer is the most aggressive cancer worldwide with poor response  to current therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/9e/d4/dddt-9-575.PMC4304576.pdf
"Keywords:  alisertib, pancreatic cancer, cell cycle, autophagy, EMT, Sirt1 Introduction Pancreatic cancer is the most aggressive cancer worldwide with a 5-year survival rate  of less than 6%.1,2 Pancreatic cancer is the 12th most common cancer, and there were  338,000 cases diagnosed with pancreatic cancer in 2012.1,2 In US, pancreatic cancer  accounts for approximately 3% of all cancers and approximately 7% of cancer-related  deaths.1,2 In 2013, there were 45,220 cases diagnosed with pancreatic cancer, and  there will be 46,420 new cases of pancreatic cancer in 2014.2 In People’s Republic  of China, pancreatic cancer is the sixth leading cause of cancer-related death with a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Alisertib kills human pancreatic cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S75221",Non-OADS,/arxiv_data1/oa_pdf/9e/d4/dddt-9-575.PMC4304576.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9e/d4/dddt-9-575.PMC4304576.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/d4/dddt-9-575.PMC4304576.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 537–560Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  537Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7368 9Plumbagin induces cell cycle arrest and autophagy  and suppresses epithelial to mesenchymal  transition involving Pi3K/akt/mTOr-mediated  pathway in human pancreatic cancer cells Feng Wang,1,2,* Qi Wang,1,*   Zhi-Wei Zhou,2,3 song-n ing Yu1   shu-Ting Pan,4 Zhi-Xu he,3   Xueji Zhang,5 Dong Wang,6   Yin-Xue Yang,7 Tianxing Yang,8   Tao sun,9 Min li,10 Jia-Xuan Qiu,4   shu-Feng Zhou2 1Department of hepatobiliary surgery, general  hospital of n ingxia Medical University,  Yinchuan, ningxia, People’s republic of china;  2Department of Pharmaceutical science, college  of Pharmacy, University of south Florida, Tampa,  Fl, Usa; 3guizhou Provincial Key laboratory  for regenerative Medicine, stem cell and Tissue  engineering research center and sino-U s Joint  laboratory for Medical sciences, guiyang Medical  University, guiyang, People’s republic of china;  4Department of Oral and Maxillofacial surgery, The  First affiliated hospital of n anchang University,  nanchang, People’s republic of china; 5research  center for Bioengineering and sensing T echnology,  University of science and T echnology Beijing,  Beijing, People’s republic of china; 6cancer center,  Daping hospital and research institute of surgery,  Third Military Medical University, chongqing,  People’s republic of china; 7Department of  colorectal  surgery, general hospital, ningxia  Medical University, Yinchuan, ningxia, People’s  republic of china; 8Department of internal  Medicine, University of Utah and salt lake Veterans  affairs Medical center, salt lake city, UT, Usa;  9Key lab of craniocerebral Diseases of ningxia,  ningxia Medical University, Yinchuan, People’s  republic of china; 10Department of Medicine  and Department of surgery, The University of  Oklahoma health sciences center, stanton l  Young Biomedical research center, Oklahoma  city, OK, Usa *These authors contributed equally to this workAbstract:  Plumbagin (PLB), an active naphthoquinone compound, has shown potent anticancer  effects in preclinical studies; however, the effect and underlying mechanism of PLB for the  treatment of pancreatic cancer is unclear.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
"Keywords:  Plumbagin, pancreatic cancer, cell cycle, autophagy, EMT, Sirt1 Introduction Pancreatic cancer is the 12th most common and the most aggressive cancer in the  world, and the incidence and death rates rise with advancing age.1 There were  338,000  cases diagnosed with pancreatic cancer in 2012, and the 5-year survival  rate is 6.7% worldwide.1,2 In the United States, there were 45,220  cases of pancreatic  cancer diagnosed in 2013, and it has been estimated that there will be 46,420  new  cases (23,530 men and 22,890 women) diagnosed and 39,590 patients (20,170 men  and 19,420 women) will die from pancreatic cancer in 2014.2 In China, pancreatic  cancer is the sixth leading cause of cancer death, and the overall 5-year survival rate is  correspondence: shu-Feng Zhou Department of Pharmaceutical sciences, college of  Pharmacy, University of south Florida, 12901 Bruce B  Downs Blvd, MDc 30, Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,   The First Affiliated Hospital of Nanchang University,   17 Yongwai Main st, nanchang 330006, Jiangxi,   People’s republic of china Tel +86 791 8869 5069 Fax +86 791 8869 2745  email qiujiaxuan@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Plumbagin kills human pancreatic cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S73689",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/dddt-9-537.PMC4304578.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/dddt-9-567.PMC4304592.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 567–574Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  567Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7451 5Combination therapy of ursodeoxycholic acid  and budesonide for PBC–AiH overlap syndrome:  a meta-analysis Huawei Zhang1,2,* Jing Yang1,* Rong Zhu1,3 Yuanyuan Zheng1 Yuqing Zhou1,2 weiqi Dai1 Fan wang1 Kan Chen1 Jingjing Li1 Chengfen wang1 Sainan Li1 T ong Liu1 Huerxidan Abudumijiti1 Zheng Zhou1,3 Jianrong wang1,3 wenxia Lu1,3 Junshan wang1 Yujing Xia1 Yingqun Zhou1 Jie Lu1 Chuanyong Guo1 1Department of Gastroenterology,   Shanghai T enth People’s Hospital,   T ongji University School of Medicine,   Shanghai, 2The First Affiliated Hospital  of Soochow University, Suzhou, 3The  First Clinical Medical College of  Nanjing Medical University, Nanjing,   People’s Republic of China *These authors contributed equally to  this work and should be considered  co-first authorsAbstract:  In this study, a meta-analysis of randomized controlled trials comparing  ursodeoxycholic acid  (UDCA) monotherapy with combination therapies utilizing UDCA and  budesonide was performed.",Non-OADS,/arxiv_data1/oa_pdf/ec/70/dddt-9-567.PMC4304592.pdf
"The presence of at least  two of the three accepted criteria was required for the diagnosis of each disease.12 The  criteria for PBC were: 1) alkaline phosphatase (AP) levels at least two times higher than Correspondence: Chuanyong Guo; Jie Lu Department of Gastroenterology,  Shanghai Tenth People’s Hospital, Tongji  University School of Medicine, Middle  Yanchang Road (301 Hao), Zhabei  District, Shanghai, People’s Republic of  China email guochuanyong@hotmail.co m;  kennisren@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome  DOI: http://dx.doi.org/10.2147/DDDT.S74515",Non-OADS,/arxiv_data1/oa_pdf/ec/70/dddt-9-567.PMC4304592.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ec/70/dddt-9-567.PMC4304592.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/dddt-9-567.PMC4304592.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/7a/ijn-10-765.PMC4304593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 765–774International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  765OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6605 8Physicochemical properties, cytotoxicity,  and antimicrobial activity of sulphated  zirconia nanoparticles ae Mftah1 Fatah h alhassan2,3 Mothanna sadiq al-Qubaisi4 Mohamed ezzat el Zowalaty4 Thomas J Webster5,6 Mohammed sh-eldin7 abdullah rasedee8 Yun hin Taufiq-Yap2,3 shah samiur rashid1 1Department of chemistry, Faculty  of Industrial sciences and T echnology,  University Malaysia Pahang, Malaysia;  2catalysis science and Technology  research centre, 3Department  of chemistry, Faculty of science,  Universiti Putra Malaysia, selangor,  Malaysia; 4Institute of Bioscience,  University Putra Malaysia, serdang,  selangor, Malaysia; 5Department of  chemical engineering, Northeastern  University, Boston, M a, Usa; 6center  of excellence for advanced Materials  research, King abdulaziz University,  Jeddah, saudi arabia; 7solar energy  research Institute, University  Kebangsaan Malaysia, selangor, 8Faculty  of Veterinary Medicine, Universiti  Putra Malaysia, selangor, MalaysiaAbstract:  Nanoparticle sulphated zirconia with Brønsted acidic sites were prepared here by  an impregnation reaction followed by calcination at 600 °C for 3 hours.",Non-OADS,/arxiv_data1/oa_pdf/de/7a/ijn-10-765.PMC4304593.pdf
"These metal oxide redox properties are employed in catalytic decontamination schemes  for the total oxidation of contaminated constituents.13–20 The metal oxide scheme with Correspondence: Yun Hin Taufiq-Yap catalysis science and Technology  research centre, Faculty of science- Universiti Putra Malaysia, 43400 UPM  serdang selangor, Malaysia Tel +60 3 8946 6809 Fax +60 3 8946 6758 email abuohamid9090@gmail.co m;  taufiq@upm.edu.m y abdullah rasedee Faculty of Veterinary Medicine, Universiti  Putra Malaysia, 43400 UPM serdang,  selangor, Malaysia Tel +60 3 8946 3455 Fax +60 3 8946 1971 email rasedee@vet.upm.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mftah et al Running head recto: Sulphated zirconia nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S66058",Non-OADS,/arxiv_data1/oa_pdf/de/7a/ijn-10-765.PMC4304593.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/de/7a/ijn-10-765.PMC4304593.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/7a/ijn-10-765.PMC4304593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/b4/ijn-10-727.PMC4304594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 727–737International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  727ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7570 6Antibacterial activity and biological performance of a  novel antibacterial coating containing a halogenated  furanone compound loaded poly(L-lactic acid)  nanoparticles on microarc-oxidized titanium Yicheng Cheng1,2,* Xianghui Zhao3,* Xianghui Liu2,* Weige Sun2 Huifang Ren1 Bo Gao1 Jiang Wu1 1State Key Laboratory of Military  Stomatology, Department of  Prosthodontics, School of Stomatology,  Fourth Military Medical University,  Xi’an, People’s Republic of China;  2Department of Stomatology, Jingdu  Hospital, Nanjing, People’s Republic  of China; 3Institute of Neuroscience,  School of Basic Medicine, Fourth  Military Medical University, Xi’an,  People’s Republic of China *These authors contributed equally  to this workAbstract:  Titanium implants have been widely used for many medical applications, but bacterial  infection after implant surgery remains one of the most common and intractable complications.",Non-OADS,/arxiv_data1/oa_pdf/44/b4/ijn-10-727.PMC4304594.pdf
"Keywords:  microarc oxidation, osteoblasts Introduction Titanium (Ti) implants continue to play essential roles in the repair or replacement of  bony tissues that have become diseased or damaged.1 However, one of the most common  and intractable complications during this process is the implant-associated infection,2  which may lead to various serious consequences, such as prolonged hospitalization,  implant failure, reoperation, osteomyelitis, amputation, and even death.3 Although the  risk of such infection can be minimized by thorough disinfection and rigorous aseptic  operation, the percentage of postoperation infections is still up to 3%.4 Once infections  occur, bacteria tend to form a biofilm on the implant surface, which protects them from  being completely eliminated by antibacterial agents coming from outside.5 Therefore,  fabricating antibacterial coatings on the surface of Ti implants is an effective approach  to prevent initial bacterial adhesion around implants, in the pathogenesis of infection.6  However, most attempts at this have failed to sustain long-term antibacterial effects.7  Further, the emerging appearance of insusceptibility of bacteria and drug resistance  also encourages the search for novel and more effective antibacterial strategies.8Correspondence: Bo Gao State Key Laboratory of Military  Stomatology, Department of  Prosthodontics, School of Stomatology,  Fourth Military Medical University, No  145, West Changle Road, Xi’an, Shaanxi  710032, People’s Republic of China Tel +86 29 8477 6469 Fax +86 29 8477 6469 Email gaobo@fmmu.edu.c n  Jiang Wu State Key Laboratory of Military  Stomatology, Department of  Prosthodontics, School of Stomatology,  Fourth Military Medical University, No  145, West Changle Road, Xi’an, Shaanxi  710032, People’s Republic of China Tel +86 29 8477 6469 Fax +86 29 8477 6469 Email wujiang@fmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Cheng et al Running head recto: Antibacterial halogenated furanone compound–loaded PLA NPs on MAO-Ti DOI: http://dx.doi.org/10.2147/IJN.S75706",Non-OADS,/arxiv_data1/oa_pdf/44/b4/ijn-10-727.PMC4304594.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/44/b4/ijn-10-727.PMC4304594.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/b4/ijn-10-727.PMC4304594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 177–183Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  177OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7399 2correlation between changes in quality of life and  symptomatic improvement in chinese patients  switched from typical antipsychotics to olanzapine William Montgomery1  Zbigniew Kadziola2  Wenye Ye3  hai Bo Xue4  li liu4  Tamás Treuer5 1global Patient Outcomes and real  World evidence, eli lilly australia  Pty ltd, West ryde, N sW, australia;   2real World analytics capabilities,   eli lilly gmbh, Vienna, austria;   3real World analytics, eli lilly and  company, indianapolis, iN, Usa; 4lilly  suzhou Pharmaceutical company, ltd,   shanghai, People’s republic of china;   5Neuroscience research, eli lilly and  company, Budapest, hungaryPurpose:  The aim of this study was to investigate the correlation between changes in symptoms  and changes in self-reported quality of life among Chinese patients with schizophrenia who were  switched from a typical antipsychotic to olanzapine during usual outpatient care.",Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
"Because of the broad spectrum  of impairment, many individuals with this disorder are unable to gain employment  or maintain a marriage.1,2 According to guidelines for the treatment of patients with  schizophrenia, the goals for treatment should include reducing or eliminating symp - toms, improving adaptive functioning and quality of life to the fullest extent, and  promoting and sustaining functioning to the highest degree possible.3 Beyond these  general areas of focus for treatment, identifying specific treatment targets and using a  range of outcome measures to assess treatment progress are also important.correspondence: William Montgomery global Patient Outcomes and real World  evidence, eli lilly australia Pty ltd,  112 Wharf rd, West ryde, NsW 2114,  australia Tel +61 2 9325 4335 Fax +61 2 9325 4334 email montgomery_bill@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Montgomery et al Running head recto: Correlation between symptomatic improvement and quality of life DOI: http://dx.doi.org/10.2147/NDT.S73992",Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
Available from: http://www.who.int/ mental_health/media/68.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/90/ndt-11-177.PMC4304595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/ijn-10-677.PMC4304596.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 677–685International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  677OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7551 4electrochemical sensing method for point-of-care  cortisol detection in human immunodeficiency  virus-infected patients ajeet Kaushik1 adriana Yndart1 Rahul Dev Jayant1 Vidya Sagar1 Venkata atluri1 shekhar Bhansali2 Madhavan Nair1 1center of Personalized  Nanomedicine,  Institute of Neuroimmune  Pharmacology, Department of   Immun  ology, Herbert Wertheim  college  of Medicine, Florida International  University, 2BioMEMS Microsystems  Laboratory, Department of Electrical  and computer engineering, Florida  International University, Miami, FL,  USAAbstract:  A novel electrochemical sensing method was devised for the first time to detect  plasma cortisol, a potential psychological stress biomarker, in human immunodeficiency virus  (HIV)-positive subjects.",Non-OADS,/arxiv_data1/oa_pdf/bf/73/ijn-10-677.PMC4304596.pdf
eduJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kaushik et al Running head recto: Cortisol detection in HIV -positive patients DOI: http://dx.doi.org/10.2147/IJN.S75514,Non-OADS,/arxiv_data1/oa_pdf/bf/73/ijn-10-677.PMC4304596.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bf/73/ijn-10-677.PMC4304596.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/ijn-10-677.PMC4304596.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/39/ijn-10-687.PMC4304597.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 687–695International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  687OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7272 6The effect of blood protein adsorption on cellular  uptake of anatase TiO2 nanoparticles Zouhir e allouni1 Nils r gjerdet1 Mihaela r cimpan1,* Paul J høl2,3,* 1Faculty of Medicine and Dentistry,   Department of clinical Dentistry,   Biomaterials, University of Bergen,   Bergen, Norway; 2Faculty of Medicine  and Dentistry, Department of clinical  Medicine, Biomaterials, University of  Bergen, Bergen, Norway; 3Department  of Orthopaedic surgery, haukeland  University hospital, Bergen, Norway *These authors contributed equally  to this workAbstract:  Protein adsorption onto nanoparticles (NPs) in biological fluids has emerged as an  important factor when testing biological responses to NPs, as this may influence both uptake and  subsequent toxicity.",Non-OADS,/arxiv_data1/oa_pdf/ab/39/ijn-10-687.PMC4304597.pdf
"A “protein corona” may be formed, which is a complex  mixture of adsorbed proteins in equilibrium on the surface of NPs.4,8–10 The protein  corona may alter the size, agglomeration state, and interfacial properties of the NPs,10  which could potentially affect the cellular uptake of NPs.3,11 correspondence: Paul Johan høl University of Bergen, Department of clinical Medicine, Biomaterials, Jonas lies veg 87, N-5021  Bergen, Norway Tel +47 5558 5443 email paul.hol@k1.uib.n oJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Allouni et al Running head recto: Protein adsorption on anatase nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S72726",Non-OADS,/arxiv_data1/oa_pdf/ab/39/ijn-10-687.PMC4304597.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ab/39/ijn-10-687.PMC4304597.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/39/ijn-10-687.PMC4304597.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 37–44Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S4724 0Romiplostim as a treatment for immune  thrombocytopenia: a review Sarah Chalmers1,2 Michael D Tarantino1–3 1University of illinois College of  Medicine – Peoria,  2The Children’s  Hospital of illinois,  3The Bleeding and  Clotting Disorders institute, Peoria,   illinois, USA Correspondence: Michael D Tarantino   6811 North Knoxville Avenue,   Suite A, Peoria, iL  61614  Tel +1 309 692 5337  Fax +1 309 693 3913  email mtarantino@ilbcdi.or gAbstract:  “Immune thrombocytopenia” (ITP) is an autoimmune disorder that leads to peripheral  destruction, as well as a decreased production of platelets.",Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/ NCT0051520 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Available  from: http://www.clinicaltrials.gov/ct2/show/study/NCT0029918 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Available from:  http://www.clinicaltrials.gov/ct2/show/NCT02052882?term=soff +romi plostim&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Available from: http://www.clinicaltrials.gov/ ct2/show/NCT0167696 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/ NCT0041328 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/e0/jbm-6-037.PMC4304598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/81/ijn-10-739.PMC4304599.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 739–748International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  739ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7582 1PEGylated apoptotic protein-loaded PLGA  microspheres for cancer therapy Hyeong Jun Byeon1 Insoo Kim1 Ji Su Choi1 Eun Seong Lee2 Beom Soo Shin3 Yu Seok Y oun1 1Department of Pharmaceutical  Sciences, School of Pharmacy,   Sungkyunkwan University, Suwon,   Republic of Korea; 2Division  of  Biotechnology, The  Catholic  University of Korea, Bucheon-si,   Republic of Korea; 3Department of  Pharmacy, College of Pharmacy,   Catholic University of Daegu,   Gyeongsan-si, Republic of KoreaAbstract:  The aim of the current study was to investigate the antitumor potential of poly   (d,l-lactic- co-glycolic acid) microspheres (PLGA MSs) containing polyethylene glycol (PEG)- conjugated (PEGylated) tumor necrosis factor–related apoptosis-inducing ligand (PEG-TRAIL).",Non-OADS,/arxiv_data1/oa_pdf/56/81/ijn-10-739.PMC4304599.pdf
"In general, protein-loaded PLGA MSs have been  plagued with typical problems in terms of rapid initial burst release, physicochemical  instability, and bioactivity loss.1,5,6 For these reasons, many reports have shown Correspondence: Yu Seok Youn Manufacturing Pharmacy Laboratory,  School of Pharmacy, Sungkyunkwan  University, 300 Cheoncheon-dong,  Jangan-gu, Suwon 440-746, Republic of  Korea Tel +82 31 290 7785 Fax +82 31 290 7724 Email ysyoun@skku.ed u Journal name: International Journal of Nanomedicine Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Byeon et al Running head recto: PEG-TRAIL-loaded PLGA microspheres DOI: http://dx.doi.org/10.2147/IJN.S75821",Non-OADS,/arxiv_data1/oa_pdf/56/81/ijn-10-739.PMC4304599.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/81/ijn-10-739.PMC4304599.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/81/ijn-10-739.PMC4304599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/3e/jbm-6-031.PMC4304600.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 31–36Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  31Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S6555 6seroprevalence of human T -cell lymphoma/ leukemia virus type-1 (hTl V-1) antibodies among  blood donors at enugu, nigeria augustine ejike Okoye1 Obike godswill ibegbulam2 robinson chukwudi Onoh3 ngozi immaculata Ugwu1 chukwudi simon anigbo2 charles emeka nonyelu2 1Department of haematology  and immunology, Federal Teaching  hospital abakaliki, ebonyi state,   nigeria; 2Department of haematology  and immunology, University of  nigeria Teaching hospital (U nTh)  ituku-Ozalla, enugu state, nigeria;   3Department of Obstetrics and  gynaecology, Federal Teaching  hospital abakaliki, ebonyi state,   nigeria correspondence: robinson chukwudi  Onoh   Department of Obstetrics and  gynaecology, Federal Teaching hospital  abakaliki, ebonyi state, PMB  102,  abakaliki, ebonyi state  480001, nigeria   Tel +234 803 700 7519,   +234 815 367 0114  email drrobonoh@gmail.co m; onoh406@ yahoo.co mBackground:  Human T -cell lymphotrophic/leukemia virus (HTL V -1) is a retrovirus implicated  in transfusion-transmitted infection.",Non-OADS,/arxiv_data1/oa_pdf/8a/3e/jbm-6-031.PMC4304600.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/8a/3e/jbm-6-031.PMC4304600.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/3e/jbm-6-031.PMC4304600.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/48/ijn-10-775.PMC4304601.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 775–789International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  775OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7350 8glycosaminoglycan-functionalized poly-lactide-co- glycolide nanoparticles: synthesis, characterization,  cytocompatibility, and cellular uptake surya P lamichhane1 Neha arya1,2 Nirdesh Ojha3 esther Kohler1 V Prasad shastri1,2,4 1Institute for Macromolecular  chemistry, University of Freiburg,   Freiburg, 2helmholtz Virtual Institute  on “Multifunctional Biomaterials  for Medicine”, 3laboratory for  Process Technology, Department  of Microsystems engineering,   University of Freiburg, Freiburg,   4centre for Biological signaling  studies (BIO ss), University  of Freiburg, Freiburg, germanyAbstract:  The efficient delivery of chemotherapeutics to the tumor via nanoparticle (NP)-based  delivery systems remains a significant challenge.",Non-OADS,/arxiv_data1/oa_pdf/24/48/ijn-10-775.PMC4304601.pdf
"“Passive targeting” utilizes the changes to perme - ability of vasculature associated with tumor environment, which promotes the diffusion  and accumulation of macromolecules and drugs by “extravasation”, the enhanced  permeation and retention effect to localize the therapy to the tumor environment.4   In this regard, NPs offer several advantages due to their size and ability to present correspondence: V Prasad shastri Institute for Macromolecular chemistry,  University of Freiburg, stefan-Meier   str 31, hermann staudinger haus,  Freiburg D-79104, germany Tel +49 761 203 6268 Fax +49 761 203 6306 email prasad.shastri@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lamichhane et al Running head recto: Glycosaminoglycan-functionalized PLGA nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S73508",Non-OADS,/arxiv_data1/oa_pdf/24/48/ijn-10-775.PMC4304601.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/48/ijn-10-775.PMC4304601.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/48/ijn-10-775.PMC4304601.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 211–222OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7582 7Meta-analysis of the association between APC  promoter methylation and colorectal cancer Zhenyu Ding1,* T ong Jiang2,* Ying Piao1 Tao han1 Yaling han3 Xiaodong Xie1 1Department of Oncology, general  hospital of shenyang Military  region, shenyang city, liaoning  Province, 2laboratory of Military  health in cold region, center  for Disease control and Prevention  of shenyang Military region, shenyang  city, liaoning Province, 3institute  of cardiovascular Disease, general  hospital of shenyang Military region,   shenyang city, liaoning Province,   People’s republic of china *These authors contributed equally  to this workAbstract:  Previous studies investigating the association between adenomatous polyposis  coli ( APC ) gene promoter methylation and colorectal cancer (CRC) have yielded conflicting  results.",Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
"Due to the high sensitivity, specificity, and convenience of methylation correspondence: Xiaodong Xie  Department of Oncology, general  hospital of shenyang Military region,  83 Wenhua road, shenhe District,  shenyang city, liaoning Province 110840,  People’s republic of china Tel +86 24 2885 6419 Fax +86 24 2885 6310 email xiaodongxie36@sina.co m  Yaling han institute of cardiovascular Disease,  general hospital of shenyang Military  region, 83 Wenhua road, shenhe  District, shenyang city, liaoning Province  110840, People’s republic of china  Tel +86 24 2885 6123 Fax +86 24 2885 6123 email yalinghan_syjq@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ding et al Running head recto: APC promoter methylation and colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S75827",Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
"Methods search strategy We conducted a literature search using the PubMed (search  updated to October 2014; http://www.ncbi.nlm.nih.gov/ pubmed /), Embase, and MEDLINE (search updated to  October 2014; http://www.embase.com /) databases using the  following search terms located in either the title or abstract:  (“adenomatous polyposis coli” or APC ) and (methyla - tion, hypermethylation, methylated, or hypomethylation)  and (“colorectal neoplasms”, “colorectal cancer”, “colon  cancer”, “rectal cancer”, “colorectal carcinoma”, “rectal car - cinoma”, “colon carcinoma”, “colon neoplasms”, or “rectal  neoplasms”).",Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/4d/ott-8-211.PMC4304602.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 153–158International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  153OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7371 7Dynamic hyperinflation and dyspnea during the  6-minute walk test in stable chronic obstructive  pulmonary disease patients Masahiro satake1 Takanobu shioya1 sachiko Uemura1 hitomi Takahashi2 Keiyu Sugawara2 Chikage Kasai2 noritaka Kiyokawa2 T oru Watanabe2 sayaka sato2 Atsuyoshi Kawagoshi2 1Department of Physical Therapy,   akita University graduate school  of health sciences, akita, Japan;   2Department of rehabilitation, akita  City hospital, akita, JapanAbstract:  The purpose of this study was to investigate the relationship between dynamic  hyperinflation and dyspnea and to clarify the characteristics of dyspnea during the 6-minute  walk test (6MWT) in chronic obstructive pulmonary disease patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
"For the change in V’O2, Troosters  et al showed the same results.7 We also measured dyspnea during the 6MWT in a  research setting and found that dyspnea increased linearly until the end of the test,  unlike the V’O2.Correspondence: Masahiro satake Department of Physical Therapy, akita  University graduate school of health  sciences 1-1-1 hondo, akita, 010-8543, Japan Tel +81 18 834 1111 Fax +81 18 884 6500 email satake@hs.akita-u.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Satake et al Running head recto: Dynamic hyperinflation and dyspnea during 6MWT in stable COPD patients DOI: http://dx.doi.org/10.2147/COPD.S73717",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
Available from: http://www.who.int/respiratory/copd/GOLD_WR_06.,OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/c9/copd-10-153.PMC4304629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/20/1c/nihms653827.PMC4304669.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Joshua B Johnson, Mayo Clinic Department of Radiology, 200 First Street SW, Rochester, MN 55905, USA, Tel +1  651 246 4001, Fax +1 507 293 3680, johnson.joshua1@mayo.edu.",Non-OADS,/arxiv_data1/oa_pdf/20/1c/nihms653827.PMC4304669.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/9d/MOL2-9-527.PMC4304881.pdf
1These authors contributed equally to this work.available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc http://dx.doi.org/10.1016/j.molonc.2014.10.006 1574-7891/ ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/9d/MOL2-9-527.PMC4304881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).MOLECULAR ONCOLOGY 9 (2015) 527 e543,Non-OADS,/arxiv_data1/oa_pdf/78/9d/MOL2-9-527.PMC4304881.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2014.10.006 .,OADS,/arxiv_data1/oa_pdf/78/9d/MOL2-9-527.PMC4304881.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(1) 1–8 DOI: 10.1177/2054270414559083",Non-OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"Aylin P, Bottle A, Jen MH and Middleton S. HSMR mortality indicators, http://www1.imperial.ac.uk/resources/3321CA24-A5BC-4A91-9CC9- 12C74AA72FDC/ (accessed 17 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"Documentation Manual, http://www.mass.gov/ Eeohhs2/docs/dhcfp/r/hdd/hidd_doc_manual_fy07_06-19-09.pdf (accessed 22 February 2012).",Non-OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"Agency for Healthcare Research and Quality, Rockville,MD, http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ ccs.jsp (accessed 22 February 2012).",OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"United States Census 2000, http://www.census.gov/ main/www/cen2000.html (accessed 17 October 2014).",OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"Dr Foster, http://www.drfosterhealth.co.uk/ (accessed 17 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/cd/d7/10.1177_2054270414559083.PMC4304889.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(1) 1–3 DOI: 10.1177/2054270414565958",Non-OADS,/arxiv_data1/oa_pdf/1e/6f/10.1177_2054270414565958.PMC4304890.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(1) 1–3 DOI: 10.1177/2054270414554246",Non-OADS,/arxiv_data1/oa_pdf/a8/32/10.1177_2054270414554246.PMC4304891.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(1) 1–3 DOI: 10.1177/2054270414562986",Non-OADS,/arxiv_data1/oa_pdf/75/ba/10.1177_2054270414562986.PMC4304892.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 6(1) 1–6 DOI: 10.1177/2054270414562984",Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/148515/Green-Book- Chapter-34-v2_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See https://www.gov.uk/gov ernment/uploads/system/uploads/attachment_data/ file/212235/Shingles_vaccine_letter.pdf (last checked 6 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See http://www.hscic.gov.uk/hes (last checked 26 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See https://indicators.ic.,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See http://www.ons.gov.uk/ons/publica- tions/re-reference-tables.html?edition ¼tcm%3A77- 162553 (last checked 10 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
See http://www.hpa.org.uk/ Topics/InfectiousDiseases/InfectionsAZ/ChickenpoxVaricellaZoster/GeneralInformation (last checked 7 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/47/e6/10.1177_2054270414562984.PMC4304893.pdf
"Avail- able at http://www.who.int/whosis/whostat/2011/en/ (accessedNovember 12, 2014).",OADS,/arxiv_data1/oa_pdf/d8/58/wrr0022-0755.PMC4304906.pdf
"Statistics Canada 2008; Retrieved on May 13th, 2011. http://www.statcan.gc.ca 11.",OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Ministry of Health 2008; Internetdocument retrieved on Mar 23, 2010. http://www.phac-aspc.gc.ca/publicat/2008/cpho-aspc/pdf/cpho-report-eng.pdf 12.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Ministry of Health 2011; Internetdocument retrieved on Nov 10, 2011. http://www.phac-aspc.gc.ca/ cphorsphc-respcacsp/2011/pdf/cpho-resp-2011-eng.pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Internet document retrieved on Nov 10, 2011. http://ftp.iza.org/dp4796.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Retrieved on May 29, 2009. http://www.mhp.gov.on.ca/english/health/smoke_free/legislation.asp 29.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Retrieved on May 29, 2009. http://www.mhp.gov.on.ca/english/health/smoke_free/chart.asp 30.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"Retrieved on May 29, 2009. http://www.e-laws.gov.on.ca/html/regs/english/elaws_regs_060048_e.htm 31.",Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
"2009; Internetdocument accessed on June 23rd, 2012. http://www.otru.org/pdf/13mr/13mr_no3.pdf 32.",OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
http://www.otru.org/pdf/mr2011/funding2011.pdf 33.,Non-OADS,/arxiv_data1/oa_pdf/c8/84/bmjopen-2014-005753.PMC4305065.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005455).,Non-OADS,/arxiv_data1/oa_pdf/0a/87/bmjopen-2014-005455.PMC4305066.pdf
"In addition, it was sent to all adult PC teams listed in the UK Hospice dir-ectory (http://www.hospiceuk.org) with the request that the recipient forward the email on to relevant team members.",Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
http://www.bhf.org.uk/research/ heart-statistics/morbidity/prevalence.aspx (accessed 8 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
http://www.escardio.org/ guidelines-surveys/esc-guidelines/Pages/acute-chronic-heart-failure.aspx (accessed 8 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
http://www.nice.org.uk/guidance/cg108/resources/ guidance-chronic-heart-failure-pdf (accessed 24 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
Federation of Royal Colleges of Physicians ’annual census of consultant physicians and medical registrars in the UK 2012. https://www.rcplondon.,Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
http://www.goldstandardsframework.org.,Non-OADS,/arxiv_data1/oa_pdf/de/a9/openhrt-2014-000188.PMC4305067.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006086).,Non-OADS,/arxiv_data1/oa_pdf/28/f4/bmjopen-2014-006086.PMC4305069.pdf
http://www.medicare.gov/ nursinghomecompare/search.html (accessed 8 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/28/f4/bmjopen-2014-006086.PMC4305069.pdf
http://www.medicare.gov/hospitalcompare/search.,Non-OADS,/arxiv_data1/oa_pdf/28/f4/bmjopen-2014-006086.PMC4305069.pdf
PQA endorsed set of measures 2006. http://pqaalliance.org/files/PQAMeasureDescriptionsForDemonstrations.pdf (accessed 30 Sep 2011).,OADS,/arxiv_data1/oa_pdf/28/f4/bmjopen-2014-006086.PMC4305069.pdf
http://pqaalliance.org/measures/survey.asp(accessed 7 May 2014).,OADS,/arxiv_data1/oa_pdf/28/f4/bmjopen-2014-006086.PMC4305069.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 22067515 (accessed 13 Mar 2012).,OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
http://www.who.int/tb/country/en/index.,OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
http://www.who.int/tb/country/data/profiles/en/ 35.,OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
2011.https://hpaintranet.hpa.org.uk/Content/ProgrammesProjects/HPAProgrammes/HPAKeyHealthProtectionProgrammes/Respiratory/ TB/StrainTyping/ (accessed 30 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
http://www.scopus.com/inward/record.url?eid=2-s2.0-84873163328&partnerID=40&md5=3994b8e5638129b621abc4d7d6d5e3b8 http://dx.doi.org/10.1371/journal.pone.0055423 60.,Non-OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0095159&representation=PDF 65.,Non-OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
http://www.scopus.com/ inward/record.url?eid=2-s2.0-84878608813&partnerID=40&md5=babbd6d006ca64e327fb19e01b6bc697 66.,Non-OADS,/arxiv_data1/oa_pdf/b4/12/bmjopen-2014-005636.PMC4305070.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006244).,Non-OADS,/arxiv_data1/oa_pdf/59/2c/bmjopen-2014-006244.PMC4305071.pdf
"Moreover, we used the Cochrane Risk of Bias tool and graded each potential source of bias as a low, high or unclear risk(http://www.cochrane-handbook.org; ﬁgures 2 and 3).",OADS,/arxiv_data1/oa_pdf/59/2c/bmjopen-2014-006244.PMC4305071.pdf
doi:10.1136/ bmjopen-2014-006191 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006191).,Non-OADS,/arxiv_data1/oa_pdf/fb/d0/bmjopen-2014-006191.PMC4305072.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007412).,Non-OADS,/arxiv_data1/oa_pdf/a7/d8/bmjopen-2014-007412.PMC4305074.pdf
Natl Heart Lung Blood Inst 2013. https://reds-iii.rti.org/ (accessed 9 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/a7/d8/bmjopen-2014-007412.PMC4305074.pdf
http://www.ices.on.ca/ (accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/a7/d8/bmjopen-2014-007412.PMC4305074.pdf
http://www.blood.ca/ (accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/a7/d8/bmjopen-2014-007412.PMC4305074.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005596).,Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
http://www.who.int/cancer/detection/breastcancer/en/index.html (accessed 6 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
http://globocan.iarc.fr/(accessed 6 May 2012).3.,Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
"Breast cancer screening among Arabic women living in the State of Qatar:awareness, knowledge, and participation in screening activities.Avicenna 2012. http://www.qscience.com/doi/abs/10.5339/avi.2012.2 19.",Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
J Immigr Minor Health 2013. http://link.springer.com.ezproxy.lib.ucalgary.ca/article/10.1007/s10903-013-9902-9 33.,Non-OADS,/arxiv_data1/oa_pdf/99/87/bmjopen-2014-005596.PMC4305075.pdf
"(http://dx.doi.org/ 10.1136/bmjresp-2014- 000069) Received 20 October 2014 Revised 27 November 2014 Accepted 28 November 2014 1Department of Respiratory Medicine, North Tyneside General Hospital, North Shields, Tyne and Wear, UK 2Newcastle University, Newcastle-upon-Tyne, UK Correspondence to Dr John Steer; john_steer@hotmail.comABSTRACT Background: Current guidelines for management of patients hospitalised with acute exacerbations ofchronic obstructive pulmonary disease (COPD)recommend that clinical decisions, including escalationto assisted ventilation, be informed by an estimate ofthe patients ’likely postdischarge quality of life.",Non-OADS,/arxiv_data1/oa_pdf/61/94/bmjresp-2014-000069.PMC4305076.pdf
"The Use of Non-Invasive Ventilation in themanagement of patients with chronic obstructive pulmonary diseaseadmitted to hospital with acute type II respiratory failure, 2008. http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/NIV/Guidelines/NIVInCOPDFullGuidelineFINAL.pdf (last accessed 6Oct).",Non-OADS,/arxiv_data1/oa_pdf/61/94/bmjresp-2014-000069.PMC4305076.pdf
"This systematic review has been registered withPROSPERO (the National Institute for Health Research (NIHR) International Prospective Register of Systematic Reviews, http://www.crd.york.ac.uk/PROSPERO) underregistration number CRD42014013488.",Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
"METHODS The present systematic review and meta-analysis will be reported according to the recommendations from the Preferred Reporting Items for Systematic Reviews andMeta-Analyses (PRISMA, http://www.prisma-statement.",Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
"In addition, we will search the following websites for unpublished or ongoingstudies: http://www.controlled-trials.com and http:// clinicaltrials.gov, and review abstracts from selected sci- entiﬁc proceedings (the Society of Critical Care Medicine and the European Society of Intensive Care Medicine).",Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
Inter-rater agreement was assessed using the kappa statistic (k<0.01: no agreement; k=0.01 – 0.20: poor agreement; k=0.21 –0.40: fair agreement; k=0.41 –0.60: moderate agreement; k=0.61 –0.80: good agreement; k=0.81 –1.00: very good or perfect agree- ment) (http://www.internovi.it/software/kappa).,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
The Jadad scale deter- mines the quality of an RCT from three domains: (1) randomisation; (2) double-blinding; (3) and explanationof withdrawals or loss to follow-up (http://www.anzjsurg.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
TheNewcastle-Ottawa Scale will be used to assess the meth- odological quality of included observational studies (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
A ﬁxed-effects model and a random-effects model will be used to pool effect size as appropriate according to the results of het-erogeneity tests (http://www.cochrane.org/handbook).,OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2014-006579.PMC4305078.pdf
http://www.euroqol.org/ .,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/40273_2014_Article_227.PMC4305105.pdf
April 2010. http://www.kvb.de .,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/40273_2014_Article_227.PMC4305105.pdf
2010. http://www.g-drg.de/cms/ .,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/40273_2014_Article_227.PMC4305105.pdf
http://www.rote-liste.de/ .,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/40273_2014_Article_227.PMC4305105.pdf
Available at: http://www.ukbiobank.ac.uk/about -biobank-uk/ [Accessed 24 June 2013].5R.,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm [Accessed 24 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://www.nhmrc.gov.au/guidelines/publications/e72 (Accessed 24 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://conselho.saude.gov.br/resolucoes/2004/Reso340.doc (Accessed 24 June 2013); JuanCarlos I.,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://www.catedraderechoygenomahumano.es/images/novedades/SpanishLawonBiomedicalResearchEnglish.pdf (Accessed 24 June 2013).Sandra K. Prucka et al.,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://www.hhs.gov/ohrp/policy/gina.html [Accessed 24 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
Available at: http://biospecimens.cancer.gov/global/pdfs/NCI_Return_Research_Results_Summary_Final-508.pdf [Accessed 24 June 2013].36S.M.,Non-OADS,/arxiv_data1/oa_pdf/cd/aa/bioe0029-0082.PMC4305195.pdf
http://www.gnb.ca/0055/pdf/ 2011/7379%20english.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/36/nur0038-0082.PMC4305208.pdf
Retrieved from http://webarchive.nationalarch- ives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_ dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_ 4127426.pdf.,OADS,/arxiv_data1/oa_pdf/1d/36/nur0038-0082.PMC4305208.pdf
2014.Available at: https://nctu.partners.org/ProACT.,Non-OADS,/arxiv_data1/oa_pdf/7c/65/ana0076-0643.PMC4305209.pdf
Available at: http://clinicaltrials.gov/show/ NCT01709149.,Non-OADS,/arxiv_data1/oa_pdf/7c/65/ana0076-0643.PMC4305209.pdf
Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM230597.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/65/ana0076-0643.PMC4305209.pdf
Journal of Biogeography Published by John Wiley & Sons Ltd.http://wileyonlinelibrary.com/journal/jbi 241 doi:10.1111/jbi.12395Journal of Biogeography (J. Biogeogr. ),Non-OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
"Workﬂows were executed using theTaverna portal (https://portal.biovel.eu/), a web interfacebuilt through the BioVeL project (http://www.biovel.eu/) thatallows users to run workﬂows without installing the Taverna workbench (http://www.taverna.org.uk/) (accessed 25 Febru- ary 2013).",OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
All versions of the ENM workﬂows canbe downloaded from the MyExperiment repository (http://purl.ox.ac.uk/workﬂow/myexp-3355.20; accessed 2 December ª2014 The Authors.,OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
"The ENM workﬂow uses occurrence and environ-mental data to model ecological niches using a web servicebased on openModeller , a library that provides a variety of algorithms to model species distribution patterns (http://openmodeller.sf.net/) (Mu ~noz et al.",OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
"The second workﬂow, the ENM Statistical Difference Workﬂow (ESW DIFF) (http://purl.ox.ac.uk/workﬂow/myexp-3959.2; accessed23 January 2014) allows the spatial computation of changesin PD maps by calculating the differences between two rasterlayers using the R statistical environment 3.0.2 (R CoreTeam, 2013).",OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
Occurrence data Occurrence data for all species were extracted from GBIF (Global Biodiversity Information Facility; http://gbif.org/)during spring 2013 (see Appendix S1 in Supporting Informa-tion) (Table 1).,OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
"All occurrence data collected for this study have been submitted to the OBISdatabase (http://www.iobis.org/) (http://www.vliz.be/nl/imis?module=dataset&dasid=4607; title of data set ‘Observations ofthree Idotea species ( I. balthica ,I. chelipes andI.",OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
Environmental data Environmental layers that are likely to affect the distribution of the species were chosen based on the literature (Table 1).Global marine layers came from Bio-Oracle (http://www.bio-oracle.ugent.be/; data downloaded 14 August 2013) at aresolution of 5 arc-minutes (Tyberghein et al.,OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
workﬂow can be downloaded from http://purl.ox.ac.uk/work- ﬂow/myexp-3725.2; last accessed 2 September 2013.,Non-OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
"ACKNOWLEDGEMENTS This work was carried out in the Linnaeus Centre for Marine Evolutionary Biology at the University of Gothenburg(http://www.cemeb.science.gu.se/), and supported by aLinnaeus grant from the Swedish Research Councils VR andFormas, and by BioVeL.",OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
Available at: http://www.diva-portal.org/ smash/get/diva2:606901/FULLTEXT01.,Non-OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
BIOSKETCH Sonja Leidenberger is a postdoctoral researcher investigat- ing species distribution in northern Europe for the EU-funded BioVel project (http://www.biovel.eu/).,Non-OADS,/arxiv_data1/oa_pdf/a7/e7/jbi0042-0241.PMC4305211.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/61/dc/apt0039-0371.PMC4305214.pdf
Availableat: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInforma- tion/Guidances/UCM205269.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/dc/apt0039-0371.PMC4305214.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/002490/WC500135624.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/dc/apt0039-0371.PMC4305214.pdf
"Figure adapted from http://www.pdb.org/ [134, 135].M.",OADS,/arxiv_data1/oa_pdf/3c/67/bies0037-0070.PMC4305269.pdf
"http://nationalpaincentre.mcmaster.ca/documents/practicetoolkit.pdf Parhami I, Hyman M, Siani A, Lin S, Collard M, Garcia J, Casaus L, Tsuang J, Fong TW.",OADS,/arxiv_data1/oa_pdf/b0/4e/ajim0058-0033.PMC4305270.pdf
Available from: http://ppsg-production.heroku.com/chart38 Kraut et al.,Non-OADS,/arxiv_data1/oa_pdf/b0/4e/ajim0058-0033.PMC4305270.pdf
"We downloaded the raw geneexpression microarray data sets from the Gene ExpressionOmnibus repository (http://www.ncbi.nlm.nih.gov/geo/) inSeptember, 2011, and concurrently normalized the four datasets by using the robust multiarray average method imple-mented in the Bioconductor R-language suite of bioinformaticstools (Irizarry et al., 2003).",OADS,/arxiv_data1/oa_pdf/32/5a/jnr0093-0199.PMC4305271.pdf
"We assumed a one-to-one mapping between a protein and its coding gene (i.e., weignored protein isoforms and other translational modiﬁcations)and used Entrez Gene ID (http://www.ncbi.nlm.nih.gov/gene)to map genes and proteins, which henceforth are used inter-changeably.",OADS,/arxiv_data1/oa_pdf/32/5a/jnr0093-0199.PMC4305271.pdf
"We collected 143 nonmetabolic canonical signalingand disease pathways representing 4,672 proteins from theKyoto Encyclopedia of Genes and Genomes (KEGG; Kanehisa et al., 2008; http://www.genome.jp/kegg/pathway.html), downloaded in December, 2011.",OADS,/arxiv_data1/oa_pdf/32/5a/jnr0093-0199.PMC4305271.pdf
"However, because these net-work regions represent uncharacterized biological functions(unlike pathways), we used the web service resources of theDatabase for Annotation, Visualization, and Integrated Discov-ery (DAVID; version 6.7; http://david.abcc.ncifcrf.gov; Huanget al., 2009) to associate modules and subnetworks with biolog-ical functions in the form of disease, tissue, and gene ontology(GO) terms (Ashburner et al., 2000).",OADS,/arxiv_data1/oa_pdf/32/5a/jnr0093-0199.PMC4305271.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet atleast one of the following criteria [recommended by the IC- MJE (http://www.icmje.org/ethical_1author.html)]: substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.abs.gov.au/ausstats/abs@.nsf/mf/4829.0.55.001/ on 04 December 2013.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.nursingmidwiferyboard.gov.au/ on 02 January 2014.Bandura A.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.bdng.org.uk/documents/EmollientBPG.pdf on 05 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.nice.org.uk/CG057 on 07 January2014.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.rch.org.au/ rchcpg/index.cfm?doc_id=9971 on 12 December 2013.,OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from https://www.rcn.org.uk/__data/assets/pdf_ﬁle/0004/259033/003317.pdf on 06 January 2014.,OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.rcpch.ac.uk/allergy on 01 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Retrieved from http://www.euro.who.int/__data/assets/pdf_ﬁle/0007/145294/E63674.pdf on 20 August 2013.,OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/f8/cf/jan0070-2483.PMC4305279.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Risk-taking in disorders of natural and drug rewards V Voon et al 812 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/b6/0f/npp2014242a.PMC4305336.pdf
doi:http://dx.doi.org/10.1017/S09545 79414000546.,Non-OADS,/arxiv_data1/oa_pdf/69/2c/cdev0086-0303.PMC4305348.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f5/d4/jpts-27-1.PMC4305533.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/92/9a/jpts-27-101.PMC4305534.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/99/02/jpts-27-105.PMC4305535.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fc/26/jpts-27-109.PMC4305536.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9d/48/jpts-27-11.PMC4305537.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/71/b0/jpts-27-115.PMC4305538.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7b/64/jpts-27-117.PMC4305539.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e9/39/jpts-27-121.PMC4305540.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/49/46/jpts-27-123.PMC4305541.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/31/7e/jpts-27-127.PMC4305542.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/25/c0/jpts-27-131.PMC4305543.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/2e/c3/jpts-27-135.PMC4305544.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f5/72/jpts-27-139.PMC4305545.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/a7/jpts-27-143.PMC4305546.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/jpts-27-145.PMC4305547.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/72/da/jpts-27-149.PMC4305548.pdf
[Medline]   [CrossRef] 30) http://www.seniam.org/.,Non-OADS,/arxiv_data1/oa_pdf/72/da/jpts-27-149.PMC4305548.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/28/35/jpts-27-15.PMC4305549.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/18/1e/jpts-27-155.PMC4305550.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ed/f2/jpts-27-159.PMC4305551.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5c/7d/jpts-27-165.PMC4305552.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/07/49/jpts-27-169.PMC4305553.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b2/4a/jpts-27-171.PMC4305554.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7b/88/jpts-27-175.PMC4305555.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5c/a6/jpts-27-179.PMC4305556.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/45/83/jpts-27-183.PMC4305557.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/57/34/jpts-27-187.PMC4305558.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/df/c4/jpts-27-19.PMC4305559.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b1/14/jpts-27-191.PMC4305560.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3a/ff/jpts-27-195.PMC4305561.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8c/36/jpts-27-199.PMC4305562.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/41/f1/jpts-27-205.PMC4305563.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f4/97/jpts-27-209.PMC4305564.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c5/01/jpts-27-213.PMC4305565.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6a/12/jpts-27-217.PMC4305566.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/90/d7/jpts-27-223.PMC4305567.pdf
"http://www.mhlw.go.jp/topics/kaigo/osirase/jigyo/m13/1312.html (Ac - cessed May 18, 2014) 3) Inoue T: Assistive products for elderly persons.",Non-OADS,/arxiv_data1/oa_pdf/90/d7/jpts-27-223.PMC4305567.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1f/33/jpts-27-227.PMC4305568.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jpts-27-23.PMC4305569.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c1/f7/jpts-27-231.PMC4305570.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/d3/jpts-27-235.PMC4305571.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/b0/jpts-27-239.PMC4305572.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cb/cb/jpts-27-243.PMC4305573.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f4/35/jpts-27-247.PMC4305574.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/16/f9/jpts-27-251.PMC4305575.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9f/09/jpts-27-255.PMC4305576.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/21/8f/jpts-27-259.PMC4305577.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/06/5a/jpts-27-265.PMC4305578.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d3/75/jpts-27-269.PMC4305579.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f7/fd/jpts-27-27.PMC4305580.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/52/d1/jpts-27-273.PMC4305581.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f1/44/jpts-27-279.PMC4305582.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/68/65/jpts-27-285.PMC4305583.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/67/2c/jpts-27-289.PMC4305584.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/65/02/jpts-27-293.PMC4305585.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/f2/b4/jpts-27-295.PMC4305586.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/d6/08/jpts-27-303.PMC4305587.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/jpts-27-309.PMC4305588.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/35/44/jpts-27-31.PMC4305589.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/11/4d/jpts-27-313.PMC4305590.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/09/1f/jpts-27-35.PMC4305591.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/75/91/jpts-27-39.PMC4305592.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/ce/1e/jpts-27-41.PMC4305593.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/84/96/jpts-27-47.PMC4305594.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e0/2c/jpts-27-5.PMC4305595.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/62/97/jpts-27-51.PMC4305596.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a7/7b/jpts-27-57.PMC4305597.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d2/b3/jpts-27-59.PMC4305598.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3a/bf/jpts-27-63.PMC4305599.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/17/bd/jpts-27-67.PMC4305600.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/83/60/jpts-27-7.PMC4305601.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fa/bc/jpts-27-71.PMC4305602.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7b/3f/jpts-27-75.PMC4305603.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bb/e7/jpts-27-79.PMC4305604.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/19/93/jpts-27-83.PMC4305605.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0f/f7/jpts-27-87.PMC4305606.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/ce/20/jpts-27-91.PMC4305607.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9a/ae/jpts-27-97.PMC4305608.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/d4/main.PMC4305620.pdf
Less well characterized Salp 15 orthologs http://dx.doi.org/10.1016/j.fob.2014.12.002 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/d4/main.PMC4305620.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: DsbA, thiol:disulﬁde interchange protein DsbA; GB1, immuno- globulin binding domain B1 of streptococcal protein G; eGFP, enhanced green ﬂuorescent protein; GST, glutathione-S-transferase; HSQC, heteronuclear single quantum coherence; MBP, maltose-binding protein; OspC, outer surface protein C;Salp15, salivary protein of 15 kDa; Trx, thioredoxin ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/f6/d4/main.PMC4305620.pdf
The TALOS-N [41] web server (http://spin.niddk.nih.gov/bax/nmrserver/talosn/ ) was used for chemical shift based identiﬁcation of secondary structure elements.,OADS,/arxiv_data1/oa_pdf/f6/d4/main.PMC4305620.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.12.002 .",OADS,/arxiv_data1/oa_pdf/f6/d4/main.PMC4305620.pdf
Secondary consideration wasContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.01.001 2211-7539/ &2015 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC4306033.pdf
A BLAST search of the ITS sequence data in Genebank at the NCBI website ( http://www.ncbi.nlm.nih.gov/BLAST/ ) revealed 95% identical sites with Scytalidium lignicola ; the next closest match was 88.4% identity with Scytalidium cuboideum .,OADS,/arxiv_data1/oa_pdf/79/b6/main.PMC4306033.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/87/main.PMC4306096.pdf
"A GeneTrails AML/MDS next-generation sequen- cing panel (Supplementary Table 1 , Knight Diagnostics Lab, Port- land, OR) was performed on marrow aspirate and was signi ﬁcantContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2014.12.003 2213-0489/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/eb/87/main.PMC4306096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/87/main.PMC4306096.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.lrr.2014.12.003 .,OADS,/arxiv_data1/oa_pdf/eb/87/main.PMC4306096.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/3f/srep08024.PMC4306106.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8010 | DOI: 10.1038/srep08010 6",Non-OADS,/arxiv_data1/oa_pdf/3e/16/srep08010.PMC4306110.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/e7/srep08023.PMC4306114.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8023 | DOI: 10.1038/srep08023 7",Non-OADS,/arxiv_data1/oa_pdf/5c/e7/srep08023.PMC4306114.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/6b/srep08008.PMC4306120.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8008 | DOI: 10.1038/srep08008 10",Non-OADS,/arxiv_data1/oa_pdf/db/6b/srep08008.PMC4306120.pdf
"We usedarrays comprising 0.4 million 50-mer to 60-mer oligonucleotides coveringchromosome 21 at a median probe density of 1 per 60 bp (Agilent Technologies).Microarray protocols, including labeling, hybridization and post-hybridizationwashing procedures, were conducted according to the manufacturer’s instructions and are available at http://www.agilent.com.",OADS,/arxiv_data1/oa_pdf/e7/f1/srep08020.PMC4306122.pdf
"designed, supervised the study, and criticallycontributed to analyzing the data Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/e7/f1/srep08020.PMC4306122.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8020 | DOI: 10.1038/srep08020 10",Non-OADS,/arxiv_data1/oa_pdf/e7/f1/srep08020.PMC4306122.pdf
Gene-specific primers werechosen with the use of the Primer3 program (http://frodo.wi.mit.edu/).,OADS,/arxiv_data1/oa_pdf/0c/b8/srep08030.PMC4306126.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/b8/srep08030.PMC4306126.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8030 | DOI: 10.1038/srep08030 8",Non-OADS,/arxiv_data1/oa_pdf/0c/b8/srep08030.PMC4306126.pdf
"and J.B. performed themicroscopic and ORAC experiments.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: This research was supported by the CSBR (Centres for Systems Biology Research) initiative from the Netherlands Organisation for ScientificResearch (NWO; No: CSBR09/013V) and a PM-Rare (Priority Medicines Rare disorders and orphan diseases) grant from ZON-MW (Netherlands Organization for Health Research and Development-Medical Sciences, No: 40-41900-98-033), the Energy4Allfoundation (www.energy4all.eu), the TIM foundation (www.timfoundation.nl) and an equipment grant of NWO (Netherlands Organization for Scientific Research, No: 911-02-008).",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/srep08035.PMC4306129.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8021 | DOI: 10.1038/srep08021 9",Non-OADS,/arxiv_data1/oa_pdf/6c/9e/srep08021.PMC4306130.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/30/srep08016.PMC4306132.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8016 | DOI: 10.1038/srep08016 10",Non-OADS,/arxiv_data1/oa_pdf/ff/30/srep08016.PMC4306132.pdf
"Lastly, a bamboo microsatellites database (http://www.bamboogdb.org/ssr) was implemented to browse and search large information of bamboo microsatellites.",OADS,/arxiv_data1/oa_pdf/da/c2/srep08018.PMC4306134.pdf
"Identification of microsatellites .The MIcroSAtellite identification tool (MISA) (http://pgrc.ipk-gatersleben.de/misa/) was used to identify microsatellite occurrences in the genome sequence data (moso bamboo data from BambooGDB49, others from Phytozome v103).",OADS,/arxiv_data1/oa_pdf/da/c2/srep08018.PMC4306134.pdf
"In addition, tovividly exhibit location of microsatellite in whole genome, microsatellite data was added in GBrowser after being converted into genome feature format (GFF).GBrowser uses MySQL as backend and was built following the configuration files provided by its developer (http://gmod.org).",OADS,/arxiv_data1/oa_pdf/da/c2/srep08018.PMC4306134.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/c2/srep08018.PMC4306134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8018 | DOI: 10.1038/srep08018 10",Non-OADS,/arxiv_data1/oa_pdf/da/c2/srep08018.PMC4306134.pdf
The MATLAB codes for running MMWF and MMWF *for general denoising of 2D and 3D signals are available at: https://sites.google.com/site/ carlovittoriocannistraci/5-datasets-and-matlab-code/median-modified-wiener- filter-for-2d-and-multidimensional-signal-denosing.,OADS,/arxiv_data1/oa_pdf/a6/86/srep08017.PMC4306135.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a6/86/srep08017.PMC4306135.pdf
"MOPAC2012 Stewart Computational Chemistry,Colorado Springs, CO, USA, http://OpenMOPAC.net (2007) Date of access:10/12/ 2014] was used to carry out the quantum chemical computations.",OADS,/arxiv_data1/oa_pdf/53/aa/srep08009.PMC4306138.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/aa/srep08009.PMC4306138.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/04/9d/srep08033.PMC4306139.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8033 | DOI: 10.1038/srep08033 12",Non-OADS,/arxiv_data1/oa_pdf/04/9d/srep08033.PMC4306139.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/e9/srep08011.PMC4306140.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/98/srep08029.PMC4306141.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8029 | DOI: 10.1038/srep08029 11",Non-OADS,/arxiv_data1/oa_pdf/11/98/srep08029.PMC4306141.pdf
Methods Molecular cloning .The amino acid sequence of the TRPM2-like channel of Nematostella vectensis was retrieved from the genomic database JGI (http://www.jgi.doe.gov/).,OADS,/arxiv_data1/oa_pdf/56/87/srep08032.PMC4306143.pdf
"The Ca21concentration of the solutions was calculated using the MAXC -program: (http://www.stanford.edu/ ,cpatton/maxc.html).",OADS,/arxiv_data1/oa_pdf/56/87/srep08032.PMC4306143.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/87/srep08032.PMC4306143.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8032 | DOI: 10.1038/srep08032 12",Non-OADS,/arxiv_data1/oa_pdf/56/87/srep08032.PMC4306143.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/52/srep08014.PMC4306144.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8014 | DOI: 10.1038/srep08014 7",Non-OADS,/arxiv_data1/oa_pdf/1c/52/srep08014.PMC4306144.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ae/83/srep08027.PMC4306145.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8027 | DOI: 10.1038/srep08027 11",Non-OADS,/arxiv_data1/oa_pdf/ae/83/srep08027.PMC4306145.pdf
http://dx.doi.org/10.1016/j.bonr.2014.10.004 2352-1872/© 2014 Elsevier Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/43/71/main.PMC4306187.pdf
"US Department of Health and Human Services, Food and DrugAdministration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), February 1999. http://www.fda.gov/downloads/Drugs/Guidances/ UCM072137.pdf .",OADS,/arxiv_data1/oa_pdf/32/0b/40262_2014_Article_196.PMC4306193.pdf
http://www.emea.europa.eu/pdfs/ human/ewp/18599006enﬁn.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/0b/40262_2014_Article_196.PMC4306193.pdf
J Oral Maxillofac Res 2014;5(4):e1 URL: http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.pdf doi: 10.5037/jomr.2014.5401 http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
[URL: http://www.cochrane.org/ cochrane-interventions-handbook ] 21.,OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
[URL: http://www.ejomr.org/JOMR/archives/2010/1/e2/e2ht.htm ] [Medline: 24421958 ] [PMC free article: 3886040 ]  [doi: 10.5037/jomr.2010.1102 ],Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
[URL: http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.htm ]  [Medline: 24421983 ] [PMC free article: 3886063 ] [doi: 10.5037/jomr.2011.2101 ] 72.,Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
"J Oral Maxillofac Res 2014;5(4):e1 URL: http://www.ejomr.org/JOMR/archives/2014/4/e1/v5n4e1ht.pdf doi: 10.5037/jomr.2014.5401 Copyright ©  Sarikov R, Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/8d/4a/jomr-05-e1.PMC4306319.pdf
J Oral Maxillofac Res 2014;5(4):e2 URL: http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.pdf doi: 10.5037/jomr.2014.5402 http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
[URL: http://www.ejomr.org/JOMR/archives/2011/1/e1/v2n1e1ht.pdf ]  [Medline: 24421983 ] [doi: 10.5037/jomr.2011.2101 ] 2.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
[URL: http://www.cochrane.org/ cochrane-interventions-handbook ] 31.,OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
"J Oral Maxillofac Res 2014;5(4):e2 URL: http://www.ejomr.org/JOMR/archives/2014/4/e2/v5n4e2ht.pdf doi: 10.5037/jomr.2014.5402 Copyright ©  Shavit I, Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/23/79/jomr-05-e2.PMC4306320.pdf
J Oral Maxillofac Res 2014;5(4):e3 URL: http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.pdf doi: 10.5037/jomr.2014.5403 http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
[URL: http://www.cochrane.org/handbook ] 12.,OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
"J Oral Maxillofac Res 2014;5(4):e3 URL: http://www.ejomr.org/JOMR/archives/2014/4/e3/v5n4e3ht.pdf doi: 10.5037/jomr.2014.5403 Copyright ©  Larmas M, Sándor GK.",Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/7f/65/jomr-05-e3.PMC4306321.pdf
J Oral Maxillofac Res 2014;5(4):e4 URL: http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.pdf doi: 10.5037/jomr.2014.5404 http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
[Medline: 19153293 ] [doi: 10.1001/archfacial.2008.507 ] http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
"J Oral Maxillofac Res 2014;5(4):e4 URL: http://www.ejomr.org/JOMR/archives/2014/4/e4/v5n4e4ht.pdf doi: 10.5037/jomr.2014.5404 Copyright ©  Goulart DR, Colombo LA, de Moraes M, Asprino L. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.20.",Non-OADS,/arxiv_data1/oa_pdf/00/87/jomr-05-e4.PMC4306322.pdf
J Oral Maxillofac Res 2014;5(4):e5 URL: http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.pdf doi: 10.5037/jomr.2014.5405 http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
[Medline: 15660750 ] [doi: 10.1111/j.1600-9657.2004.00262.x ] http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
[URL: http://www.who.int/ageing/pubblications/Falls_prevention7March.pdf ] 29.,Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
"J Oral Maxillofac Res 2014;5(4):e5 URL: http://www.ejomr.org/JOMR/archives/2014/4/e5/v5n4e5ht.pdf doi: 10.5037/jomr.2014.5405 Copyright ©  Roccia F, Boffano P, Bianchi FA, Zavattero E. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/53/b9/jomr-05-e5.PMC4306323.pdf
"Accepted for publication: 13 December 2014 To cite this article: Baherimoghaddam T, Oshagh M, Naseri N, Nasrbadi NI, Torkan S. Changes in Cephalometric Variables after Orthognathic  Surgery and Their Relationship to Patients’ Quality of Life and Satisfaction J Oral Maxillofac Res 2014;5(4):e6 URL: http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.pdf doi: 10.5037/jomr.2014.5406 http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.",Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.htm J Oral Maxillofac Res 2014 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
"J Oral Maxillofac Res 2014;5(4):e6 URL: http://www.ejomr.org/JOMR/archives/2014/4/e6/v5n4e6ht.pdf doi: 10.5037/jomr.2014.5406 Copyright ©  Baherimoghaddam T, Oshagh M, Naseri N, Nasrbadi NI, Torkan S. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 29 December 2014.",Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/43/0c/jomr-05-e6.PMC4306324.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/fe/nihms-656630.PMC4306343.pdf
"We use  a battery of assays applicable to the human, monkey, and mouse organotypic cultures and  supravital tissue to identify neuronal progenitors in the cortical VZ/SVZ niche that produce a  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ *Correspondence: nzecevic@neuron.uchc.edu.7Co-first author Supplemental Information: Supplemental Information includes Supplemental Experimental Procedures, seven figures, and two tables  and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2014.11.026 .",Non-OADS,/arxiv_data1/oa_pdf/a9/1b/nihms653760.PMC4306459.pdf
"Published online September 18, 2013.  http://dx.doi.org/10.1093/cer-cor/bht254 Anderson SA, Eisenstat DD, Shi L, Rubenstein JL.",OADS,/arxiv_data1/oa_pdf/a9/1b/nihms653760.PMC4306459.pdf
"Published online  August 21, 2014. http://dx.doi.org/10.1093/cercor/bhu183 Radonjić NV, Ortega JA, Memi F, Dionne K, Jakovcevski I, Zecevic N. The complexity of the  calretinin-expressing progenitors in the human cerebral cortex.",OADS,/arxiv_data1/oa_pdf/a9/1b/nihms653760.PMC4306459.pdf
http://dx.doi.org/10.1016/j.chembiol.2014.11.010 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/main.PMC4306531.pdf
"This modeling approach is imple-mented in Integrative Modeling Platform(IMP) ( http://integrativemodeling.org ), an open source software suite for computing and characterizing models of macromo-lecular assemblies based on varied types of data ( Russel et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/dc/ee/main.PMC4306531.pdf
"Data, Software, and Results The implementation of our integrative protocol is based on the open sourceIMP software package ( http://integrativemodeling.org ).",OADS,/arxiv_data1/oa_pdf/dc/ee/main.PMC4306531.pdf
"The input data ﬁles, IMP modeling scripts, and output models for the seven benchmark casesand the eIF3:eIF5 complex are available at https://github.com/apolitis/eif3 andhttps://github.com/apolitis/ms_benchmark .",OADS,/arxiv_data1/oa_pdf/dc/ee/main.PMC4306531.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and six tables and can be found with this article online at http://dx.doi.org/10.1016/j.chembiol.2014.,OADS,/arxiv_data1/oa_pdf/dc/ee/main.PMC4306531.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/5e/21/pas-39-266.PMC4306537.pdf
"Guest Editor for this article was Markku Kaste, MD, PhD.The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.",OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.114.006849,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
"Fluid-attenuated inversion recovery sequences were analyzed us-ing an MRIcro (http://www.mricro.com), a semiautomated method described previously.",OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
Standardized quality control procedures were applied before imputation using IMPUTE version 2 (http://mathgen.stats.ox.ac.uk/impute/impute_v2.html) and HapMap3 and 1000 Genomes Project Phase pilot (June 2010).,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
Imputed genotype dosage data were converted to hard-call using a strict level of confidence (r 2>0.95) in  PLINK version 1.07 (http://pngu.mgh.harvard.edu/≈purcell/plink/).,OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
"Statistical Analyses For statistical analyses, SPPS version 16 (http://www.ibm.com/soft-ware/uk/analytics/spss) and R version 3.1.1 (http://www.r-project.com) were used, and P<0.05 was considered significant.",OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
"Heritability Analyses To estimate the heritability from the GWAS data, we used the ge-nome-wide Complex Tool version 1.02 (http://www.complextrait- genomics.com/software/gcta/).",OADS,/arxiv_data1/oa_pdf/e1/b0/str-46-348.PMC4306538.pdf
"Martinello et al., 2015, Neuron 85, 346–363 January 21, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.neuron.2014.12.030",OADS,/arxiv_data1/oa_pdf/5e/f6/main.PMC4306544.pdf
"Neuron Article Cholinergic Afferent Stimulation Induces Axonal Function Plasticityin Adult Hippocampal Granule Cells Katiuscia Martinello,1Zhuo Huang,1Rafael Lujan,2Baouyen Tran,3Masahiko Watanabe,4Edward C. Cooper,3 David A. Brown,5and Mala M. Shah1,* 1UCL School of Pharmacy, University College London, London, WC1N 1AX, UK 2Departamento de Ciencias Medicas, Universidad de Castilla-La Mancha, 02006 Albacete, Spain 3Neurology and Neuroscience, Baylor College of Medicine, TX 77030, USA 4Anatomy, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan 5Neuroscience, Physiology and Pharmacology, University College London, London, WC1E 6BT, UK *Correspondence: mala.shah@ucl.ac.uk http://dx.doi.org/10.1016/j.neuron.2014.12.030 This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5e/f6/main.PMC4306544.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures, four tables, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/5e/f6/main.PMC4306544.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/ NIH Public Access Author Manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/0d/63/nihms646670.PMC4306576.pdf
https://grist.files.wordpress.com/2011/10/ fastfacts_3in10.pdfGatny et al.,Non-OADS,/arxiv_data1/oa_pdf/0d/63/nihms646670.PMC4306576.pdf
"143 Lab Anim Res 2014: 30(4), 143-150 http://dx.doi.org/10.5625/lar.2014.30.4.143 Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models Seung-Hee Kim, Cho-Won Kim, So-Ye Jeon, Ryeo-Eun Go, Kyung-A Hwang*, Kyung-Chul Choi* Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea Genistein is one of isoflavones mostly derived in a leguminous plant.",Non-OADS,/arxiv_data1/oa_pdf/78/1a/lar-30-143.PMC4306701.pdf
"151 Lab Anim Res 2014: 30(4), 151-160 http://dx.doi.org/10.5625/lar.2014.30.4.151 Effects of pectin lyase-modified red ginseng extracts in high-fat diet-fed obese mice Hak-Yong Lee1#, Kwang-Hyun Park2#, Young-Mi Park1, Dae-In Moon1, Hong-Geun Oh1, Dae-Young Kwon3,  Hye-Jeong Yang3, Okjin Kim4, Dong-Woo Kim4, Ji-Hyun Yoo5, Se-Chul Hong5, Kun-Hee Lee5, Su-Yeon Seol5, Yong-Sik Park5, Jong-Dae Park5, Mi-Kyung Pyo5* 1Huvet Co., Ltd., Iksan, Korea 2Department of Oriental Pharmaceutical Development, Nambu University, Gwangju, Korea 3Korea Food Research Institute, Seungnam, Korea 4Center for Animal Resources Development, Wonkwang University, Iksan, Korea 5International Ginseng and Herb Research Institute, Geumsan, Korea Red ginseng and its extracts have been used as traditional medicines and functional foods in countries worldwide.",Non-OADS,/arxiv_data1/oa_pdf/df/45/lar-30-151.PMC4306702.pdf
"161 Lab Anim Res 2014: 30(4), 161-168 http://dx.doi.org/10.5625/lar.2014.30.4.161 Onion peel water extracts enhance immune status in forced swimming rat model Hyun-A Lee1, Sang-Jun Han1, Sunhwa Hong1, Dong-Woo Kim1, Gi-Wook Oh1, Okjin Kim1,2* 1Center for Animal Resources Development, Wonkwang University, Iksan, Korea 2Institute of Animal Experiment & Efficacy Evaluation, Wonkwang University, Iksan, Korea Onion peel contains a high concentration of quercetin and other flavonoids.",Non-OADS,/arxiv_data1/oa_pdf/95/c2/lar-30-161.PMC4306703.pdf
"169 Lab Anim Res 2014: 30(4), 169-173 http://dx.doi.org/10.5625/lar.2014.30.4.169 Anticoccidial effects of the root bark of Dictamnus dasycarpus  Turcz  extract on experimental Eimeria tenella  infection Sunhwa Hong1, Hyun-A Lee1, Dong-Woo Kim1, Gi-Wook Oh1, Okjin Kim1,2* 1Center for Animal Resources Development, Wonkwang University, Iksan, Korea 2Institute of Animal Experiment & Efficacy Evaluation, Wonkwang University, Iksan, Korea Anticoccidial effects of the root bark of Dictamnus dasycarpus Turcz (Rutaceae) extract (DDE) were evaluated in chickens following oral infection with Eimeria (E.) tenella .",Non-OADS,/arxiv_data1/oa_pdf/ba/1a/lar-30-169.PMC4306704.pdf
"174 Lab Anim Res 2014: 30(4), 174-180 http://dx.doi.org/10.5625/lar.2014.30.4.174 Protective effects of pine bark extract against cisplatin-induced  hepatotoxicity and oxidative stress in rats Je-Won Ko, In-Chul Lee, Sung-Hyuk Park, Changjong Moon, Seong-Soo Kang,  Sung-Ho Kim, Jong-Choon Kim* College of Veterinary Medicine, Chonnam National University, Gwangju, Korea We investigated the protective effects of pine bark extract (pycnogenol®, PYC) against cisplatin-induced hepatotoxicity and oxidative stress in rats.",Non-OADS,/arxiv_data1/oa_pdf/7f/21/lar-30-174.PMC4306705.pdf
"181 Lab Anim Res 2014: 30(4), 181-184 http://dx.doi.org/10.5625/lar.2014.30.4.181 Suppurative bite wound by repetitive aggression of dominance  hierarchy during group housing in rhesus monkeys Yunjung Choi1, Kyung-Ha Ahn3, Jae-Il Lee1,2* 1Transplantation Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea 2Laboratory of Transplantation Immunology, Department of Medicine, Seoul National University College of Medicine, Seoul, Korea 3Department of Neurology, Seoul National University Hospital, Seoul, Korea Group formation of rhesus monkeys, often leads to victims of repeated attacks by the high ranking animal.",Non-OADS,/arxiv_data1/oa_pdf/65/2c/lar-30-181.PMC4306706.pdf
"185 Lab Anim Res 2014: 30(4), 185-189 http://dx.doi.org/10.5625/lar.2014.30.4.185 Unilateral cryptorchidism in duces morphological changes of testes and hyperplasia of Sertoli cells in a dog Joon Ho Moon1,4#, Dae Young Yoo2,4#, Young Kwang Jo1,4, Geon A Kim1,4, Hyo Young Jung2,4, Jung Hoon Choi3, In Koo Hwang2,4*, Goo Jang1,4,5,6* 1Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Seoul, Korea 2Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul, Korea 3Department of Anatomy, College of Veterinary Medicine, Kangwon National University, Chuncheon, Korea 4BK21 PLUS Program for Creative Veterinary Science Research, and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea 5Institute of Green Bio Science & Technology, Seoul National University, Pyeong Chang, Kangwon-do, Korea 6Emergence Center for Food-Medicine Personalized Therapy System, Advanced Institutes of Convergence Technology, Seoul National University, Gyeonggi-do, Korea Cryptorchidism is one of the most common genital defects in dogs.",Non-OADS,/arxiv_data1/oa_pdf/5c/29/lar-30-185.PMC4306707.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
The online supplemental   material is available at http://www.jgp.org/cgi/content/full/jgp.201411304/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/ j.neuron.2011.11.014 Bezzina, C.R., and C.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1161/ CIRCEP.108.791434 Bezzina, C.R., M.B.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"92:159– 168. http://dx.doi.org/10.1161/01.RES.0000052672.97759.36 Blanchet, J., and M. Chahine.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1007/ s00232-007-9016-1 Bukauskas, F.F., A. Bukauskiene, M.V.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/S0006- 3495(01)75687-1 Cha, A., P.C.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80680-7 Chahine, M., S. Pilote, V. Pouliot, H. Takami, and C. Sato.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1007/s00232-004-0701-z Cheng, J., A. Morales, J.D.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1111/j.1752- 8062.2010.00249.x Darden, T., D. York, and L. Pedersen.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1063/1.464397 Delemotte, L., W. Treptow, M.L.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/S0008-6363(00)00006-7 Eswar, N., B. Webb, M.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1093/brain/ awt300 Feller, S.E., and A.D. MacKerrell Jr. 2000.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
http://dx.doi .org/10.1007/s00424-009-0761-0,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/ 10.1016/j.bpj.2011.10.057 Krepkiy, D., M. Mihailescu, J.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1038/ nature08542 Lacroix, J.J., S.A. Pless, L. Maragliano, F.V.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1085/jgp.201210827 Lacroix, J.J., H.C. Hyde, F.V.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1073/pnas.1406161111 Larkin, M.A., G. Blackshields, N.P.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"23:2947– 2948. http://dx.doi.org/10.1093/bioinformatics/btm404 Laurent, G., S. Saal, M.Y.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"60:144– 156. http://dx.doi.org/10.1016/j.jacc.2012.02.052 Li, Q., S. Wanderling, P. Sompornpisut, and E. Perozo.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1038/nsmb.2747 Lin, M.C., J.Y.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1085/ jgp.201110642 Liu, B., S.B.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1371/journal.pone.0038259 MacKerell, A.D., Jr., D. Bashford, M. Bellott, R.L.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1002/jcc.20065 Mann, S.A., M.L.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/j.jacc.2012.05.050 Matthews, E., R. Labrum, M.G.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1212/01.wnl.0000342387.65477.46 McNair, W.P., G. Sinagra, M.R.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/ 10.1021/jp0007843 Gamal El-Din, T.M., H. Heldstab, C. Lehmann, and N.G.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.4161/chan.4.2.10672 Gamal El-Din, T.M., G.Q.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1085/jgp.201311012 Gamal El-Din, T.M., T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/ 10.1085/jgp.201411210 Gellens, M.E., A.L.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1371/journal.pone .0038331 Gosselin-Badaroudine, P., A. Moreau, and M. Chahine.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.4161/chan.27179 Groome, J.R., F. Lehmann-Horn, C. Fan, M. Wolf, V. Winston, L.  Merlini, and K. Jurkat-Rott.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1093/ brain/awu015 Henrion, U., J. Renhorn, S.I.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1073/pnas.1116938109 Huang, H., S.G.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1152/ajpheart.00539.2010 Izaguirre, J.A., S. Reich, and R.D.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1063/1.478995 Jensen, M.O., V. Jogini, D.W. Borhani, A.E.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1126/science .1216533 Jogini, V., and B. Roux.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1063/1.445869 Jurkat-Rott, K., M.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/ j.jacc.2010.09.084 Miceli, F., M.V.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"102:1372– 1382. http://dx.doi.org/10.1016/j.bpj.2012.02.004 Moreau, A., P. Gosselin-Badaroudine, and M. Chahine.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"5:53. http://dx.doi.org/10.3389/ fphar.2014.00053 Moreau, A., P. Gosselin-Badaroudine, and M. Chahine.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10 .1017/S0033583514000109 Nair, K., R. Pekhletski, L. Harris, M. Care, C. Morel, T. Farid, P.H.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.3345/kjp.2010.53.10.909 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1038/nature10238 Phillips, J.C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid,  E. Villa, C. Chipot, R.D.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1002/jcc.20289 Ramsey, I.S., Y. Mokrab, I. Carvacho, Z.A.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"17:869– 875. http://dx.doi.org/10.1038/nsmb.1826 Remme, C.A., and A.A. Wilde.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/ 10.1038/nrcardio.2009.44 Schwaiger, C.S., S.I.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1371/journal .pone.0045880 Sokolov, S., T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1038/nature05598Sokolov, S., T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10 .1073/pnas.0810562105 Struyk, A.F., and S.C. Cannon.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1085/ jgp.200709755 Tao, X., A. Lee, W. Limapichat, D.A.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1126/science.1185954 Tombola, F., M.M.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1016/ j.neuron.2004.12.047 Tombola, F., M.M.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1038/ nature05396 Treptow, W., and M. Tarek.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"2:8. http://dx.doi.org/10.3389/ fphar.2011.00008 Vargas, E., V. Yarov-Yarovoy, F. Khalili-Araghi, W.A.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/ 10.1085/jgp.201210873 Wood, M.L., E.V.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi .org/10.1016/j.bbamem.2011.07.045 Wu, F., W. Mi, D.K.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1172/JCI57398 Wu, F., W. Mi, E.O.",OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
"http://dx.doi.org/10.1172/ JCI66091 Yarov-Yarovoy, V., P.G.",Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
http://dx.doi.org/ 10.1073/pnas.1118434109,Non-OADS,/arxiv_data1/oa_pdf/a8/2b/JGP_201411304.PMC4306709.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1074/jbc.M110.150888 Lee, J.H., C.K.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1016/j.cell.2014.03.064 Leipold, E., A. Hansel, A. Borges, and S.H.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi .org/10.1038/nature06265 Martin, M.F., L.G.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1007/978-3-0348- 8466-2_10 Murata, Y., H. Iwasaki, M. Sasaki, K. Inaba, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/ nature03650 Neumann, T., H.D.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.2174/15680 2607782341073 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/nature10238 Ramsey, I.S., M.M.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/nature04700 Rogers, J.C., Y. Qu, T.N.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1074/jbc.271.27.15950 Sasaki, M., M. Takagi, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"312:589– 592. http://dx.doi.org/10.1126/science.1122352 Schuck, P., and H. Zhao.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1007/978-1-60761-670-2_2 Südhof, T.C., and J.E.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi .org/10.1126/science.1161748 Swartz, K.J.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/nature07620 Swartz, K.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80306-2R E F E R E N C E S Alabi, A.A., M.I.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/nature06266 Bende, N.S., S. Dziemborowicz, M. Mobli, V. Herzig, J. Gilchrist,  J. Wagner, G.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/376683a0 Benzinger, G.R., J.W.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/ 10.1074/jbc.273.1.80 Bezanilla, F. 2008.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/nrm2376 Bosmans, F., M.F.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1038/ nature07473 Bosmans, F., M. Puopolo, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1085/jgp .201110614 Capes, D.L., M.P.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1085/jgp.201310998 Cestèle, S., Y. Qu, J.C. Rogers, H. Rochat, T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80606-6 Cestèle, S., V. Yarov-Yarovoy, Y. Qu, F. Sampieri, T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1074/jbc.M603814200 Chioni, A.M., S.P.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1016/j .jneumeth.2005.03.010 Crest, M., G. Jacquet, M. Gola, H. Zerrouk, A. Benslimane, H.  Rochat, P. Mansuelle, and M.F.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1007/978-3-642-41588-3_10 Gur, M., R. Kahn, I. Karbat, N. Regev, J. Wang, W.A.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1074/jbc .M111.259507 Kalia, J., M. Milescu, J. Salvatierra, J. Wagner, J.K. Klint, G.F. King, B.M.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
http://dx.doi.org/10.1016/j.jmb.2014.07.027,OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1021/ bi9004599 Unnerståle, S., F. Madani, A. Gräslund, and L. Mäler.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1021/bi300188t Wan, X., S. Chen, A. Sadeghpour, Q. Wang, and G.E.",OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
"http://dx.doi.org/10.1074/jbc.M111.282509 Zhang, J.Z., V. Yarov-Yarovoy, T. Scheuer, I. Karbat, L. Cohen, D.  Gordon, M. Gurevitz, and W.A.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
287:30719– 30728. http://dx.doi.org/10.1074/jbc.M112.370742,Non-OADS,/arxiv_data1/oa_pdf/a6/ef/JGP_201411268.PMC4306711.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
The online supplemen - tal material is available at http://www.jgp.org/cgi/content/full/jgp.201411250/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1085/jgp.112.3.297 Baylor, S.M., and S. Hollingworth.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi .org/10.1085/jgp.200709827 Baylor, S.M., W.K.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/jphysiol.1983.sp014959 Canato, M., M. Scorzeto, M. Giacomello, F. Protasi, C. Reggiani, and  G.J.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/jphysiol.1994.sp020423 Celichowski, J., and K. Grottel.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1097/00001756-199312000-00003 Cieslar, J., M.T.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1016/S0006-3495(88)83071-6 Cox, J.A., D.R.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1016/S0300-9084(79)80157-1 Everts, M.E., T. Lømo, and T. Clausen.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1111/ j.1748-1716.1993.tb09512.x Fénelon, K., C.R.H.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"140:403– 419. http://dx.doi.org/10.1085/jgp.201110730 Fenn, W.O.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/jphysiol.1996 .sp021388 Gissel, H., and T. Clausen.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1002/mus.880110809 Godt, R.E., and D.W. Maughan.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/ 10.1085/jgp.106.2.259 Pape, P.C., K. Fénelon, C.R.H.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/ 10.1113/jphysiol.2006.126474 Peachey, L.D., and A.F.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1083/jcb.13.1.177 Posterino, G.S., and G.D. Lamb.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi .org/10.1113/jphysiol.2003.040022 Protasi, F., C. Paolini, and M. Dainese.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi .org/10.1113/jphysiol.2009.171967 Ringer, S. 1883.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/jphysiol .1883.sp000120 Robertson, S.P ., J.D.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1016/S0006-3495(81)84868-0 Rojas, L., and C. Zuazaga.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1016/0304- 3940(88)90312-6 Scorzeto, M., M. Giacomello, L. Toniolo, M. Canato, B. Blaauw,  C. Paolini, F. Protasi, C. Reggiani, and G.J.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1371/journal.pone.0074919 Sztretye, M., J. Yi, L. Figueroa, J. Zhou, L. Royer, P. Allen, G. Brum,  and E. Ríos.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1085/ jgp.201010592 Tsien, R.Y.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1021/bi00552a018 Yoshida, M., A. Yonetani, T. Shirasaki, and K. Wada.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1152/ ajpregu.00684.2004 Zhang, L., J. Kelley, G. Schmeisser, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"272:23389– 23397. http://dx.doi.org/10.1074/jbc.272.37.23389Harrison, S.M., and D.M.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1016/ 0304-4165(87)90102-4 Heizmann, C.W., M.W.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/ 10.1113/jphysiol.2011.220780 Inesi, G., M. Kurzmack, C. Coan, and D.E.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1085/jgp.89.1.1 Kake-Guena, S.A., C.R.H.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/jphysiol.1975.sp011178 Lamboley, C.R., R.M.",OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1113/ jphysiol.2007.138024 Paolini, C., M. Quarta, L. D’Onofrio, C. Reggiani, and F. Protasi.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
"http://dx.doi.org/10.1155/2011/ 634075 Pape, P.C., D.-S. Jong, and W.K.",Non-OADS,/arxiv_data1/oa_pdf/e4/4d/JGP_201411250.PMC4306712.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"3:1444– 1463. http://dx.doi.org/10.1002/pro.5560030911 Berman, H.M., J. Westbrook, Z. Feng, G. Gilliland, T.N.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1093/ nar/28.1.235 Choe, S., M.J. Bennett, G. Fujii, P.M.G.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1038/ 357216a0 Donovan, J.J., M.I.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1073/pnas.78.1.172 Gordon, M., and A. Finkelstein.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/ jgp.118.5.471 Greenfield, L., M.J. Bjorn, G. Horn, D. Fong, G.A.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1073/ pnas.80.22.6853 Gross, A., L. Columbus, K. Hideg, C. Altenbach, and W.L.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1021/bi990856k Hattori, M., and E. Gouaux.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1038/nature11010 Hoch, D.H., M. Romero-Mira, B.E.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1073/ pnas.82.6.1692 Huynh, P.D., C. Cui, H. Zhan, K.J.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/jgp.110.3.229 Johnson, N.L., S. Kotz, and N. Balakrishnan.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1073/pnas.78.8.4950 Karlin, A.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/jgp.117.3.235 Karlin, A., and M.H.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
http://dx.doi.org/ 10.1016/S0076-6879(98)93011-7experiments with the L307R mutant.),Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/ jgp.200810042 Lai, B., G. Zhao, and E. London.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1021/bi7025134 Mindell, J.A.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/ 10.1016/0076-6879(74)32053-8 Murphy, J.R. 2011.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1126/science.273.5276.810 Oh, K.J., H. Zhan, C. Cui, C. Altenbach, W.L.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/ 10.1021/bi990520a Oh, K.J., L. Senzel, R.J. Collier, and A. Finkelstein.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1074/jbc.M111.221895 Pascual, J.M., and A. Karlin.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/jgp.111.6.717 Roberts, D.D., S.D.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1021/bi00367a038 Rosconi, M.P., and E. London.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"277:16517– 16527. http://dx.doi.org/10.1074/jbc.M200442200 Rosconi, M.P., G. Zhao, and E. London.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1371/journal.pcbi.1003255 Senzel, L., P.D.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1085/jgp.112.3.317 Senzel, L., M. Gordon, R.O.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1007/BF00234995 Stauffer, D.A., and A. Karlin.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1021/ bi00188a013 Wang, J., and E. London.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1021/ bi9014665 Wilson, G.G., and A. Karlin.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1016/S0006-3495(90)82376-6 Zhan, H., K.J.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi .org/10.1021/bi00014a043 Zhang, H., and A. Karlin.",OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"http://dx.doi.org/10.1021/ bi972357u Zhao, G., and E. London.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
http://dx.doi.org/10.1021/ bi047705o,Non-OADS,/arxiv_data1/oa_pdf/9a/7a/JGP_201411326.PMC4306713.pdf
"We are strong because of you.To better serve our community: Introducing new Associate Editors   and an expanded Editorial Advisory Board for 2015 Sharona E. Gordon Editor-in-Chief, The Journal of General Physiology © 2015 Gordon  This article is distributed under the terms of an Attribution–Noncommer- cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/53/79/JGP_201411352.PMC4306714.pdf
"After six months it is available under a Creative Com- mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/53/79/JGP_201411352.PMC4306714.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2015, 6: 24972 - http://dx.doi.org/10.3402/dfa.v6.24972 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/DFA-6-24972.PMC4306752.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24972 - http://dx.doi.org/10.3402/dfa.v6.24972",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/DFA-6-24972.PMC4306752.pdf
"First dressing change scheduled on postopera- tive day 7.Platelet-rich plasma in split-thickness skin graft donor sites Citation: Diabetic Foot & Ankle 2015, 6: 24972 - http://dx.doi.org/10.3402/dfa.v6.24972 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/DFA-6-24972.PMC4306752.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24972 - http://dx.doi.org/10.3402/dfa.v6.24972",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/DFA-6-24972.PMC4306752.pdf
"Adv SkinWound Care 2008; 21: 568 /C175.Platelet-rich plasma in split-thickness skin graft donor sites Citation: Diabetic Foot & Ankle 2015, 6: 24972 - http://dx.doi.org/10.3402/dfa.v6.24972 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/DFA-6-24972.PMC4306752.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/47/awu311.PMC4306818.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/8a/srep08055.PMC4306913.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/bc/srep08049.PMC4306914.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/12/srep08005.PMC4306916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8005 | DOI: 10.1038/srep08005 5",Non-OADS,/arxiv_data1/oa_pdf/e3/12/srep08005.PMC4306916.pdf
"All authors are participated in interpretation of results, manuscript writing and commenting.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/84/dc/srep08064.PMC4306918.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8064 | DOI: 10.1038/srep08064 7",Non-OADS,/arxiv_data1/oa_pdf/84/dc/srep08064.PMC4306918.pdf
"Methods RNA-seq data sets .Publicly available RNA-seq data of ribosomal RNA (rRNA) depleted RNAs (RiboMinus, Life Technologies) from twelve matched CRC tissues and normal colon mucosa (SRA043728, experiment SRP00758416, downloaded from the Sequence Read Archive (SRA) and comprised of 71.7 million short sequencing reads (Illumina GAII, 72 bp paired end reads)) were mapped using RNA Seq Unified Mapper (RUM) and circRNAs predicted by the pipeline published by Memczak et al.3 and http://circrna.org (find_circ.tar.gz, version 1).",OADS,/arxiv_data1/oa_pdf/78/18/srep08057.PMC4306919.pdf
"(2014), available at: http://www.R-project.org, date of access:18/11/2014)).",Non-OADS,/arxiv_data1/oa_pdf/78/18/srep08057.PMC4306919.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/18/srep08057.PMC4306919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8057 | DOI: 10.1038/srep08057 10",Non-OADS,/arxiv_data1/oa_pdf/78/18/srep08057.PMC4306919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8062 | DOI: 10.1038/srep08062 7",Non-OADS,/arxiv_data1/oa_pdf/34/7d/srep08062.PMC4306920.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8060 | DOI: 10.1038/srep08060 7",Non-OADS,/arxiv_data1/oa_pdf/f1/de/srep08060.PMC4306921.pdf
"Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Philip LoGrasso serves as a consultant for OPKO Health How to cite this article: Park, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/85/srep08047.PMC4306959.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/97/srep08041.PMC4306960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8041 | DOI: 10.1038/srep08041 5",Non-OADS,/arxiv_data1/oa_pdf/fc/97/srep08041.PMC4306960.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8038 | DOI: 10.1038/srep08038 6",Non-OADS,/arxiv_data1/oa_pdf/8e/a9/srep08038.PMC4306962.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/64/8c/srep08061.PMC4306963.pdf
"Since February 2013, novel influenza A viruses of the H7N9 subtype [A(H7N9)] have infected more than 457 individuals, causing 167 deaths as of November 18th, 2014 (http://www.who.int/csr/don/18-november- 2014-avian-influenza/en/).",Non-OADS,/arxiv_data1/oa_pdf/63/7f/srep08039.PMC4306964.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8039 | DOI: 10.1038/srep08039 4",Non-OADS,/arxiv_data1/oa_pdf/63/7f/srep08039.PMC4306964.pdf
The photo is provided through the courtesy of Machida-Sagamihara portal site Vita (http://vita.tc) and Tamagawa Coffee Club and is allowed for use in this paper with reference to the companies.,Non-OADS,/arxiv_data1/oa_pdf/a5/42/srep08046.PMC4306967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/42/srep08046.PMC4306967.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8046 | DOI: 10.1038/srep08046 6",Non-OADS,/arxiv_data1/oa_pdf/a5/42/srep08046.PMC4306967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/1e/srep08044.PMC4306973.pdf
Available at: http://celiac.org/celiac-disease/dermatitis-herpetiformis/.,Non-OADS,/arxiv_data1/oa_pdf/75/24/cde-0006-0283.PMC4307007.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/94/11/srep08059.PMC4307012.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Cho, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/84/c7/srep08052.PMC4307013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8052 | DOI: 10.1038/srep08052 6",Non-OADS,/arxiv_data1/oa_pdf/84/c7/srep08052.PMC4307013.pdf
Contents lists available at ScienceDirect Applied & Translational Genomics journal homepage: www.elsevier.com/locate/atg http://dx.doi.org/10.1016/j.atg.2014.09.0052212-0661/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Reverse engineer agonistes A couple of years ago, a consortium of advocates, academics and clin- ical diagnostic laboratories led by Robert Nussbaum at the University of California, San Francisco, launched Free the Data ( http://www.free-the- data.org/ ) and Sharing Clinical Reports ( http://www.iccg.org/about- the-iccg/collaborations/sharing-clinical-reports-project/ ).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"And investigators with the Global Alliance for Genomics and Health, a consortium of institutions working in healthcare, research, disease advocacy and bioinformatics, are pooling data from all over the world on variants from current sequencing efforts in HBOC ( Hayden, 2014 ) (http://genomicsandhealth.org/our-work/working-groups/clinical- working-group ).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Meanwhile, as of late August 2014, just seven of the 78 labs offeringBRCA testing (as listed in both genetests.org and the Genetic Testing Registry [ http://www.ncbi.nlm.nih.gov/gtr/ ]) had committed to depos- iting their BRCA1 /2data into ClinVar ( http://www.free-the-data.org/ ; last accessed on 20 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
http://dx.doi.org/10.1111/cge.12461 .,Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"15 (4), 597 –637 ( http://ncjolt.org/wp-content/ uploads/2014/2007/Conley_Final.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
U.S.A. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Forbes (20 August, Retrieved from http://search.proquest.com/docview/1559075533?accountid=10598).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Sequencing News (26 June, http://www.genomeweb.com/sequencing/competition-myriad-heats-us-testing-labs-launch- brca-tests-hereditary-cancer-pan).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"N.Y. Times (12 April, http://www.nytimes.com/2013/04/13/health/dna-project-aims-to- make-companys-data-public.html?pagewanted=all&_r=0).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Globe Newswire (2 June, http://investor.myriad.com/releasedetail.cfm?releaseid=851822).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"Genome Web Daily News (2 June, http://www.genomeweb.com/clini-cal-genomics/multiple-institutions-labs-collaborating-registry-study-rare-heredi- tary-cancer-g).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"(12 February, http://www.genomeweb.com/clinical-genomics/tackling-vus-challenge-are-public-databases-solution-or-liability- labs).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
"(12 August, http://forward.com/articles/203739/genetics-lab-refuses-to-share-data- that-could-save/?p=all).",Non-OADS,/arxiv_data1/oa_pdf/f8/4d/main.PMC4307597.pdf
Available at http://www.idf.org/diabetesatlas Last accessed 16 April 2014.,Non-OADS,/arxiv_data1/oa_pdf/b1/b6/dme0032-0097.PMC4307641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 1–9Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  1OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S7083 1effects of food and alcohol on the  pharmacokinetics of an oral, extended-release  formulation of hydrocodone in healthy volunteers stephen J Farr1 Cynthia Y robinson1 Christopher M rubino2,3 1Zogenix, inc., emeryville,   CA, 2institute for Clinical  Pharmacodynamics, latham,   nY, 3school of Pharmacy and  Pharmaceutical sciences, The state  University of new York, University   at Buffalo, Buffalo, nY, UsA Correspondence: stephen J Farr   Zogenix, inc.,  5858 horton street,   suite 455, emeryville, CA  94608, UsA   Tel +1 510 550 8330  Fax +1 510 550 8340  email sfarr@zogenix.co mBackground:  The purpose of this study was to evaluate the pharmacokinetics, bioavailability,  and safety of oral extended-release hydrocodone (HC-ER) when administered with food or  alcohol.",Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
Available from: http://www.fda.gov/Drugs/ DrugSafety/ucm38164 4.,Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ac/05/ briefing/2005-4187B1_01_08-Alcohol-Induced.pd f. Accessed May  7,  2014.",Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
Available from: http://www.ich.org/fileadmin/Public_ Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guidelin e. pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/a7/cpaa-7-001.PMC4307648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 625–629Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  625Hypo THesisopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7085 2Design of a new therapy for patients with chronic  kidney disease: use of microarrays for selective  hemoadsorption of uremic wastes and toxins  to improve homeostasis Mohammad Rashid   shahidi Bonjar1 Leyla shahidi Bonjar2 1school of Dentistry, Kerman  University of Medical sciences,   Kerman, iran; 2Department of  pharmacology, College of pharmacy,   Kerman University of Medical  sciences, Kerman, iranAbstract:  The hypothesis proposed here would provide near to optimum homeostasis for  patients with chronic kidney disease (CKD) without the need for hemodialysis.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Statistically, up to two-thirds of  those affected are patients with diabetes and hypertension.2,4 According to one survey,  approximately 5%–7% of the world’s population has mild CKD, and the disease is more  common in developing countries as well as disadvantaged and minority populations.5Correspondence: Leyla shahidi Bonjar Department of pharmacology, College of  pharmacy, Kerman University of Medical  sciences, Haft Baagh Blvd, Kerman,  7616913555, iran Tel +98 913 198 5712 Fax +98 343 212 0725 email shahidileylaa@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Hypothesis Y ear: 2015 Volume: 9 Running head verso: Shahidi Bonjar and Shahidi Bonjar Running head recto: Microarrays for hemoadsorption of uremic wastes and toxins in CKD DOI: http://dx.doi.org/10.2147/DDDT.S70852",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Available from: http://www.cdc.gov/nchs/fastats/leading-causes-of- death.ht m. Accessed July 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Available  from: http://www.kidney.org/kidneydisease/aboutckd.cf m. Accessed  July 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
Avail - able from: http://www.mayoclinic.org/diseases-conditions/kidney- disease/basics/definition/con-2002677 8.,Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Available from: https://www.kidney.org/professionals/kdoqi/ guidelines_updates /doqiuphd_ii.htm l. Accessed July 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
"Available from: http://kidney.niddk.nih.gov/kudiseases/pubs/ hemodialysisdose/#UR R. Accessed July 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/8a/dddt-9-625.PMC4307649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/08/dddt-9-603.PMC4307650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 603–624Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  603Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6291 2Altered γ-aminobutyric acid neurotransmission  in major depressive disorder: a critical review  of the supporting evidence and the influence  of serotonergic antidepressants Alan L Pehrson Connie Sanchez external Sourcing and Scientific  excellence, Lundbeck Research USA,   Paramus, NJ, USAAbstract:  Evidence suggesting that central nervous system γ-aminobutyric acid (GABA) concentra - tions are reduced in patients with major depressive disorder (MDD) has been present since at least  1980, and this idea has recently gained support from more recent magnetic resonance spectroscopy  data.",Non-OADS,/arxiv_data1/oa_pdf/b0/08/dddt-9-603.PMC4307650.pdf
"Patients with MDD are more likely to be unemployed Correspondence: Alan L Pehrson External Sourcing and Scientific  excellence, Lundbeck Research USA, 215  College Road, Paramus, NJ 07652, USA Tel +1 201 350 0142 Fax +1 201 261 0623 email apeh@lundbeck.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Pehrson and Sanchez Running head recto: GABA neurotransmission in major depressive disorder DOI: http://dx.doi.org/10.2147/DDDT.S62912",Non-OADS,/arxiv_data1/oa_pdf/b0/08/dddt-9-603.PMC4307650.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b0/08/dddt-9-603.PMC4307650.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/08/dddt-9-603.PMC4307650.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/47/2e/JOVR-9-291.PMC4307652.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/JOVR-9-289.PMC4307656.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/JOVR-9-289.PMC4307656.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/87/f4/JOVR-9-296.PMC4307658.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/67/db/JOVR-9-305.PMC4307661.pdf
"472Editorial http://dx.doi.org/10.1590/1678-77572014ed006 2014;22(6):472Eight years of an outstanding experience as the Editor-in- Chief of the Journal of Applied Oral Science (JAOS) Over the last eight years, I had the privilege  of being the Editor-in-Chief of the Journal of Applied Oral Science (JAOS), one of the richest H[SHULHQFHVLQP\VFLHQWL¿FDGPLQLVWUDWLYH career.",Non-OADS,/arxiv_data1/oa_pdf/35/3b/1678-7757-jaos-22-6-0472.PMC4307757.pdf
"473ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140254 2014;22(6):473-6Oral potentially malignant disorders in a large dental population Alessandro VILLA1, Anita GOHEL2 1- Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, and Department of Oral Medicine, Infection and Immuni ty, Harvard School of  Dental Medicine, Boston MA.2- Department of General Dentistry, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, United States.",Non-OADS,/arxiv_data1/oa_pdf/c7/6a/1678-7757-jaos-22-6-0473.PMC4307758.pdf
"Available from: http://www.ada.org/~/media/CODA/Files/ predoc_2013.ashx.5- Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M,  Macpherson LM.",OADS,/arxiv_data1/oa_pdf/c7/6a/1678-7757-jaos-22-6-0473.PMC4307758.pdf
Available from: http://seer.cancer.gov/csr/1975_2010/.,Non-OADS,/arxiv_data1/oa_pdf/c7/6a/1678-7757-jaos-22-6-0473.PMC4307758.pdf
Available from: http://www.nidcr.nih.,Non-OADS,/arxiv_data1/oa_pdf/c7/6a/1678-7757-jaos-22-6-0473.PMC4307758.pdf
"477ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130311 Telegenetics: application of a tele-education program in genetic syndromes for Brazilian students Luciana Paula MAXIMINO1, Mirela Machado PICOLINI-PEREIRA2, José Luiz Brito de CARVALHO2 1- Department of Speech-Language Pathology and Audiology, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil .",Non-OADS,/arxiv_data1/oa_pdf/66/36/1678-7757-jaos-22-6-0477.PMC4307759.pdf
Activity at a distance The educational content of the activity at  a distance was available on the Young Doctor Project interactive website (http://www.projetojovemdoutor.org.br).,Non-OADS,/arxiv_data1/oa_pdf/66/36/1678-7757-jaos-22-6-0477.PMC4307759.pdf
Access to the Cybertutor was conducted at  the Young Doctor Project website (http://www.projetojovemdoutor.com.br) with the student ID  and password.,Non-OADS,/arxiv_data1/oa_pdf/66/36/1678-7757-jaos-22-6-0477.PMC4307759.pdf
Censo  'HPRJUi¿FR>KRPHSDJH@>FLWHG0D\@$YDLODEOH from: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/tabelas_pdf/Brasil_tab_1_15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/36/1678-7757-jaos-22-6-0477.PMC4307759.pdf
Available from: http://www.teses.usp.br/teses/disponiveis/25/25143/tde- 06122011-092357/pt-br.php.Telegenetics: application of a tele-education program in genetic syndromes for Brazilian student 2014;22(6):477-83,Non-OADS,/arxiv_data1/oa_pdf/66/36/1678-7757-jaos-22-6-0477.PMC4307759.pdf
"484ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130603 Evaluation of caries-associated virulence of ELR¿OPVIURP Candida albicans  isolated from  saliva of pediatric patients with sickle-cell anemia Fernanda Lourenção BRIGHENTI1, Amanda Coelho MEDEIROS2, Bruno Mello MATOS2, Zulene Eveline Abreu  RIBEIRO2, Cristiane Yumi KOGA-ITO2 1- Araraquara Dental School, Univ.",Non-OADS,/arxiv_data1/oa_pdf/74/80/1678-7757-jaos-22-6-0484.PMC4307760.pdf
"490ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130664 Monitoring the effectiveness of root canal procedures on endotoxin levels found in teeth with chronic apical periodontitis Ariane Cassia Salustiano MARINHO, Frederico Canato MARTINHO, Alexandre Augusto ZAIA, Caio Cezar Randi FERRAZ, Brenda Paula Figueiredo de Almeida GOMES Department of Restorative Dentistry, Endodontics Division, Piracicaba Dental School, State University of Campinas - UNICAMP, Pi racicaba, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/a4/18/1678-7757-jaos-22-6-0490.PMC4307761.pdf
"496ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140069 A castor oil-containing dental luting agent: effects RIF\FOLFORDGLQJDQGVWRUDJHWLPHRQÀH[XUDOstrength Juliana dos Reis DERCELI1, Laiza Maria Grassi FAIS2, Lígia Antunes Pereira PINELLI2 1- Department of Restorative Dentistry, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil .",Non-OADS,/arxiv_data1/oa_pdf/a2/85/1678-7757-jaos-22-6-0496.PMC4307762.pdf
Corresponding address: %LOJH*OVP1XU'HSDUWPHQWRI3HDGLDWULF'HQWLVWU\)DFXOW \RI'HQWLVWU\ùLID8QLYHUVLW\ø]PLU7XUNH\3KRQH  3434445/1725 - 0505 4421826 - Fax: +90 232 3435656 - e-mail: dtbilgenur@hotmail.com 6XEPLWWHG$SULO0RGL¿FDWLRQ-XO\$FFHSW HG6HSWHPEHU ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140110 OEMHFWLYH7KLVVWXG\DLPHGWRDVVHVVWKHTXDOLW\RIURRW¿OOLQJ VFRURQDOUHVWRUDWLRQV FRPSOLFDWLRQVRIDOOURRW¿OOHGWHHWKDQGWKHLUDVVRFLDWLRQZLW KDSLFDOSHULRGRQWLWLV (AP)  detected by cone-beam computed tomography (CBCT) images from an adult Turkish  subpopulation.,Non-OADS,/arxiv_data1/oa_pdf/43/e6/1678-7757-jaos-22-6-0502.PMC4307763.pdf
"509ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130705 Shaping ability of Reciproc and TF Adaptive systems in severely curved canals of rapid microCT-based prototyping molar replicas Ronald ORDINOLA-ZAPATA1, Clovis Monteiro BRAMANTE1, Marco Antonio Hungaro DUARTE1, Bruno Cavalini  CAVENAGO1, David JARAMILLO2, Marco Aurélio VERSIANI3 1- Department of Operative Dentistry, Endodontics and Dental Materials, Bauru School of Dentistry, University of São Paulo, Bau ru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/e8/d8/1678-7757-jaos-22-6-0509.PMC4307764.pdf
"Available from: http://axis.sybronendo.com/tfadaptive_ FRQ¿GHQFH 23- Versiani MA, Leoni GB, Steier L, De-Deus G, Tassani S, Pécora JD, et al.",OADS,/arxiv_data1/oa_pdf/e8/d8/1678-7757-jaos-22-6-0509.PMC4307764.pdf
"516ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140117 Thickness and marking quality of different occlusal contact registration strips Maria Fernanda de Souza Mauá Serapião TOLEDO1, Renata Pilli JÓIAS2, Yves Santini MARQUES-IASI1, Ana Christina  Claro NEVES3, Sigmar de Mello RODE4 1- Private Practice, São Paulo, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ac/a4/1678-7757-jaos-22-6-0516.PMC4307765.pdf
"522ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130544 (I¿FLHQF\RI&ODVV,DQG&ODVV,,PDORFFOXVLRQtreatment with four premolar extractions Guilherme JANSON, Alexandre NAKAMURA, Sérgio Estelita BARROS, Roberto BOMBONATTI, Kelly CHIQUETO Department of Pediatric Dentistry, Orthodontics and Community Health, Bauru School of Dentistry, University of São Paulo, Bauru , SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/64/73/1678-7757-jaos-22-6-0522.PMC4307766.pdf
"528ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140164 Association between periodontal condition and subgingival microbiota in women during pregnancy: a longitudinal study Priscila Viola BORGO¹, Viviane Aparecida Arenas RODRIGUES², Alfredo Carlos Rodrigues FEITOSA¹, Karla Correa Barcelos XAVIER¹, Mario Julio AVILA-CAMPOS² 1- Dentistry Clinic, Federal University of Espírito Santo, Vitória, ES, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3a/fd/1678-7757-jaos-22-6-0528.PMC4307767.pdf
"534ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720130578 Effect of coffee and a cola-based soft drink on the color stability of bleached bovine incisors considering the time elapsed after bleaching Rodrigo PIROLO1, Rafael Francisco Lia MONDELLI2, Gisele Maria CORRER3, Carla Castiglia GONZAGA3, Adilson  Yoshio FURUSE2 1- Private practice, Curitiba, PR, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/37/e6/1678-7757-jaos-22-6-0534.PMC4307768.pdf
"541ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140190 Immunolocalization of markers for bone formation during guided bone regeneration in osteopenic rats Tábata de Mello TERA1, Rodrigo Dias NASCIMENTO2, Renata Falchete do PRADO1, Mauro Pedrine SANTAMARIA2,  Maria Aparecida Neves JARDINI2 'HSDUWPHQWRI%LRVFLHQFHDQG2UDO'LDJQRVLV,QVWLWXWRGH&L rQFLDH7HFQRORJLDí,&78QLY(VWDGXDO3DXOLVWDí81(636mR -RVpGRV&DPSRV63%UD]LO 'HSDUWPHQWRI'LDJQRVLVDQG6XUJHU\,QVWLWXWRGH&LrQFLDH 7HFQRORJLDí,&78QLY(VWDGXDO3DXOLVWDí81(636mR-RVpGRV &DPSRV63%UD]LO Corresponding address:  Maria Aparecida Neves Jardini - Department of Diagnosis and Surgery - Av.",Non-OADS,/arxiv_data1/oa_pdf/a3/9e/1678-7757-jaos-22-6-0541.PMC4307769.pdf
"554ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140209 Radiopacity and cytotoxicity of Portland cement associated with niobium oxide micro and nanoparticles Leticia Boldrin MESTIERI1, Mário TANOMARU-FILHO1, Ana Livia GOMES-CORNÉLIO1, Loise Pedrosa SALLES1,  Maria Inês Basso BERNARDI2, Juliane Maria GUERREIRO-TANOMARU1 1- Department of Restorative Dentistry, Araraquara Dental School, Univ.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/1678-7757-jaos-22-6-0554.PMC4307770.pdf
"560ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140218 Alkali production in the mouth and its relationship with certain patient’s characteristics Valeria Veiga GORDAN1, Deborah Landry McEDWARD1, Marc Edward OTTENGA1, Cynthia Wilson GARVAN2, Pearl  Ann HARRIS1 1- College of Dentistry, Department of Restorative Dental Sciences at University of Florida, Gainesville, Florida, USA.",Non-OADS,/arxiv_data1/oa_pdf/6f/8f/1678-7757-jaos-22-6-0560.PMC4307771.pdf
Available from: http://apps.nccd.cdc.gov/brfss/list.asp?cat=AC&yr=2010&qkey=4413&state=All.,OADS,/arxiv_data1/oa_pdf/6f/8f/1678-7757-jaos-22-6-0560.PMC4307771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/02/jeu277.PMC4307775.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References BROOKS, A.",Non-OADS,/arxiv_data1/oa_pdf/e5/e8/inpractg5063.PMC4307778.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.08.005 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/1b/43/main.PMC4307792.pdf
"Production and hosting by Elsevier B.V. All rights reserved.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2014) 1, 188e198",Non-OADS,/arxiv_data1/oa_pdf/1b/43/main.PMC4307792.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.07.003 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/0b/47/main.PMC4307803.pdf
"Production and hosting by Elsevier B.V. All rights reserved.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes & Diseases (2014) 1, 113e119",Non-OADS,/arxiv_data1/oa_pdf/0b/47/main.PMC4307803.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.006 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
"Marseille, France: Centre Saint Paul-Henri Gastaut; 2010 37 –9.http://dx.doi.org/10.1111/ j.1528-1167.2009.02441.x [piergen@aol.com ].",Non-OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
Clin Neurophysiol 2013;124(5):1013 –8.http://dx.doi.org/10.1016/j.clinph.2012.11.011 .,OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
Internet J Neurol 2005;5:1. http://dx.doi.org/10.5580/ 365.,OADS,/arxiv_data1/oa_pdf/c4/7e/main.PMC4307868.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/main.PMC4307869.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/main.PMC4307869.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/main.PMC4307869.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4307870.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.04.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4307870.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4307870.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/2d/main.PMC4307871.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.009 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/2d/main.PMC4307871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/2d/main.PMC4307871.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/09/main.PMC4307872.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.02.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/96/09/main.PMC4307872.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/09/main.PMC4307872.pdf
Ann Neurol 2013. http://dx.doi.org/10.1002/ ana.24061 .,OADS,/arxiv_data1/oa_pdf/96/09/main.PMC4307872.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/cb/main.PMC4307873.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.01.009 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/cb/main.PMC4307873.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/cb/main.PMC4307873.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC4307874.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.07.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC4307874.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC4307874.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.004 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2007.07.007 .,OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
Neuroscience 2010;167(3):929 –45.http://dx.doi.org/10.1016/j.neuroscience.2010.,OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
Neurology 2006; 67(11):2048 –9.http://dx.doi.org/10.1212/01.wnl.0000247231.25231.2e .,Non-OADS,/arxiv_data1/oa_pdf/50/f1/main.PMC4307875.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/94/main.PMC4307876.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.05.001 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/main.PMC4307876.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/94/main.PMC4307876.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/53/main.PMC4307878.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.08.006 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/53/main.PMC4307878.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/53/main.PMC4307878.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/ba/main.PMC4307879.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.07.004 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/ba/main.PMC4307879.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/ba/main.PMC4307879.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/a2/main.PMC4307880.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/a2/main.PMC4307880.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.01.002,OADS,/arxiv_data1/oa_pdf/30/a2/main.PMC4307880.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/main.PMC4307881.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.06.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/main.PMC4307881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/3f/main.PMC4307881.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4307882.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.02.004 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4307882.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/5d/main.PMC4307882.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/e0/main.PMC4307883.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/e0/main.PMC4307883.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/e0/main.PMC4307883.pdf
"While much is known of the mechanisms and consequences of H. pylori  infection,  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/nihms648725.PMC4307917.pdf
"*Correspondence: csiitoy@nus.edu.sg.4Co-first author SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three figures, and two tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.06.003 .",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/nihms648725.PMC4307917.pdf
"This research is supported by the Translational  and Clinical Research Flagship Programme ( http://www.nmrc.gov.sg ), the National Research Foundation Singapore  (http://www.nrf.gov.sg ) and the Singapore Ministry of Education, under its Research Centres of Excellence  Initiative.",Non-OADS,/arxiv_data1/oa_pdf/c5/c5/nihms648725.PMC4307917.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/cf/main.PMC4307954.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.05.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/cf/main.PMC4307954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/cf/main.PMC4307954.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/5f/main.PMC4307955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/5f/main.PMC4307955.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.11.002,OADS,/arxiv_data1/oa_pdf/aa/5f/main.PMC4307955.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/fc/main.PMC4307956.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2013.12.005 2213-3232 © 2013 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/fc/main.PMC4307956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/fc/main.PMC4307956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.12.008,OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
the uncinate and stria of the fornix (using Freesurfer software; http://surfer.nmr.mgh.harvard.edu/ )[20] showed results within plus or minus one standard deviation of healthy subjects.,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
3):131 –51.http://dx.doi.org/10.1111/j.1528- 1167.2009.02043.x .,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
Neurology 2006;67(4):626 –31.http://dx.doi.org/10.1212/ 01.wnl.0000230139.45304.eb .,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
NeuroImage 2012;62(2):774 –81.http://dx.doi.org/10.1016/ j.neuroimage.2012.01.021 .,OADS,/arxiv_data1/oa_pdf/b6/f5/main.PMC4307957.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/29/main.PMC4307958.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.06.001 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/29/main.PMC4307958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/29/main.PMC4307958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/main.PMC4307959.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.05.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/main.PMC4307959.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/9d/main.PMC4307959.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/a7/main.PMC4307960.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/a7/main.PMC4307960.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.11.003 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr,Non-OADS,/arxiv_data1/oa_pdf/16/a7/main.PMC4307960.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/main.PMC4307961.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/main.PMC4307961.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/main.PMC4307961.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/75/main.PMC4307962.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/75/main.PMC4307962.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.12.002,OADS,/arxiv_data1/oa_pdf/53/75/main.PMC4307962.pdf
Clin Pharmacokinet Oct 13 2013. http://dx.doi.org/ 10.1007/s40262-013-01017-0 .,Non-OADS,/arxiv_data1/oa_pdf/53/75/main.PMC4307962.pdf
Br J Clin Pharmacol 2013. http://dx.doi.org/10.1111/ bcp.12213 .,Non-OADS,/arxiv_data1/oa_pdf/53/75/main.PMC4307962.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/c8/main.PMC4307963.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/c8/main.PMC4307963.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.12.001,OADS,/arxiv_data1/oa_pdf/bc/c8/main.PMC4307963.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/87/main.PMC4307964.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.01.008 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/87/main.PMC4307964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/87/main.PMC4307964.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/main.PMC4307965.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.04.001 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/main.PMC4307965.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/main.PMC4307965.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/ef/main.PMC4307966.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/ef/main.PMC4307966.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.12.006 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr,Non-OADS,/arxiv_data1/oa_pdf/16/ef/main.PMC4307966.pdf
http://www.medicines.org.uk/emc/ medicine/6768/SPC/Topamax+25+ mg%2c+50mg%2c+100mg%2c+200mg+ Tablets+and+Sprinkle+Capsules+15%2c+25+or+50+mg./#UNDESIRABLE_ EFFECTS ; 2013 .,Non-OADS,/arxiv_data1/oa_pdf/16/ef/main.PMC4307966.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.07.001 2213-3232/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/main.PMC4307967.pdf
"Jong Woo Lee, MD, PhD President, Greater Boston Epilepsy Society 2013 –14 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAEpilepsy & Behavior Case Reports 2 (2014) 90 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.02.001 2213-3232/© 2014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/43/10/main.PMC4307968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/10/main.PMC4307968.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/main.PMC4308026.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.08.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/main.PMC4308026.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/main.PMC4308026.pdf
Case Rep Emerg Med 2013;2013:634174. http://dx.doi.org/10.1155/2013/634174 .,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/main.PMC4308026.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4308027.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4308027.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.10.002,OADS,/arxiv_data1/oa_pdf/93/35/main.PMC4308027.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC4308028.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC4308028.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.01.004,OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC4308028.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/13/main.PMC4308029.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.006 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/13/main.PMC4308029.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/13/main.PMC4308029.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/a5/main.PMC4308030.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.02.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/a5/main.PMC4308030.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/a5/main.PMC4308030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/4d/main.PMC4308031.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.005 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/4d/main.PMC4308031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/4d/main.PMC4308031.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/72/main.PMC4308032.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.010 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/72/main.PMC4308032.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/72/main.PMC4308032.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/3a/main.PMC4308033.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/3a/main.PMC4308033.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.11.001,OADS,/arxiv_data1/oa_pdf/95/3a/main.PMC4308033.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/b8/main.PMC4308038.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.007 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/b8/main.PMC4308038.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/b8/main.PMC4308038.pdf
We also thank the int.site “Picture: http://prosite.expasy.,Non-OADS,/arxiv_data1/oa_pdf/93/b8/main.PMC4308038.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/bc/main.PMC4308042.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.008 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/bc/main.PMC4308042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/bc/main.PMC4308042.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/ff/main.PMC4308050.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.08.004 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/88/ff/main.PMC4308050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/ff/main.PMC4308050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/96/main.PMC4308055.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.09.008 2213-3232/ © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/96/main.PMC4308055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/96/main.PMC4308055.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/5f/main.PMC4308059.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.08.005 2213-3232/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ef/5f/main.PMC4308059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/5f/main.PMC4308059.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/bc/main.PMC4308061.pdf
: + 90 224 2951723; fax: + 90 224 4429177. http://dx.doi.org/10.1016/j.ebcr.2014.08.002 2213-3232/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/3f/bc/main.PMC4308061.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/bc/main.PMC4308061.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/ee/main.PMC4308062.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.08.001 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/ee/main.PMC4308062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/ee/main.PMC4308062.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/67/main.PMC4308063.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.01.007 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/67/main.PMC4308063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/67/main.PMC4308063.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/88/main.PMC4308086.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.01.001 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/88/main.PMC4308086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/88/main.PMC4308086.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/a3/main.PMC4308087.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.03.007 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/a3/main.PMC4308087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/a3/main.PMC4308087.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/25/main.PMC4308089.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/25/main.PMC4308089.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.01.006,OADS,/arxiv_data1/oa_pdf/4c/25/main.PMC4308089.pdf
"Public Health Image Library, Centers for Dis- ease Control and Prevention; 2002 [Available from: http://phil.cdc.gov/phil/ details.asp?pid=3417 ].",OADS,/arxiv_data1/oa_pdf/4c/25/main.PMC4308089.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/90/main.PMC4308090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/90/main.PMC4308090.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.01.003 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr,Non-OADS,/arxiv_data1/oa_pdf/e0/90/main.PMC4308090.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/1e/main.PMC4308096.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.03.005 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/1e/main.PMC4308096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/1e/main.PMC4308096.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/35/main.PMC4308097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/35/main.PMC4308097.pdf
http://dx.doi.org/10.1016/j.ebcr.2013.12.003,OADS,/arxiv_data1/oa_pdf/35/35/main.PMC4308097.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/70/main.PMC4308099.pdf
1Professor Emerita of Neuropsychiatry 2Comprehensive Epilepsy Center 3Former Nurse Coordinator Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.03.004 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/70/main.PMC4308099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/70/main.PMC4308099.pdf
"U.S. Census bu reau projections show a slower  growing, older, more diverse nation a half century from now,  2012. http://www.census.gov/news room/releases/archives/po-pulation/cb12-243.html (acce ssed on September 20, 2014).",OADS,/arxiv_data1/oa_pdf/af/24/jgc-12-01-044.PMC4308458.pdf
http://www.cdc.gov/nchs/  fastats/lifexpec.htm.,OADS,/arxiv_data1/oa_pdf/af/24/jgc-12-01-044.PMC4308458.pdf
http://clinicaltrials.gov/ show/NCT01675440.,Non-OADS,/arxiv_data1/oa_pdf/af/24/jgc-12-01-044.PMC4308458.pdf
"http://www.who.int/cancer/palliative/definition/en/; ac-cessed online 5/10/13 (accessed September 24, 2014).",Non-OADS,/arxiv_data1/oa_pdf/2f/3b/jgc-12-01-057.PMC4308459.pdf
"http://consensus.nih.gov/2004/  2004EndOfLifeCareSOS024html.htm  (accessed September  24, 2014).",OADS,/arxiv_data1/oa_pdf/2f/3b/jgc-12-01-057.PMC4308459.pdf
"http://www.annenbergclass- room.org/glossaries.aspx?term=d istributive-justice&AspxAuto- DetectCookieSupport=1 (accessed September 24, 2014).",Non-OADS,/arxiv_data1/oa_pdf/2f/3b/jgc-12-01-057.PMC4308459.pdf
"1, http://links.lww.com/MPG/A370 ).",Non-OADS,/arxiv_data1/oa_pdf/65/dd/jpga-60-192.PMC4308495.pdf
"2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/65/dd/jpga-60-192.PMC4308495.pdf
"3, http://links.lww.com/MPG/ A370 ).",Non-OADS,/arxiv_data1/oa_pdf/65/dd/jpga-60-192.PMC4308495.pdf
WEB RESOURCES 1. eMERGE web site: http://www.gwas.net 2. eMERGE Coordinating Center genotyping data: http://emerge.,OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
PheKB phenotype: http://phekb.org/phenotype/herpes-zoster 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
R package Hmisc: http://cran.r-project.org/web/packages/ Hmisc/index.html 5.,Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
R package rms: http://cran.r-project.org/web/packages/rms/ index.html 6.,Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
R package SNPRelate: https://github.com/zhengxwen/SNPRelate 7.,Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
R package PheWAS: https://knowledgemap.mc.vanderbilt.edu/ research/content/phewas-r-package CONFLICT OF INTEREST The authors declare no con ﬂict of interest.,Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Genes and Immunity website (http://www.nature.com/gene)HCP5 and herpes zoster DR Crosslin et al 7 © 2015 Macmillan Publishers Limited Genes and Immunity (2015) 1 –7",Non-OADS,/arxiv_data1/oa_pdf/a4/0e/gene201451a.PMC4308645.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Tamoxifen metabolism and premenopausal breast cancer outcome P Saladores et al 94 The Pharmacogenomics Journal (2015), 84 – 94 &2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4e/cc/tpj201434a.PMC4308646.pdf
"About the USCACA       The US Chinese Anti-Cancer Association (USCACA, 美中抗癌协会 , http://www.uscaca.org/) is a non-profit professional organization  founded in 2009.",Non-OADS,/arxiv_data1/oa_pdf/8a/10/cjc-33-12-620.PMC4308658.pdf
Available at: http://www.fda.gov/newsevents/ newsroom/pressAnnouncements/ucm374761.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/10/cjc-33-12-620.PMC4308658.pdf
Available at: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/8a/10/cjc-33-12-620.PMC4308658.pdf
Available at: http://www.onclive.com/ conference -coverage/ilcc -2014/Next -Generation -ALK -Inhibitors - Effective -in-Patients -With -Brain -Metastases.,Non-OADS,/arxiv_data1/oa_pdf/8a/10/cjc-33-12-620.PMC4308658.pdf
"Availability and implementation: FungiFun2, examples and tutorials are publicly available at https://elbe.hki-jena.de/fungifun/.",OADS,/arxiv_data1/oa_pdf/a4/a3/btu627.PMC4308660.pdf
"For Permissions, please e-mail: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/a3/btu627.PMC4308660.pdf
"Tabhu includes tools for human template selection, grafting, back-mutation evaluation, antibody modelling and structuralanalysis, helping the user in all the critical steps of the humanizationexperiment protocol.Availability: http://www.biocomputing.it/tabhu Contact: anna.tramontano@uniroma1.it, pi erpaolo.olimpieri@uniroma1.it Supplementary information : Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/07/d5/btu667.PMC4308665.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/d5/btu667.PMC4308665.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8091 | DOI: 10.1038/srep08091 5",Non-OADS,/arxiv_data1/oa_pdf/ba/40/srep08091.PMC4308693.pdf
"JM Energy Corporation, Feature of LIC , Available at: http://www.jmenergy.co.jp/ en/product_whats.html.",OADS,/arxiv_data1/oa_pdf/b0/a0/srep08085.PMC4308695.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/a0/srep08085.PMC4308695.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fa/8e/srep08067.PMC4308697.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8067 | DOI: 10.1038/srep08067 9",Non-OADS,/arxiv_data1/oa_pdf/fa/8e/srep08067.PMC4308697.pdf
The putative N-terminal signal peptides and the most likely cleavage site were predicted by the SignalP 3.0 program62(http://www.cbs.dtu.dk/services/SignalP/).,OADS,/arxiv_data1/oa_pdf/04/1d/srep08073.PMC4308698.pdf
the amino acid sequences of these AlinCSPs were made using ClustalX 1.83 with the default gap penalty parameters of a gap opening of 10 and an extension of 0.2 andsubsequently edited using ESPript (http://espript.ibcp.fr/ESPript/ESPript/) 63and WebLogo (http://weblogo.berkeley.edu/)64.,OADS,/arxiv_data1/oa_pdf/04/1d/srep08073.PMC4308698.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/04/1d/srep08073.PMC4308698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8073 | DOI: 10.1038/srep08073 13",Non-OADS,/arxiv_data1/oa_pdf/04/1d/srep08073.PMC4308698.pdf
SynBioLGDB (http://bioinformatics.ac.cn/synbiolgdb/) aims to provide the synthetic biology community with a useful resource for efficient browsing and visualization of genetic logic gates.,OADS,/arxiv_data1/oa_pdf/4e/18/srep08090.PMC4308699.pdf
"Because genetic logic gates are the basic building biobricks of electronic circuits we developed a synthetic biology database of experimentally validated logic gates (SynBioLGDB, http://bioinformatics.ac.cn/synbiolgdb/) to facilitate related research.",OADS,/arxiv_data1/oa_pdf/4e/18/srep08090.PMC4308699.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/fc/srep08079.PMC4308701.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8079 | DOI: 10.1038/srep08079 10",Non-OADS,/arxiv_data1/oa_pdf/8f/fc/srep08079.PMC4308701.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/81/srep08089.PMC4308705.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8077 | DOI: 10.1038/srep08077 12",Non-OADS,/arxiv_data1/oa_pdf/cc/c5/srep08077.PMC4308706.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/24/srep08092.PMC4308708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8092 | DOI: 10.1038/srep08092 7",Non-OADS,/arxiv_data1/oa_pdf/57/24/srep08092.PMC4308708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8080 | DOI: 10.1038/srep08080 6",Non-OADS,/arxiv_data1/oa_pdf/37/76/srep08080.PMC4308709.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/fc/srep08066.PMC4308710.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8066 | DOI: 10.1038/srep08066 9",Non-OADS,/arxiv_data1/oa_pdf/0d/fc/srep08066.PMC4308710.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/49/srep08070.PMC4308713.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8070 | DOI: 10.1038/srep08070 11",Non-OADS,/arxiv_data1/oa_pdf/e4/49/srep08070.PMC4308713.pdf
"1568  Neuroscience, University College London, London,  England ; http://www.fil.ion.ucl.ac.uk/spm).",Non-OADS,/arxiv_data1/oa_pdf/04/98/NRR-7-1563.PMC4308752.pdf
The cerebellum lateral ization index (LI) was calculated with xjview8  (http://www.alivelearn.net/xjview8/about/).,OADS,/arxiv_data1/oa_pdf/04/98/NRR-7-1563.PMC4308752.pdf
Retrieved from:   http://people.hsc.edu/faculty-staff/robbk/Coms331/Lectures/L ectures%202011/Lecture%2016%20-%20Meshes%20and%20Cross%20Products.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/e9/NRR-7-1637.PMC4308766.pdf
http://www.jove.com/index/details.,Non-OADS,/arxiv_data1/oa_pdf/12/ea/NRR-7-1378.PMC4308787.pdf
"We used the Group Internal Carotid Artery fMRI Toolbox, version 2.0a (http://icatb.sourceforge.net) to analyze the fMRI data [25-26].",OADS,/arxiv_data1/oa_pdf/44/c3/NRR-7-1386.PMC4308788.pdf
"Samples with the genotypes present were selected to test (performed by Sangon Biotech of Shanghai, China) and the amplified DNA fragment was consistent with the sequence found in the National Center of Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/pubmed/).",OADS,/arxiv_data1/oa_pdf/14/57/NRR-7-1420.PMC4308794.pdf
"Furthermore, Current Controlled Trials (http://controlled-trials.com), Clinical Trials.gov (http://clinicaltrials.gov), and Chinese Clinical Trial Registry (http://www.chictr.org) were also searched.",OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
DATA AND METHODS   Data retrieval A search strategy for RCTs recommended by the Cochrane Dementia and Cognitive Improvement Group (http://ims.cochrane.org/) was used in this review.,OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
"We searched the Cochrane Dementia and Cognitive Improvement Group Specialized Register of trials (May 2011), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 3, 2011), Medline (Ovid SP, 1948 to April 2011), Embase (1966 to April 2011), the Chinese Biomedical Literature Database available at http://cbm.imicams.ac.cn (1949 to April 2011), and the Chinese National Knowledge Infrastructure and references lists of articles.",OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
"We also tried to identify ongoing and unpublished trials by searching the following databases: Current Controlled Trials (http://controlled-trials.com), Clinical Trials.gov (http://clinicaltrials.gov), Chinese Clinical Trial Registry (http://www.chictr.org), and by contacting authors of relevant trials.",Non-OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
Quality evaluation and data extraction Studies were assessed according to criteria for methodological quality described in the Cochrane Reviewer’s Handbook 5.0.1 (http://www.cochrane-handbook.org/).,OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
Statistical analysis We pooled data from trials if they were sufficiently similar using Review Manager (RevMan) (http://ims.cochrane.org/revman/download).,OADS,/arxiv_data1/oa_pdf/6e/b9/NRR-7-1344.PMC4308807.pdf
Available at: http://qualitynet.org/dcs/ContentServer?cid=1141662756099&pagename=QnetPublic%2FPage%2FQnetTier2&c=page: 1–119.,Non-OADS,/arxiv_data1/oa_pdf/99/2f/jah3-3-e000944.PMC4309035.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/3c/2b/jah3-3-e000079.PMC4309036.pdf
"); For the Pediatric Heart Network Investigator s. The contents of this article are solely the responsibility of the authors and do not necessarily represent the of ﬁcial views of the National Heart, Lung, and Blood Institute.An accompanying Appendix S1, which contains a complete list of the Single Ventricle Reconstruction Trial, is available at http://jaha.ahajournals .org/content/3/ 2/e000079/suppl/DC1 Correspondence to: Phillip T. Burch, MD, Division Cardiothoracic Surgery, Primary Children ’s Medical Center, 100 North Mario Capecchi Dr., Salt Lake City, UT 84113.",Non-OADS,/arxiv_data1/oa_pdf/3c/2b/jah3-3-e000079.PMC4309036.pdf
Available at http://www.fdma.go.jp/html/data/tuchi1107/110706kyu_176.htm.,OADS,/arxiv_data1/oa_pdf/e6/af/jah3-3-e000499.PMC4309039.pdf
Available at http://www.city.yanagawa.fukuoka.jp/reiki_int/re- iki_honbun/r203RG00000931.html#e000000143.,Non-OADS,/arxiv_data1/oa_pdf/e6/af/jah3-3-e000499.PMC4309039.pdf
"Accompanying Figures S1 through S3 are available at http://jaha.ahajour- nals.org/content/3/3/e000515/suppl/DC1 Correspondence to: Jonathan Doux ﬁls, PharmD, University of Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), Rue de Bruxelles, 61,B-5000, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/4c/44/jah3-3-e000515.PMC4309041.pdf
Available at: http://trials.boehringer- ingelheim.com/trial_results/clinical_trials_overview/clinical_trial_result.c=n.i= 21.html.,Non-OADS,/arxiv_data1/oa_pdf/4c/44/jah3-3-e000515.PMC4309041.pdf
MS/MS spectra were extracted from the RAW ﬁle with the use of Readw.exe (http://sourceforge.net/projects/sashimi).,OADS,/arxiv_data1/oa_pdf/95/f1/jah3-3-e000527.PMC4309042.pdf
"The authors thank the other investigators, the staff, and theparticipants of the REGARDS study for their valuable contributions.A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.",Non-OADS,/arxiv_data1/oa_pdf/21/be/jah3-3-e000635.PMC4309046.pdf
"Statistical Analysis Statistical analyses were performed using GraphPad Prismsoftware (V6.0; GraphPad Software Inc., La Jolla, CA) and R-3.1.0 (http://cran.cnr.berkeley.edu/).",OADS,/arxiv_data1/oa_pdf/69/0e/jah3-3-e000670.PMC4309049.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajour- nals.org/content/3/3/e000714/suppl/DC1 Correspondence to: Jeremiah R. Brown, PhD, MS, HB 7505 DHMC One Medical Center Drive, Lebanon, NH.",Non-OADS,/arxiv_data1/oa_pdf/2f/c3/jah3-3-e000714.PMC4309053.pdf
Available at: http://www.dartmouthatlas.org/downloads/reports/ Capacity_Report_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2f/c3/jah3-3-e000714.PMC4309053.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/3/3/e000728/suppl/DC1 Correspondence to: Robert W. Yeh, MD, MSc, Cardiology Division, GRB 800, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114.",Non-OADS,/arxiv_data1/oa_pdf/af/16/jah3-3-e000728.PMC4309056.pdf
Data elements and de ﬁnitions are listed at https://www.ncdr.com/webncdr/care/home/data- collection.,OADS,/arxiv_data1/oa_pdf/af/16/jah3-3-e000728.PMC4309056.pdf
Statistical Analyses Analyses were done in R (http://www.r-project.org/) using the available standard regression tools.,OADS,/arxiv_data1/oa_pdf/65/d5/jah3-3-e000902.PMC4309059.pdf
"ISSN 0021-9150, available at: http://dx.doi.org/10.1016/j.atherosclerosis.2006.11.037.",OADS,/arxiv_data1/oa_pdf/65/d5/jah3-3-e000902.PMC4309059.pdf
"Fibrillin-1 has been identi ﬁed as the gene responsible for MFS.40Recently, elevated circulating TGF- b1 concentrations and the critical role of TGF- b–activated MAPK signaling were reported in human and mouse MFS, respectively.41,42Hic-5 was originally identi ﬁed as a TGF- b1–inducible gene; moreover, the Gene Coexpression Database, which is a database of comparative gene coexpression networks in mammals (http://www.cox- presdb.jp/),43revealed that ﬁbrillin-1 and Hic-5 were spatio- temporally coexpressed in mice and humans.",OADS,/arxiv_data1/oa_pdf/0a/fe/jah3-3-e000747.PMC4309060.pdf
"This means that with the elongated shape of cardiomyocytes, the intracellular lifetime is primarily sensitive to changes in cell diameter .16 Statistical Analyses Statistical analysis was performed using SAS 9.3 (SAS Institute) or R (version 3.01, R Foundation; http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/d3/5e/jah3-3-e000790.PMC4309062.pdf
Accessed at http://www.fda.gov/ drugs/drugsafety/ucm256581.htm#sa.,Non-OADS,/arxiv_data1/oa_pdf/2d/d5/jah3-3-e000784.PMC4309063.pdf
Accompanying Data S1 through S6 are available at http://jaha.ahajour- nals.org/content/3/3/e000787/suppl/DC1 Correspondence to: Elizabeth M.C.,Non-OADS,/arxiv_data1/oa_pdf/9b/b0/jah3-3-e000787.PMC4309064.pdf
"Accompanying Figures S1 through S2 and Tables S1 through S12 are available at http://jaha.ahajournals.org/content/3/3/e000981/suppl/DC1 Correspondence to: Collin M. Stultz, MD, PhD, Room 36-796, 77 Massa- chusetts Avenue, Cambridge, MA 02139.",Non-OADS,/arxiv_data1/oa_pdf/00/31/jah3-3-e000981.PMC4309066.pdf
"a widely used, publicly reported metric designed to judge the effectiveness of inpatient HF care provided by any Medicare- certiﬁed hospital (http://www.hospitalcompare.hhs.gov).",Non-OADS,/arxiv_data1/oa_pdf/1a/1a/jah3-3-e000806.PMC4309072.pdf
Clinical Trial Registration- —URL: http://www.controlled-trials.com/.,Non-OADS,/arxiv_data1/oa_pdf/8f/08/jah3-3-e000828.PMC4309073.pdf
Available at: http://www.stats.gov.cn/ tjsj/pcsj/rkpc/6rp/indexch.htm.,OADS,/arxiv_data1/oa_pdf/47/c5/jah3-3-e000912.PMC4309076.pdf
Available at:http://www.who.int/choice/costs/CER_thresholds/en/.,Non-OADS,/arxiv_data1/oa_pdf/47/c5/jah3-3-e000912.PMC4309076.pdf
"Clinical Trial Registration- —URL: http://www.clinicaltrial.gov Unique identi ﬁer: SMART: NCT00027352, ESPRIT: NCT00004978, SILCAAT: NCT00013611.",Non-OADS,/arxiv_data1/oa_pdf/60/71/jah3-3-e000844.PMC4309077.pdf
"Accompanying Table S1 is available at http://jaha.ahajournals.org/content/ 3/3/e000844/suppl/DC1 *A list of all INSIGHT SMART, ESPRIT Study Groups and the SILCAAT Scienti ﬁc Committee participants is provided in Data S1, available at http://jaha.ahajournals.org/content/3/3/e000844/suppl/DC1.",Non-OADS,/arxiv_data1/oa_pdf/60/71/jah3-3-e000844.PMC4309077.pdf
Available at http://aidsinfo.nih.gov/ content ﬁles/lvguidelines/adultandadolescentsgl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/71/jah3-3-e000844.PMC4309077.pdf
Availalbe at: http://CRAN.R-project.org/package=survIDINRI.,Non-OADS,/arxiv_data1/oa_pdf/73/a3/jah3-3-e000857.PMC4309081.pdf
Available at: http://www.ine.es/prensa/ np606.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/9c/jah3-3-e000864.PMC4309083.pdf
Available at: http://www.ine.es/inebmenu/mnu_dinamicapob.htm.,Non-OADS,/arxiv_data1/oa_pdf/00/9c/jah3-3-e000864.PMC4309083.pdf
Available at: http://www.census.gov/2010census/data/.,OADS,/arxiv_data1/oa_pdf/1f/79/jah3-3-e000879.PMC4309086.pdf
"Data were normalized by using the locally weighted scatterplot smoothing regression modeling method, and statistical signiﬁcance of the differentially expressed genes was analyzed by using microarray ANOVA with R statistical software (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/bb/99/jah3-3-e000884.PMC4309087.pdf
Mouse and human sequences were aligned using PIPmaker (http://www.bx.psu.edu/miller_lab/).,OADS,/arxiv_data1/oa_pdf/bb/99/jah3-3-e000884.PMC4309087.pdf
"To obtain a global picture of the changes entailed, DAVID analyses (http://david.abcc.",Non-OADS,/arxiv_data1/oa_pdf/bb/99/jah3-3-e000884.PMC4309087.pdf
A full list of principal Cardiovas- cular Health Study investigators and institutions can be found at https://CHS-NHLBI.org.,Non-OADS,/arxiv_data1/oa_pdf/11/67/jah3-3-e000889.PMC4309088.pdf
Accompanying Movies S1 through S2 are available at http://jaha.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/34/12/jah3-3-e000921.PMC4309094.pdf
Accompanying Figures S1 through S4 and Tables S1 through S3 are availableat http://jaha.ahajournals.org/content/3/3/e000949/suppl/DC1.,OADS,/arxiv_data1/oa_pdf/f3/a1/jah3-3-e000949.PMC4309099.pdf
"An accompanying Video S1 is available at http://jaha.ahajournals.org/content/3/3/e000743/suppl/DC1Correspondence to: Haruchika Masuda, MD, PhD, or Takayuki Asahara, MD, PhD, Division of Basic Clinical Science, Department of Regenerative Medicine Science, Tokai University School of Medicine, Shimokasuya, Isehara, Kanagawa 259-1143, Japan.",Non-OADS,/arxiv_data1/oa_pdf/70/ae/jah3-3-e000743.PMC4309104.pdf
"Notably, Has2is essential for endocardial to mesenchymal transformation and heart valve formation.6,51,55,56Gene network analysis using the Genemania open freeware (http://www.genema- nia.org) further revealed potential genetic and/or physical interactions among genes or pathways involved in heart development.",OADS,/arxiv_data1/oa_pdf/53/b6/jah3-3-e000976.PMC4309105.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e52198 | Page 1 of 8Video Article Production and Targeting of Monovalent Quantum Dots Daeha Seo*1,2,3, Justin Farlow*4,5,6, Kade Southard1,4,7, Young-wook Jun1,7, Zev J. Gartner4,5,6,7 1Department of Otolaryngology, University of California, San Francisco 2Department of Chemistry, University of California, Berkeley 3Materials Science Division, Lawrence Berkeley National Laboratory 4Department of Pharmaceutical Chemistry, University of California, San Francisco 5Tetrad Graduate Program, University of California, San Francisco 6Center for Systems and Synthetic Biology, University of California, San Francisco 7Chemistry and Chemical Biology Graduate Program, University of California, San Francisco *These authors contributed equally Correspondence to: Young-wook Jun at YJun@ohns.ucsf.edu , Zev J. Gartner at zevgartner@gmail.com URL: http://www.jove.com/video/52198 DOI: doi:10.3791/52198 Keywords: Bioengineering, Issue 92, monovalent quantum dots, single particle tracking, SNAP tag, steric exclusion, phosphorothioate, DNA, nanoparticle bioconjugation, single molecule imaging Date Published: 10/23/2014 Citation: Seo, D., Farlow, J., Southard, K., Jun, Y.w., Gartner, Z.J.",Non-OADS,/arxiv_data1/oa_pdf/1e/eb/jove-92-52198.PMC4309134.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52198/ Introduction The dynamics of single molecules on live cells contributes to their biological function.,Non-OADS,/arxiv_data1/oa_pdf/1e/eb/jove-92-52198.PMC4309134.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2014 |  91  | e51675 | Page 1 of 10Video Article Design and Fabrication of Ultralight Weight, Adjustable Multi-electrode Probes for Electrophysiological Recordings in Mice Philip M. Brunetti*1, Ralf D. Wimmer*1, Li Liang1, Joshua H. Siegle2, Jakob Voigts2, Matthew Wilson2, Michael M. Halassa1 1The Neuroscience Institute, New York University Langone Medical Center 2Department of Brain and Cognitive Science, Massachusetts Institute of Technology *These authors contributed equally Correspondence to: Michael M. Halassa at michael.halassa@nyumc.org URL: http://www.jove.com/video/51675 DOI: doi:10.3791/51675 Keywords: Neuroscience, Issue 91, multi-electrode, micro-drives, electrophysiology, single units, brain circuit recording, deep brain structure Date Published: 9/8/2014 Citation: Brunetti, P.M., Wimmer, R.D., Liang, L., Siegle, J.H., Voigts, J., Wilson, M., Halassa, M.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/9e/jove-91-51675.PMC4309135.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51675/ Introduction Mus musculus has, due to its genetic tractability, quickly become the animal model of choice for physiologists interested in microcircuit-level dissection of genetically-identified neurons and in investigating mouse models of human disease.",Non-OADS,/arxiv_data1/oa_pdf/e8/9e/jove-91-51675.PMC4309135.pdf
"The most common type of external Z-score is computed using LMS values from a growth reference that is the basis of a growthchart, such as those produced by the Centers for Disease Control and Prevention in the United States of America (http://www.cdc.gov/growthcharts/) (Kuczmarski et al., 2000), the Royal College of Paediatrics and Child Health in the United Kingdom (http://www.rcpch.ac.uk/growth-charts) (Wright et al., 2010), and the World Health Orga- nization (http://www.who.int/childgrowth/standards/) (WHO, 2006).",Non-OADS,/arxiv_data1/oa_pdf/41/24/ajhb0027-0069.PMC4309180.pdf
"There you can ﬁnd online courses, videos and voice-over presentations, datasets with accompanying code, software, recommended books, and so on: http://www.bristol.ac.uk/cmm/Although many universities and other organizations run short courses on statistical techniques relevant to human growth research, those provided by the Utrecht Summer School and the Interuniversity Consortium for Political and Social Research (ICPSR) are recommendedto researchers wanting to apply latent growth curve mod- els or growth mixture models: http://www.utrechtsu mmerschool.nl/courses/social-sciences http://www.icpsr.umich.edu/icpsrweb/landing.jsp From the website of Harlow Healthcare, it is possible to download a free excel macro called LMSgrowth which, among other things, computes external Z-scores according to a number of growth references.",Non-OADS,/arxiv_data1/oa_pdf/41/24/ajhb0027-0069.PMC4309180.pdf
"Also available from thiswebsite is LMSchartmaker, a user-written program to construct your own growth reference: http://www.health- forallchildren.com/ The Centers for Disease Control and Prevention in the United States of America and the World Health Organiza-tion also have software that can be used to compute exter- nalZ-scores according to their growth references: http://www.cdc.gov/growthcharts/computer_programs.htmhttp://www.who.int/childgrowth/software/ Most statistical packages have the capability to ﬁt the models described in this article, although Stata is recom- mended for everything up to and including mixed effects growth curve models and Mplus is recommended for latent growth curve models and growth mixture models: http://www.stata.com/ https://www.statmodel.com/ The utility of Stata for mixed effects growth curve mod- eling is greatly improved with the use of the command runmlwin , which calls on MLwiN, a specialist software package for mixed effects modeling, to ﬁt a model and returns the results to Stata: http://www.bristol.ac.uk/cmm/software/runmlwin/ The statistical packages R and SAS are recommended for non-linear mixed effects growth curve models (i.e.,where the dependent variable is not a linear function of the parameters), because Stata and MLwiN do not have this capability: http://www.r-project.org/ http://www.sas.com/en_us/software/analytics/stat.html LITERATURE CITED Adair LS, Fall CH, Osmond C, Stein AD, Martorell R, Ramirez-Zea M, Sachdev HS, Dahly DL, Bas I, Norris SA, Micklesﬁeld L, Hallal P,Victora CG.",Non-OADS,/arxiv_data1/oa_pdf/41/24/ajhb0027-0069.PMC4309180.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/3.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/e4/gfu212.PMC4309190.pdf
"In the USA, as well as single- centre independent PKD programmes, there are also competi- tive non-pro ﬁt registries such as National Kidney Registry or The Alliance for Paired Donation ( http://www.paireddonation.",Non-OADS,/arxiv_data1/oa_pdf/20/e4/gfu212.PMC4309190.pdf
"Transplant pro- grammes may choose to accept kidneys of different quality, de-pending on the age and the medical circumstances of each particular candidate, by establishing candidate-speci ﬁcK D P I acceptability thresholds ( http://optn.transplant.hrsa.gov ).",Non-OADS,/arxiv_data1/oa_pdf/20/e4/gfu212.PMC4309190.pdf
available at http://eurostam.eu/page10.html 32.,Non-OADS,/arxiv_data1/oa_pdf/20/e4/gfu212.PMC4309190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/21/main.PMC4309249.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.001,OADS,/arxiv_data1/oa_pdf/f6/21/main.PMC4309249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/db/main.PMC4309250.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.09.012,OADS,/arxiv_data1/oa_pdf/3f/db/main.PMC4309250.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/69/main.PMC4309251.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.09.013,OADS,/arxiv_data1/oa_pdf/b7/69/main.PMC4309251.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC4309255.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.007,OADS,/arxiv_data1/oa_pdf/af/4b/main.PMC4309255.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4309256.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.003,OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4309256.pdf
Methylation Validation in The Cancer Genome Atlas Samples To verify the patterns of methylation observed in cancer samples data was downloaded and analyzed form The Cancer Genome Atlas(TCGA) Project (https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4309256.pdf
The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/a3/cd/main.PMC4309256.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/12/main.PMC4309257.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.008,OADS,/arxiv_data1/oa_pdf/b2/12/main.PMC4309257.pdf
"Recent studies have reported that lncRNAs may function by positively or negatively regulating the expression oftheir neighboring protein-coding genes [14,16,26 –28].Thus, we retrieved the genomic locus information from the UCSC genomebrowser (http://genome.ucsc.edu/) and found that the tumoroncogene SNCG is located 8.6 kb downstream of AK058003,whereas another tumor suppressor gene, BMPR1A, is found 33.3 kbupstream of AK058003 ( Figure 5 A).",OADS,/arxiv_data1/oa_pdf/b2/12/main.PMC4309257.pdf
http://dx.doi.org/10.1016/j.mgene.2014.11.003 2214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/6d/main.PMC4309258.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/6d/main.PMC4309258.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/6d/main.PMC4309258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/3f/main.PMC4309259.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.11.006,OADS,/arxiv_data1/oa_pdf/be/3f/main.PMC4309259.pdf
http://dx.doi.org/10.1016/S1470-2045(14)71113-1 .,OADS,/arxiv_data1/oa_pdf/be/3f/main.PMC4309259.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/65/main.PMC4309260.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.002,OADS,/arxiv_data1/oa_pdf/2c/65/main.PMC4309260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/b5/main.PMC4309261.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.09.011,OADS,/arxiv_data1/oa_pdf/1d/b5/main.PMC4309261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/e0/main.PMC4309262.pdf
1476-5586/14http://dx.doi.org/10.1016/j.neo.2014.10.005,OADS,/arxiv_data1/oa_pdf/9a/e0/main.PMC4309262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/3b/main.PMC4309263.pdf
"1476-5586/14 http://dx.doi.org/10.1016/j.neo.2014.10.004Address all correspondence to: Diana Bellavia, PhD and Isabella Screpanti, MD, Laboratory of Molecular Pathology, Department of Molecular Medicine, SapienzaUniversity of Rome, Viale Regina Elena 291, 00161 Rome, Italy.E-mail: diana.bellavia@uniroma1.it ;isabella.screpanti@uniroma1.it 1This article refers to supplementary materials, which are designated by Figures S1 to S3 and are available online at www.neoplasia.com .",Non-OADS,/arxiv_data1/oa_pdf/c3/3b/main.PMC4309263.pdf
"Notch and NF- κB signaling pathways regulate miR-223/FBXW7 axis in T- cell acute lymphoblastic leukemia ,Leukemia .http://dx.doi.org/10.1038/leu.2014.133 [Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/c3/3b/main.PMC4309263.pdf
<http://www.jarm.jp/special/sp_0002.htm> (in Japanese) 29.,Non-OADS,/arxiv_data1/oa_pdf/93/ad/jrm-5-129.PMC4309314.pdf
<http://epi.ncc.go.jp/en/jphc/ > (accessed in 2009) 40.,Non-OADS,/arxiv_data1/oa_pdf/93/ad/jrm-5-129.PMC4309314.pdf
<http://www.nihs.go.jp/GINC/me eting/7th/ meet-rep.html>.,Non-OADS,/arxiv_data1/oa_pdf/93/ad/jrm-5-129.PMC4309314.pdf
Available at:http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_clinicians.html.Accessed 2 September 2009.,OADS,/arxiv_data1/oa_pdf/b4/74/jrm-5-140.PMC4309316.pdf
Avail - able from: http://www.evb.ch/cm_data/Paraquat_Unaccept ableHealthRisk_3rdEdition_2011_mb_print.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://www.mhlw.go.jp/toukei/list/80-1.html.,OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from:  http://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/ekigaku/0504sisin.html.,OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://db-out.nies.go.jp/kis-plus/noyaku_php/noyaku_select.php?cas_id=1910-42-5.,OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://www.who.int/ipcs/publications/pesti - cides_hazard_2009.pdf.,OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://pmep.cce.cornell.edu/profiles/extoxnet/metiram-propoxur/paraquat- ext.html.,Non-OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://toxipedia.org/display/toxipedia/Paraquat.,Non-OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
Available from: http://www.herbiguide.com.au/MSDS/MPAR20_58734-1204.PDF.,Non-OADS,/arxiv_data1/oa_pdf/58/e9/jrm-8-228.PMC4309333.pdf
http://www.ningen-dock.jp/concerned/press/pdf/hainteikubun_120405.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/6b/jrm-8-198.PMC4309334.pdf
http://www.health-station.com/t-85.html.,Non-OADS,/arxiv_data1/oa_pdf/35/6b/jrm-8-198.PMC4309334.pdf
http://www.cdc.gov/nchs/washington_group.htm (ac-cessed 2013/06/27)  8.,Non-OADS,/arxiv_data1/oa_pdf/47/1b/jrm-8-212.PMC4309337.pdf
2001. http://www.aiiku.or.jp/aiiku/ji-gyo/contents/kanren/kr0108/kr0108.htm.,Non-OADS,/arxiv_data1/oa_pdf/9c/e2/jrm-8-205.PMC4309338.pdf
Comprehensive sur - vey of living conditions of the people on health and welfare 2009. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k- tyosa09/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9c/e2/jrm-8-205.PMC4309338.pdf
2010 Available [online]: http://www.bas.gov.ph   3.,Non-OADS,/arxiv_data1/oa_pdf/6d/ae/jrm-5-184.PMC4309357.pdf
"Fertilizer and Pesticide Authority, Philippines, 2002; Available at http://www.fadinap.org/philippines/.",Non-OADS,/arxiv_data1/oa_pdf/f7/15/jrm-5-153.PMC4309360.pdf
Med J DLSU-EACM 1987; 3: 88–97; Availabl e at http://www.wpro.who.int/ hse/pages/abstract6.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/15/jrm-5-153.PMC4309360.pdf
"A paper presented on the 1st DOLE Research Conference held at Occupational Safety and Health Center,Diliman, Quezon City, on 5 December 2001 Available [online]: http://www.ilsd ole.gov.ph/PAPs/ResCon/rcon_01osh6.htm.",Non-OADS,/arxiv_data1/oa_pdf/f7/15/jrm-5-153.PMC4309360.pdf
http://info.cancerre- searchuk.org/cancerstats/index.htm (accessed April2014).,Non-OADS,/arxiv_data1/oa_pdf/18/c3/ijcp0069-0106.PMC4309408.pdf
"CG175 Prostate cancer, 2014. http://guidance.nice.org.uk/CG175/NICEGuidance/pdf/English (accessedMay 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/c3/ijcp0069-0106.PMC4309408.pdf
"http://www.bug.uk.com/publications.php, Sep-tember 2013 (accessed April 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/c3/ijcp0069-0106.PMC4309408.pdf
http://www.cebm.net/index.aspx?o=1025 (accessed April 2014).,Non-OADS,/arxiv_data1/oa_pdf/18/c3/ijcp0069-0106.PMC4309408.pdf
"References 1 Global Strategy for Asthma Management and Pre- vention, 2012. http://www.ginasthma.org/ (accessed7 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/08/c2/ijcp0068-0812.PMC4309409.pdf
"2 Global Strategy for Diagnosis, Management, and Prevention of COPD, 2011. http://www.goldcopd.org/ (accessed 7 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/08/c2/ijcp0068-0812.PMC4309409.pdf
"SPAD values were measured using a SPAD-502 chlorophyll meter (Konica Minolta, http://www.konicaminolta.com).",OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"All treatments contained equal amounts of Fe (30 lM) and were conducted in the same growth chamber (Panasonic MLR-351H, http://panasonic.net/business/) under a 16-h light/8-h dark photoperiod at 28 °C with a light inten- sity of 5700 lux.",Non-OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"The residue was dissolved in 3 ml of 1% HNO 3900ll of the sample was diluted 10 times by adding 8.1 ml of deionized water and ﬁltrated with 0.45- lm ﬁlter before metal content was measured by inductively coupledplasma atomic emission spectrometry (ICPE-9000, Shimadzu; http://www.shimadzu.com/an/index.html).",Non-OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"After removing the washing solution from the seedlingswith ﬁlter paper (Whatman 3MM, http://www.3m.com), the seed-lings were divided into shoots and roots with a razor blade.",Non-OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"Quantitative RT-PCR RNA was extracted using RNeasy Plant Mini Kit (Qiagen, http://www.qiagen.com) and used for both microarray analysis and qRT-PCR.",OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"cDNA was synthesised using the PrimeScript RT reagent kit with gDNA Eraser (Perfect Real Time) (TaKaRa, http://www.ta-kara-bio.com).",OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"Technologies Corp., http://www.lifetechnologies.com).",OADS,/arxiv_data1/oa_pdf/26/ae/tpj0081-0233.PMC4309410.pdf
"Seeds were sterilized in 10% sodium hypochloric acid solution by vacuum inﬁltration for 1 h,and then immersed in aqueous 2% PPM TMsolution (Nacalai Tes- que, Kyoto, Japan, http://www.nacalai.co.jp/) at 28 °C for 1 day in darkness.",Non-OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
"Frozen rice tissue was homogenized in ﬁve volumes of cold 80% aqueous methanol containing an inter-nal standard (0.5 mg L /C01lidocaine, Tokyo Kasei, Tokyo, Japan, http://www.tcichemicals.com/), using a mixer mill (MM 300, Rets- ch, Haan, Germany, http://www.retsch.com/) and a zirconia bead for 6 min at 20 Hz.",Non-OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
"electrospray quadrupole time-of-ﬂight tandem mass spectrometry with an Acquity BEH ODS column (LC-ESI-QToF/MS, HPLC: WatersAcquity UPLC system; MS: Waters QToF Premier, http://www.wa- ters.com/).",Non-OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
Data obtained in this study are avail-able on the PRIMe website (http://prime.psc.riken.jp/) (Sakurai et al.,OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
All statistical analyses were performed in R2.15.1 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
DATA AVAILABILITY Raw metabolome data obtained in this study are available on the PRIMe website (http://prime.psc.riken.jp/).,OADS,/arxiv_data1/oa_pdf/dc/c3/tpj0081-0013.PMC4309412.pdf
Statistical analysis and plots were per- formed by R software (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"All used seeds were sterilized by washing in 70% ethanol for 10 min and in 99% ethanol for 5 min, stratiﬁed for 2 days on 4 °C, pre-grown on ger- mination half-strength Murashige and Skoog medium (Duchefa,http://www.duchefa-biochemie.com/) for 2 weeks then moved into the soil and grown under the long day conditions (16 h light at 21°C, 8 h dark at 19 °C, with 50 –60% relative humidity).",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"For each polymerase chain reaction (PCR) 0.25 lMprimers, 0.5 U MyTaq DNA polymer- ase (Bioline, http://www.bioline.com/), and 6 –8 ng of genomic DNA were used.",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"The analysis was performed by StepOnePlus TMReal- Time PCR system (Applied Biosystems, http://www.appliedbiosys-tems.com/absite/us/en/home.html) using FastStart SYBR Green Master (Roche, http://www.roche.com/).",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Statistical analysis Statistical analysis and plots were done in Rsoftware (Free Soft- ware Foundation, http://www.r-project.org) using the non-pairedtwo-sided Mann –Witney –Wilcoxon test ( a=0.05).",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Signals on membranes were visualized using the FLA7000 imager (Fujiﬁlm, http://www.fujiﬁlm.com/) and a gray-scale intensity proﬁle was generated by Multi Gauge software (Fu- jiﬁlm).",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Plant treatments To inhibit ATM kinase, Arabidopsis plants were sown on Petri plates containing ku55933 (ATM inhibitor or IATM –Calbiochem, http://www.calbiochem.com/) at 10 lM(Amiard et al.",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"After permeabilization in Triton 0.5%, EdU detection was performed as indicated by the manufacturer (Invitrogen-click-it EdU Alexa ﬂuor 594 Imaging kit, http://www.lifetechnologies.com/cz/en/home/brands/invitrogen.html) and previously described(Amiard et al.",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
", 2009), using F17A22 BAC from ribosomic regions of Arabidopsis chromosome 2, labelled with biotin (Amersham, http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-uk/brands/amersham/)by nick translation (Roche).",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"followed by goat anti-avidin conjugated with biotin (1:100, Vector Laboratories, https://www.vectorlabs.com/) and avidin –Texas Red (1:500) were used.",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Slides were observed by ﬂuorescence microscopy and images were further processed andenhanced using ADOBE PHOTOSHOP (Adobe, http://www.adobe.com/) software.",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"We used mix of three enzymes (0.3% each), in 10 m Mcitrate buffer –cellulase (On- ozuka R10, Serva), pectolyase (Duchefa) and cytohelicase (Sigma, https://www.sigmaaldrich.com/).",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Slides were then stained with DAPI (1 lgm l/C01) in Vectashield (Vector Laboratories) and anapha- ses were count on each slide using Zeiss Axioimager Z1 with spe- ciﬁc ﬁlter corresponding to DAPI excitation and emission spectra (AHF Analysentechnik, http://www.ahf.de/).",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"RNA extraction and reverse transcription Total RNA was extracted from 16-day-old seedlings using theRNeasy plant mini kit (Qiagen, http://www.qiagen.com).",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"RNA wastreated with Turbo DNase (Ambion, http://www.lifetechnologies.com/cz/en/home/brands/ambion.html) for 40 min to eliminate contaminant DNA and quality was checked on 0.8% agarose gel.",Non-OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"The synthesis of cDNA was performed on 1 lg of RNA with the random hexamers (Finnzymes, http://www.thermoscientiﬁcbio.com/ﬁnnzymes/) using an M-MuLV reverse transcriptase kit (Finnzymes).",OADS,/arxiv_data1/oa_pdf/29/0e/tpj0081-0198.PMC4309414.pdf
"Recently, the genome sequence of the AP13 individual ofAlamo, a lowland tetraploid cultivar, was reported by theJoint Genome Institute (http://www.phytozome.net/dataU-sagePolicy.php?org=Org_Pvirgatum) (Casler et al.",Non-OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"The ﬁnal probe set used in this study (904 693 probes) isavailable from Roche-NimbleGen as the SeqCap EZ Devel-oper probe pool ‘120911_Switchgrass_GLBRC_R_EZ_HX1’.In total, 64 496 transcript sequences obtained from PlantGDB (http://plantgdb.org/) and a de novo assembly of ©2014 The Authors The Plant Journal published by Society for Experimental Biology and John Wiley & Sons Ltd., The Plant Journal , (2014), 79, 993–1008994 Joseph Evans et al.",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"Alignment of the probe set tothe Joint Genome Institute (JGI) Release 0 of the switch-grass genome (http://www.phytozome.net/dataUsagePoli-cy.php?org=Org_Pvirgatum) resulted in 869 680 (96%)aligned probes, of which 837 359 met the alignment crite-ria of 50% coverage and 90% identity (Figure S1b).",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
Filtered reads for each genotype were alignedto both the hard-masked and unmasked version of theAP13 Release 0 switchgrass genome (Joint GenomeInstitute; http://www.phytozome.com/dataUsagePolicy.php?org=Org_Pvirgatum_v0.0) using BOWTIE (Langmead et al.,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"To assess the genome distribution of structural variation in switchgrass, we mapped the Release0 genes to the pseudomolecules of Release 1, which has636 Mb of the total 1230 Mb assembled genome anchored to 18 pseudomolecules (http://www.phytozome.net/panic-umvirgatum_er.php).",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
The pyrosequencing-derived RNA-Seqreads were trimmed of low-quality sequences using the fastq_quality_trimmer tool from the FASTX TOOLKIT (version 0.0.13; http://hannonlab.cshl.edu/fastx_toolkit/).,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"The runAssembly program from the NEWBLER package (Roche, http://www.454.com/products/analysis-software/) was used to assemble the sequences.",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"Representation of annotated genic sequences by the probes in the Roche-NimbleGen SeqCap EZ Developer probe pool design 120911_Switchgrass_GLBRC_R_EZ_HX1 (904 693 probes) wasdetermined by alignment of the probe sequences to the AP13 ref- erence genome Release 0 (http://www.phytozome.net/dataUsage- Policy.php?org=Org_Pvirgatum) using GMAP (version 2013-03-31) (Wu and Watanabe, 2005) with default parameters.",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
Initial read quality assessment was performed using the FASTQC program (v0.10.0; http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"Cutadapt (v1.1; https://code.google.com/p/cutadapt/) was used to remove adapter sequences, PCR primers, and to trim bases with a quality score below 20.",Non-OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
Filtered exome capture sequence reads were aligned to the hard- masked P. virgatum Release 0 reference genome (http://www.phy tozome.net/dataUsagePolicy.php?org=Org_Pvirgatum) using BOWTIE version 0.12.7 (Langmead et al.,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
Resulting trees were visualized with FIGTREE v. 1.4.0 (http://tree.bio.ed.ac.uk/ software/ﬁgtree/).,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
P-values were computed using a biological coefﬁcient of variation of 0.4 using EDGER follow- ing the authors’ instructions (http://www.bioconductor.org/pack-ages/release/bioc/vignettes/edgeR/inst/doc/edgeRUsersGuide.pdf).,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"Annotated genes (65 878) from the JGIRelease 0 annotation (http://www.phytozome.net/panicumvirga- tum.php) were aligned to the Release 1 pseudomolecules using GMAP (version 2013-03-31) (Wu and Watanabe, 2005) with default parameters.",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
(version 3.0.1) (http://www.r-project.org) and MeV Multiple Experi- ment Viewer (http://www.tm4.org/).,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
", 2003) with default parameters was used to search for ortholog clusters in the predicted proteomes of six grass species including switchgrass(Release 0), B. distachyon ((The International Brachypodium Initiative, 2010) http://www.phytozome.net/brachy.php), Oryza sativa ((International Rice Genome Sequencing Project, 2005), http:// rice.plantbiology.msu.edu/), S. italica [(Bennetzen et al.",OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
", 2009), http://www.phytozome.net/maize.php], and Sorghum bicolor [sorghum, (Paterson et al.",Non-OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
", 2009) http://www.phytozome.net/ sorghum_er.php].",Non-OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
Single nucleotide polymorphisms identiﬁed in this study (Table S3) are available for download from the Dryad Digital Repository (http://datadryad.org/) at this DOI (http://doi.org/10.5061/dryad.b52p5).,OADS,/arxiv_data1/oa_pdf/62/e0/tpj0079-0993.PMC4309430.pdf
"The isolated RNA was reverse transcribed using the PrimeScriptTMRT reagent Kit (TaKaRa, http://www.takara-bio.com/) following the manufac- turer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/tpj0081-0053.PMC4309432.pdf
"qRT-PCR was analyzed using SYBR Green master mix (TaKaRa) on a StepOne Plus real-time PCR system(Applied Biosystems, http://www.appliedbiosystems.com/).",OADS,/arxiv_data1/oa_pdf/e1/cf/tpj0081-0053.PMC4309432.pdf
"The extract was transferred to a glasstube, and C17 LCB, C12 Ceramide, C12 glucosylceramide (Avanti, http://www.avantilipids.com/) were added as internal standards, followed by incubation at 60 °C for 15 min with occasional shak- ing.",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/tpj0081-0053.PMC4309432.pdf
"The combined supernatants were subsequently evaporated under nitrogen and de-esteriﬁed in 33% methylamine in ethanol/water (7:3; v/v) followed by a 1-h incubation at 50 °C (Markham and Jaworski, 2007).The extracts were dried under nitrogen, then dissolved in 1 ml of methanol and analyzed on a triple TOF 5600 MS/MS system(AB SCIEX, http://www.absciex.com/, Canada).",Non-OADS,/arxiv_data1/oa_pdf/e1/cf/tpj0081-0053.PMC4309432.pdf
"Separations were accomplished on an Agilent Eclipse XDB C8 column (5092.1 mm, 1.8 lm) (Agilent, http://www.agilent.com/).",OADS,/arxiv_data1/oa_pdf/e1/cf/tpj0081-0053.PMC4309432.pdf
"The main biosynthetic processes were described with overall reactions for: (i) the biosynthesis of cell wall poly-saccharides from UDP-glucose ( V cw); (ii) protein synthesis (Vprotein ), with the molar proportion of four classes of amino acids (glutamate, aspartate, alanine and serine) according to the averaged amino acid composition of pro- teins in tomato (Friedman, 2002) (Table S2); (iii) fatty acidssynthesis (diacyl glycerol; V dag) from pyruvate and trioses phosphate; and (iv) nucleotide synthesis (DNA and RNA;V nucleotides ) from ribose-5-phosphate by using plant meta- bolic pathway databases (http://www.plantcyc.org).",OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
Total cell wall polysaccharides were analysed on dry samples at the BIBS platform (http://www.bibs.inra.fr) on alcohol-insoluble material (AIM).,OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"Approximately 50 –200 mg of frozen tomato ﬂesh was lyophilized and ground into ﬁne powder using the Fast-Prep-24 instrument (MP Biochemicals, http://www.mpbio.com) ata speed of 6.5 m s /C01for 60 s. Samples were transferred in 22 –mL cells of the ASE/C226350, dried at 40 °C overnight under vacuum over P2O5, weighed and AIM was extracted using 80% ethanol at a ﬂow rate of 2 ml min/C01.",Non-OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"(1983), and were chromatographed on a TG-225 GC column (3090.32 mm inner diamater) using TRACETMUltra Gas Chro- matograph (Thermo Scientiﬁc, http://www.thermoscientiﬁc.com;temperature 205 °C, carrier gas H 2).",Non-OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"The FAMES (1 ll) samples were injected in an Agilent 7890 gas chromatograph equipped with a Carbowax column (15 m 90.53 mm, 1.2 lm; Alltech Associates, Deerﬁeld, IL, USA, https://grace.com/) and ﬂame ionization detec-tion.",OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"FAMES were identiﬁed by compar- ing their retention times with commercial fatty acid standards(Sigma-Aldrich, http://www.sigmaaldrich.com) and quantiﬁed byusing ChemStation (Agilent, http://www.agilent.com) to calculate the peak surfaces, and then comparing them with the C17:0 response.",OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"RNA was extracted from up to 100 mg of frozen material using the Ambion RNA TRIzol/C226Reagent (Invitrogen, now Life Technologies, http://www.lifetechnologies.com), following themanufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
"From these curves, we derived a 95% interval of prediction for the derivatives, and thesevalues were used as boundaries to the corresponding ﬂuxes.Mathematical problems were implemented using MATLAB (Math- works, http://www.mathworks.fr/) and the optimization toolbox, solver quadprod , with the interior-point-convex algorithm for the quadratic convex minimization (code provided in Appendix S2) .Another optimization program with the fmincon solver and the sequential quadratic programming algorithm using a random start was implemented (code provided in Appendix S3).",Non-OADS,/arxiv_data1/oa_pdf/68/89/tpj0081-0024.PMC4309433.pdf
These data can be obtained free of charge from The CambridgeCrystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/46/ncomms6801.PMC4309444.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Zhang, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/53/46/ncomms6801.PMC4309444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6801 8 NATURE COMMUNICATIONS | 6:5801 | DOI: 10.1038/ncomms6801 | www.nature.com/naturecommunications &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/53/46/ncomms6801.PMC4309444.pdf
"Prior to the study, the wrists of each animal were s.c. implanted with unique RFID microchips (DATAMARS; http://www.datamars.com).",OADS,/arxiv_data1/oa_pdf/17/21/jne0027-0033.PMC4309459.pdf
Available at: http://www.abs.gov.au/ausstats/abs@.nsf/Products/6302.0~Nov +2013~Main+Features~Australia?OpenDocument (cited 30 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/05/d1/ecc0024-0060.PMC4309461.pdf
Available at:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (cited 2014).,Non-OADS,/arxiv_data1/oa_pdf/05/d1/ecc0024-0060.PMC4309461.pdf
Department of Health (2005) AC a r e e r Framework for Healthcare Scientists .U R L webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publica tionsandstatistics/Publications/Publications PolicyAndGuidance/DH_4123205(Accessed21/10/14).,Non-OADS,/arxiv_data1/oa_pdf/c3/27/tme0024-0335.PMC4309462.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201406501.,Non-OADS,/arxiv_data1/oa_pdf/aa/a6/anie0054-0221.PMC4309464.pdf
To view this mini commentary visit http://dx.doi.org/10.1111/1471-0528.13107.,Non-OADS,/arxiv_data1/oa_pdf/24/43/bjo0122-0249.PMC4309469.pdf
Available from: http://www.unicef.ca/sites/default/ﬁles/imce_uploads/UTILITY%20NAV/MEDIA%20CENTER/PUBLICATIONS/sowc_2014.pdf[accessed February 2014].,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.unicef.org/ paciﬁcislands/Fiji_Equity_Atlas_Web_version.pdf [accessed February2014].,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.unescap.org/stat/data/syb2013/ESCAP-syb2013.pdf [accessed January 2014].,OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://mdgs.un.org/unsd/mdg/Data.aspx [accessed April 2014].,OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
"Available from: http://www.unicef.org/ paciﬁcislands/Children_in_Solomon_Islands_2011_An_Atlas_of_Social_Indicators(1).pdf [accessed 1 August 2014], 1–80.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.unicef.org/png/activities_4369.html[accessed April 2014].,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://databank.worldbank.org [accessed April2014].,OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
"Available from: http://pngpaediatricsociety.org/wp-content/uploads/2013/06/PNG-Child-Health-Policy-and-Plan-2009-2020.pdf [accessed April2014], PNG Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
"Available from:http://www.who.int/child-adolescent-health/publications/CHILD_HEALTH/PB.htm, www.ichrc.org.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from:: http://www.human-resources-health.com/content/pdf/ 1478-4491-10-45.pdf:doi:10.1186/1478-4491-10-45 [accessed 10December 2014].,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.un.org/esa/population/publications/wcu2010/WCP_2010/Data.html [accessed February 2014].,OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.wpro.who.int/immunization/documents/international_epi_review_SLB_nov_2012.pdf?ua=1[accessed 1 August 2014] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.childinfo.org/ﬁles/ Solomon_Islands_2000_2012.pdf [accessed 1 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://pngpaediatricsociety.org/?page_id=192 [accessed April 2014].,OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available from: http://www.who.int/school_youth_health/gshi/hps/en/ [accessed April 2014].T Duke et al.,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jpc0051-0054.PMC4309470.pdf
Available at: http://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available at: http://www.clini- caltrials./.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available at: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
"An open label, dose-escalation study of encapsu- lated cell biodelivery of nerve growth factor to the cholinergic basalforebrain of Alzheimer’s disease patients (study NCT01163825).Available at: http://www.clinicaltrials./.",Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available at: http://www.clinical-trials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available at: http://clinicaltrials.gov/ct2/show/NCT01163825.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available at: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
eLS 2010. http://onlinelibrary.wiley.com/doi/10.1002/9780470015902.a0000510.pub3/full.,Non-OADS,/arxiv_data1/oa_pdf/7e/08/jbm0103-0846.PMC4309473.pdf
Available from: http://www2.dupont.com/Titanium_ Technologies/en_US/tech_info/literature/Coatings/CO_B_H_65969_Coatings_ Brochure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/26/c4/ieam0011-0010.PMC4309481.pdf
Available from: http://www.nanoriskframework.com/files/2011/11/6496_Nano ‐Risk ‐Framework.pdf [EC] European Commission.,OADS,/arxiv_data1/oa_pdf/26/c4/ieam0011-0010.PMC4309481.pdf
"Available from: http://www.jetro.go.jp/en/reports/regulations/pdf/foodext2010e.pdf Jovanovi /C19c B, Pali /C19c D. 2012.",Non-OADS,/arxiv_data1/oa_pdf/26/c4/ieam0011-0010.PMC4309481.pdf
Available from: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfCFR/CFRSearch.cfm?fr ¼73.575.,OADS,/arxiv_data1/oa_pdf/26/c4/ieam0011-0010.PMC4309481.pdf
"Available from: http://minerals.usgs.gov/minerals/pubs/commodity/titanium/mcs ‐2013 ‐ titan.pdf Walker CH, Sibly RM, Hopkin SP , Peakall DB.",OADS,/arxiv_data1/oa_pdf/26/c4/ieam0011-0010.PMC4309481.pdf
doi:http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/66/desc0018-0146.PMC4309482.pdf
doi:http://dx.doi.org/10.1016/j.jml.,OADS,/arxiv_data1/oa_pdf/ae/66/desc0018-0146.PMC4309482.pdf
"Trends in Cognitive Sciences ,4(11), 417 – 423. doi:http://dx.doi.org/10.1016/S1364-6613(00)01538 Baddeley, A.",Non-OADS,/arxiv_data1/oa_pdf/ae/66/desc0018-0146.PMC4309482.pdf
"doi:http://dx.doi.org/10.1016/ 0749-596X(92)90036-W McDade, H.L., Simpson, M.A., & Lamb, D.E.",OADS,/arxiv_data1/oa_pdf/ae/66/desc0018-0146.PMC4309482.pdf
"doi:http://dx.doi.org/10.1016/ 0749-596X(90)90042-X Repov /C20s, G., & Baddeley, A.",OADS,/arxiv_data1/oa_pdf/ae/66/desc0018-0146.PMC4309482.pdf
"Male circumcision: global trends and determinants of prevalence, safety and acceptability ,2007.Available at: http://www.who.int/hiv/pub/malecircumcision/globaltrends/en/.AccessedApril 2014 57 Statistics Canada.",Non-OADS,/arxiv_data1/oa_pdf/3e/e1/bju0114-0E90.PMC4309483.pdf
"Institut de la Statistique du Québec,2003.Available at: http://www.stat.gouv.qc.ca/statistiques/ recensement/2001/recens2001_06/religion/religion06.htm.Accessed May2013 Correspondence: Marie-Élise Parent,Unité d’épidémiologie et biostatistique,INRS-InstitutArmand-Frappier Université duQuébec,531,boul.des Prairies,Laval,Québec H7V 1B7,Canada.",Non-OADS,/arxiv_data1/oa_pdf/3e/e1/bju0114-0E90.PMC4309483.pdf
"as compared to untreated or normal PBMC–treated UC-MSCs, TCR-stimulated lupus PBMCs failed to fur-ther up-regulate the aforementioned cytokines (Supple-mentary Figure 1, available on the Arthritis & Rheuma- tology web site at http://onlinelibrary.wiley.com/doi/ 10.1002/art.38674/abstract).",Non-OADS,/arxiv_data1/oa_pdf/20/7d/art0066-2234.PMC4309486.pdf
"We found that UC-MSCs inhib - ited B cell differentiation (as determined by CD138staining), proliferation (as determined by CFSE label-ing), and IgG production (as determined by ELISA)(Supplementary Figure 2, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.38674/abstract).",OADS,/arxiv_data1/oa_pdf/20/7d/art0066-2234.PMC4309486.pdf
"Unexpectedly, we found that non-CD4 /H11001cells from lupus patients drove UC-MSCs to increase expression of mRNA for IDO andexhibited higher levels of IDO enzymatic activity whencompared to CD4 /H11001T cells from lupus patients (Supple- mentary Figure 3, available on the Arthritis & Rheuma- tology web site at http://onlinelibrary.wiley.com/doi/ 10.1002/art.38674/abstract).",Non-OADS,/arxiv_data1/oa_pdf/20/7d/art0066-2234.PMC4309486.pdf
"In vitro stimulation by lupus CD8 /H11001T cells resulted in a significant increase in IFNGR1 but notIFNGR2 in UC-MSCs (Figure 5A and SupplementaryFigure 4A, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38674/abstract).",Non-OADS,/arxiv_data1/oa_pdf/20/7d/art0066-2234.PMC4309486.pdf
"Furthermore, in an-other clinical study, we found that percentages of peri-pheral blood CD3 /H11001CD4/H11001T cells decreased after UC- MSC transplantation in patients (Supplementary Figure5, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.38674/abstract).",Non-OADS,/arxiv_data1/oa_pdf/20/7d/art0066-2234.PMC4309486.pdf
"Similarly, in the patients without overt CVD, after con- trolling for multiple confounding factors, SUA quartiles were still independently associated with increased preva- lences of HTN and MetS (Table S1, http://links.lww.com/ HJH/A425).",Non-OADS,/arxiv_data1/oa_pdf/85/93/jhype-33-482.PMC4309490.pdf
Anonymous data from the survey are available fornot-for-proﬁt research from the UK Data Archive (http://www.data-archive.ac.uk/) – the source of data used in thepresent study (Department of Health 2011–2012b).,OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
Available at: http://dx.doi.org/10.5255/UKDA-SN-6742-1 Department of Health (2011–2012a) National Cancer Patient ExperienceSurvey – National Report .,Non-OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
"Available at: http://dx.doi.org/10.5255/UKDA-SN-7134-1 El Turabi A., Abel G.A., Roland M. & Lyratzopoulos G. (2013) Variation inreported experience of involvement incancer treatment decision making: evi-dence from the National Cancer PatientExperience Survey.",OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
Available at: http://webarchive.nationalarchives.gov.uk/20100410180038/http://communities.gov.uk/communities/neighbourhoodrenewal/deprivation/deprivation07/ Institute of Medicine (IOM) (2001) Crossing the Quality Chasm: A New HealthSystem for the 21st Century .,Non-OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
Availableat: http://www.iom.edu/Reports/2013/Identifying-and-Addressing-the-Needs-of-Adolescents-and-Young-Adults-with-Cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
"Available at: http://www.nice.org.uk/nicemedia/live/10899/28876/28876.pdf Saunders C.L., Abel G.A., El Turabi A., Ahmed F. & Lyratzopoulos G. (2013)Accuracy of routinely recorded ethnicgroup information compared with self-reported ethnicity: evidence from theEnglish Cancer Patient Experiencesurvey.",Non-OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
"Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/213055/121109-NHS-Outcomes-Framework-2013-14.pdf Weech-Maldonado R., Morales L.S., Elliott M., Spritzer K., Marshall G. & Hays R.D.",Non-OADS,/arxiv_data1/oa_pdf/d4/cb/ecc0024-0085.PMC4309492.pdf
"Prediction and validation of targets of drought- regulated miRNAs and siRNAs To analyse the molecular function of drought-regulated miRNAs, their targets were predicted using psRNAtarget (http://plantgrn.noble.org/psRNATarget/).",OADS,/arxiv_data1/oa_pdf/f5/42/pbi0013-0002.PMC4309496.pdf
miRNA targets were predicted using psTarget (http://plantgrn.noble.org/psRNATarget).,OADS,/arxiv_data1/oa_pdf/f5/42/pbi0013-0002.PMC4309496.pdf
"Somatic copy number alterations (CNAs) were called us- ing BIC-Seq [Xi et al., 2011], ControlFREEC [Boeva et al., 2011], dwac-seq (https://github.com/Vityay/DWAC-Seq), and Patchwork [Mayrhofer et al., 2013].",Non-OADS,/arxiv_data1/oa_pdf/10/d1/humu0036-0118.PMC4309499.pdf
"For validation of re- maining SNVs, the allele fraction (AF) from the target capture ex- periment was calculated with a custom Python script (available at https://github.com/Molmed/Berglund-Lindqvist-2013).",OADS,/arxiv_data1/oa_pdf/10/d1/humu0036-0118.PMC4309499.pdf
"Variant Calling in the Validation Cohort SNVs and indels in the validation cohort were called with Free- Bayes (http://arxiv.org/abs/1207.3907) and the GATK Haplotype- Caller [DePristo et al., 2011], respectively.",OADS,/arxiv_data1/oa_pdf/10/d1/humu0036-0118.PMC4309499.pdf
"By comparing with a Wolbachia MLST database (http://pubmlst.org/ wolbachia/), the sequence type (ST) number ST213 was obtained,which was consistent with our previous study 30.Discussion The effect of Wolbachia on host evolution .The cotransmission of Wolbachia and mitochondria is expected to cause the bacteria to have an indirect impact on mitochondrial DNA diversity, as a re-sult of a selective sweep of the mito-type associated with the infec-tion 21,22.",Non-OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
"MaTr, marginal tropical zone; MTr, middle tropical zone; ARDC, ancient rice domestication center; HGI, mitochondrial DNA haplogroup I; HGII, mitochondrial DNA haplogroup II (The map is made by ArcGIS 10.2 software, http://www.arcgis.com/features/).Geographic Distance (Log)3.40 3.20 3.00 2.80 2.60 2.40 2.20Genetic Distance0.80 0.60 0.40 0.20 0.00Geographic Distance (Log)3.40 3.20 3.00 2.80 2.60 2.40 2.20Genetic Distance0.15 0.100.050.00 -0.05 -0.10A BMicrosatellites mtDNA Figure 6 |Scatter plots of genetic distance ( FST/12FST) vs. geographic distance for pairwise population comparisons based on microsatellite (A) or mtDNA data (B).",OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
The primer pair for the COI gene (F: 5 9-TCTCATTACATATCGCTGGAGTTAG-3 9;R :59- GTAGTCTGAATATCGTCGTGGTATT-3 9) was designed from the published complete mitochondrial genome of SBPH 28using Primer premier 5.0 software (http://www.premierbiosoft.com).,Non-OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
The convergence of the chain was checked by the T RACER v1.5 program (http://tree.bio.ed.ac.uk/software/tracer) to ensure that effective sample sizes were above 200.,OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
"Additional information Data Accessibility: GPS values of the sampling locations, microsatellite genotype data, data matrix of the concatenated partial COIand COII gene sequences from 1323 individuals, and the 107 haplotype sequences of the concatenated partial COI and COII gene sequences are all deposited at Dryad (Doi:10.5061/dryad.66jr2, http://datadryad.org/review?wfID 536983&token 518a66b98-ad73-4dc2-90e0-850da33cd7d7).",OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/18/srep08045.PMC4309506.pdf
"In the wake of the HGP, efforts of the Cancer Genome Association (TCGA; cancergenome.nih.gov/) and ICGG (http://icgc.org/) provide complete characterization of cancer genomes.",Non-OADS,/arxiv_data1/oa_pdf/e8/01/bcpt0116-0009.PMC4309509.pdf
Available at: http://www.nice.org.uk/niceMedia/documents/smoking_cessation_treatments.pdf (accessed 20 November 2013)(Archived at http://www.webcitation.org/6LGqIA5sd).,Non-OADS,/arxiv_data1/oa_pdf/e2/63/add0109-1184.PMC4309513.pdf
Available at: http:// www.dh.gov .uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_125389 (accessed 20November 2013) (Archived at http://www.webcitation.org/6LGqaHhdW).,Non-OADS,/arxiv_data1/oa_pdf/e2/63/add0109-1184.PMC4309513.pdf
Available from: http://www.medicinescomplete.com/mc/martindale/current/9035-v.htm?q ¼danazol&t ¼ search&ss ¼text&p¼1#m9035-a1-d. 22.,Non-OADS,/arxiv_data1/oa_pdf/c7/07/pbc0062-0208.PMC4309514.pdf
Available from: http://us.gsk.com/products/assets/us_promacta.pdf.,OADS,/arxiv_data1/oa_pdf/c7/07/pbc0062-0208.PMC4309514.pdf
ALTEX Available at: http://www.altex.ch/ resources/WR Juberg epub.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9c/57/bdrb0101-0063.PMC4309517.pdf
Available at: http://search.oecd.org/ofﬁcialdocuments/ displaydocumentpdf/?cote =env/jm/mono(2003)1&doclanguage = en.,OADS,/arxiv_data1/oa_pdf/9c/57/bdrb0101-0063.PMC4309517.pdf
Available at: http://search.oecd.org/ofﬁcialdocuments/displaydocumentpdf/?,Non-OADS,/arxiv_data1/oa_pdf/9c/57/bdrb0101-0063.PMC4309517.pdf
Available at: http://search.oecd.org/ofﬁcialdocuments/displaydocumentpdf/?,Non-OADS,/arxiv_data1/oa_pdf/9c/57/bdrb0101-0063.PMC4309517.pdf
Available at: http://www.epa.gov/comptox/toxcast/.,OADS,/arxiv_data1/oa_pdf/9c/57/bdrb0101-0063.PMC4309517.pdf
"Public database for localization data To allow for efficient visualization and sharing of our dynamic protein localization library, we have developed apublicly accessible online database with all the raw andprocessed data, as well as analysis scripts, organized ina searchable list (http://mtshasta.phys.washington.edu/localizome).",OADS,/arxiv_data1/oa_pdf/29/85/mmi0095-0064.PMC4309519.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 45–54Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  45REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7013 9How can clinician-educator training programs   be optimized to match clinician motivations   and concerns?,Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
"Available from:  http://www.royalcollege.ca/portal/page/portal/rc/ common /documents / canmeds/resources/publications/framework_full_e.pd f. Accessed  October  11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
"Available  from: https://www.afmc.ca/pdf/Study%20of%20Clinical% 20 Teachers %20-%20Discussion%20Paper.pd f. Accessed October  11,  2014.",Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/ce/amep-6-045.PMC4309549.pdf
"Competing Interests All authors have completed the Uniﬁed Competing Inter-est form at http://www.icmje.org/coi_disclosure.pdf (avail-able on request from the corresponding author) anddeclare no support from any organization for the submit-ted work, no ﬁnancial relationships with any organizationsthat might have an interest in the submitted work in theprevious 3 years and no other relationships or activitiesthat could appear to have inﬂuenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/37/c2/bcp0079-0241.PMC4309630.pdf
Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (last accessed July 2014).,OADS,/arxiv_data1/oa_pdf/37/c2/bcp0079-0241.PMC4309630.pdf
Available at http://www.ema.europa.eu/ema/index.jsp?curl =pages/includes/medicines/medicines_landing _page.jsp&mid =(last accessed August 2014).,Non-OADS,/arxiv_data1/oa_pdf/37/c2/bcp0079-0241.PMC4309630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/90/bctt-7-037.PMC4309671.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 37–41Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  37Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S7399 7a comparison of letrozole and anastrozole  followed by letrozole in breast cancer patients Potchavit aphinives Damnern Vachirodom Chaiyut Thanapaisal Dhanes rangsrikajee Ongart somintara Department of surgery, Faculty   of Medicine, Khon Kaen University,   Khon Kaen, Thailand Correspondence: Potchavit aphinives   Department of surgery, Faculty of  Medicine, Khon Kaen University, 123  group 16, Mittraparp rd, Muang, Khon  Kaen province, 40002, Thailand   Tel +66 43 363 252   Fax +66 43 348 393   email potchavit@gmail.co mBackground:  We previously studied the noninferiority of anastrozole (ANZ) versus ANZ   followed by letrozole (A-LTZ) due to reimbursement policy.",Non-OADS,/arxiv_data1/oa_pdf/ec/90/bctt-7-037.PMC4309671.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ec/90/bctt-7-037.PMC4309671.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/e0/main.PMC4309682.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.007,OADS,/arxiv_data1/oa_pdf/48/e0/main.PMC4309682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ba/main.PMC4309683.pdf
1476-5586/15 http://dx.doi.org/10.1016/j.neo.2014.11.009,OADS,/arxiv_data1/oa_pdf/61/ba/main.PMC4309683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/79/main.PMC4309684.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.008,OADS,/arxiv_data1/oa_pdf/7f/79/main.PMC4309684.pdf
Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.Oncogene .http://dx.doi.org/10.1038/onc.2013.473 .,Non-OADS,/arxiv_data1/oa_pdf/7f/79/main.PMC4309684.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/3d/main.PMC4309685.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.12.004,OADS,/arxiv_data1/oa_pdf/73/3d/main.PMC4309685.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/22/main.PMC4309725.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.003,OADS,/arxiv_data1/oa_pdf/3b/22/main.PMC4309725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/64/main.PMC4309726.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.005,OADS,/arxiv_data1/oa_pdf/49/64/main.PMC4309726.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/84/main.PMC4309729.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.002,OADS,/arxiv_data1/oa_pdf/78/84/main.PMC4309729.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/main.PMC4309730.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.10.010,OADS,/arxiv_data1/oa_pdf/ea/fa/main.PMC4309730.pdf
Endocr Rev .http://dx.doi.org/10.1210/er.2014-1026 .,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/main.PMC4309730.pdf
http://dx.doi.org/10.1210/jc.2014-2151 .,Non-OADS,/arxiv_data1/oa_pdf/ea/fa/main.PMC4309730.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/40/main.PMC4309731.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.004,OADS,/arxiv_data1/oa_pdf/56/40/main.PMC4309731.pdf
"Thus, we screened the sequence of HULCand CLOCK using bioinformatics ( http://blast.ncbi.nlm.nih.gov/Blast.",OADS,/arxiv_data1/oa_pdf/56/40/main.PMC4309731.pdf
"http://dx.doi.org/10.1016/j.neo.2014.06.005 [pii: S1476-5586(14)00079-7, Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/56/40/main.PMC4309731.pdf
http://dx.doi.org/10.1016/j.ccr.2014.03.010 [Epub 2014 Apr 24].,OADS,/arxiv_data1/oa_pdf/56/40/main.PMC4309731.pdf
This is an openaccess article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.12.001,OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1007/ s10620-006-9248-4 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1038/ modpathol.3800976 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1038/sj.bjc.6605743 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1007/s10620-006-9480-y .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1001/ archsurg.2009.108 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1053/hupa.2002.123545 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1093/annonc/mds252 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/ 10.1016/j.suc.2011.06.007 .Neoplasia Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1055/s-0031-1271596 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1007/s00535-007-2082-4 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1093/annonc/mdq078 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1016/j.ijsu.2010.03.008 .,OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1016/j.suronc.2010.06.004 .,OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1016/j.ijsu.2014.03.004 .,OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1097/EDE.0b013e3181577511 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
http://dx.doi.org/10.1055/s-2005-858378 .,Non-OADS,/arxiv_data1/oa_pdf/6f/42/main.PMC4309732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4309733.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.11.001,OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4309733.pdf
http://dx.doi.org/10.1002/0471142735.im0701s85 .,Non-OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4309733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/d2/main.PMC4309734.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.10.009,OADS,/arxiv_data1/oa_pdf/0b/d2/main.PMC4309734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/6f/main.PMC4309735.pdf
1476-5586/15http://dx.doi.org/10.1016/j.neo.2014.12.002,OADS,/arxiv_data1/oa_pdf/8f/6f/main.PMC4309735.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/38/ndt-11-185.PMC4309773.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 185–189Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  185OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7570 1The prevalence and correlates of the positive  Androgen Deficiency in the Aging Male (ADAM)  questionnaire among psychiatric outpatients: a  cross-sectional survey of 176 men in a general  hospital in Taiwan chin-Pang lee1,2 Yu chen2–4 Kun-hao Jiang2,4,5 chun-lin chu1,2,4 shih-chieh hsu1,2,4 Jiun-liang chen2,4,5 ching-Yen chen1,2,4 1Department of Psychiatry, chang  Gung Memorial Hospital, Linkou,   Taiwan; 2Men’s Health Center, Chang  Gung Memorial Hospital, Taoyuan,   Taiwan; 3Department of Urology,   Chang Gung Memorial Hospital,   Linkou, Taiwan; 4School of Medicine,   chang gung University, Taoyuan;   5Department of Traditional chinese  Medicine, Chang Gung Memorial  Hospital, Linkou, TaiwanIntroduction:  The Androgen Deficiency in the Aging Male (ADAM) questionnaire is widely  used to screen for late-onset hypogonadism.",Non-OADS,/arxiv_data1/oa_pdf/9a/38/ndt-11-185.PMC4309773.pdf
"It is not uncommon in daily practice to see middle-aged or older male correspondence: ching-Yen chen Department of Psychiatry, chang gung  Memorial Hospital, Linkou, No 5, Fusing St,  gueishan, Taoyuan, 33305 Taiwan Tel +886 3 328 1200 ext 3836 Fax +886 3 328 0267 email psycychen@yahoo.com.t w Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Lee et al Running head recto: Positive ADAM among psychiatric outpatients DOI: http://dx.doi.org/10.2147/NDT.S75701",Non-OADS,/arxiv_data1/oa_pdf/9a/38/ndt-11-185.PMC4309773.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9a/38/ndt-11-185.PMC4309773.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/38/ndt-11-185.PMC4309773.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/aa/tacg-8-019.PMC4309774.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 19–25The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S4962 8Tay-Sachs disease: current perspectives from  Australia Raelia M Lew1,7 Leslie Burnett2,3,4 Anné L Proos2 Martin B Delatycki5,6 1Department of Obstetrics and  Gynecology, Q eii Research institute  for Mothers and infants, The  University of Sydney, Australia; 2NSw  Health Pathology North, Royal North  Shore Hospital, St Leonards, Australia;   3SeALS, Prince of wales Hospital,   Randwick, Australia; 4Sydney Medical  School-Northern, Royal North Shore  Hospital e25, University of Sydney,   Sydney, Australia; 5Department of  Clinical Genetics, Austin Health,   Heidelberg, Australia; 6Bruce Lefroy  Centre for Genetic Health Research,   Murdoch Childrens Research institute,   Parkville, Australia; 7Department  of Obstetrics and Gynaecology,   Dentistry and Health Sciences,   Faculty of Medicine, The University of  Melbourne, Melbourne, Australia Correspondence: Raelia M Lew   Department of Obstetrics and  Gynaecology, D02 - The Queen elizabeth ii  Research institute for Mothers and infants,  The Queen elizabeth ii Research and  victor Coppleson Building, Blackburn  Avenue, The University of Sydney,  NSw 2006, Australia   Tel + 612 9351 2722   Fax + 612 9351 4560   email r lew2064@uni.sydney.edu.a uAbstract:  Tay-Sachs disease (TSD) is a fatal, recessively inherited neurodegenerative condition  of infancy and early childhood.",Non-OADS,/arxiv_data1/oa_pdf/9f/aa/tacg-8-019.PMC4309774.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/9f/aa/tacg-8-019.PMC4309774.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/aa/tacg-8-019.PMC4309774.pdf
"Available  from: http://www.bailii.org/uk/cases/UKHL/1985/7.htm l. Accessed  October 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9f/aa/tacg-8-019.PMC4309774.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/96/vhrm-11-071.PMC4309775.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 71–78Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  71ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7659 9Real-world effectiveness of amlodipine/valsartan  and amlodipine/valsartan/hydrochlorothiazide   in high-risk patients and other subgroups samir Helmy assaad-Khalil1 Robert najem2 Jorge sison3 asad Riaz Kitchlew4 Belong cho5 Kwo-chang Ueng6 shelley DiT ommaso7 abhijit shete7 1Department of Diabetology,   lipidology and Metabolism,   alexandria Faculty of Medicine,   alexandria University, alexandria,   egypt; 2lebanese University Hospital,   Beirut, lebanon; 3Medical center  Manila, Manila, Philippines; 4Pakistan  institute of Medical sciences,   islamabad, Pakistan; 5seoul national  University college of Medicine, seoul,   south Korea; 6chung shan Medical  University Hospital, Taichung city,   Taiwan; 7novartis Pharma ag, Basel,   switzerland correspondence: samir Helmy   assaad-Khalil   Department of Diabetology, lipidology  and Metabolism, alexandria Faculty  of Medicine, alexandria University,  champollion street, alexandria, 21526,  egypt   Tel +20 12 2219 7789   Fax +20 3 3487 4204   email assaadkhalil@hotmail.co mBackground:  The clinical EXCITE (EXperienCe of amlodIpine and valsarTan in hypErten - sion) study reported clinically relevant blood pressure (BP) reductions across all doses of  amlodipine/valsartan (Aml/Val) and Aml/Val/hydrochlorothiazide (HCT) single-pill combina - tions.",Non-OADS,/arxiv_data1/oa_pdf/b3/96/vhrm-11-071.PMC4309775.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b3/96/vhrm-11-071.PMC4309775.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/96/vhrm-11-071.PMC4309775.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 27–39Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  27ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S7544 0Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
"Or use: http://dvpr.es/1Ama06 Zlongevity expectations in the pension fund,  insurance, and employee benefits industries alex Zhavoronkov Biogerontology Research Foundation,   london, United Kingdom correspondence: alex Zhavoronkov   Biogerontology Research Foundation,    4 hill street, london, W1J  5ne,   United Kingdom   Tel +44 7578 66 9995  email alex@biogerontology.or gAbstract:  Considerable progress has been made in many areas of biomedical science since the   1960s, suggesting likely increases in life expectancy and decreases in morbidity and mortality  in the adult population.",Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
Available  from: http://crr.bc.edu/briefs/do-longevity-expectations-influence- retirement-plans /.,Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/46/d8/prbm-8-027.PMC4309776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/50/ppa-9-133.PMC4309777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 133–138Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  133OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6429 5Patient values and preferences when choosing  anticoagulants Ana M Palacio1–3 irene Kirolos2,3 leonardo Tamariz1–3 1The Department of Medicine, Miller  school of Medicine, University of Miami,  2The Veterans Affairs Medical center,  Miami, Fl, UsA; 3Division of Public  health sciences, University of Miami,  Miami, Florida, UsABackground:  New oral anticoagulants have similar efficacy and lower bleeding rates compared  with warfarin.",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ppa-9-133.PMC4309777.pdf
"Keywords:  warfarin, oral anticoagulant, bleeding risk, atrial fibrillation, patient decision  making, medication selection Introduction Warfarin has been an effective medication for the prevention of stroke among atrial  fibrillation (AF) patients for many decades.1 However, it requires frequent international  normalized ratio (INR) monitoring and diet restrictions that impact quality of life.2  Only half of patients with AF and without a contraindication to anticoagulation use  warfarin.3 This underutilization is not fully understood; however, physicians’ bleeding  risk perceptions might play a role.4 Novel anticoagulants (NOAC) have been a welcomed alternative for the prevention  of stroke among subjects with AF.5 Several non-inferiority studies showed that the  NOAC are at least as effective as warfarin and that at efficacious doses have similar correspondence: Ana Palacio The Department of Medicine, Miller  school of Medicine, University of Miami,  1120 nW 14th st, suite 967, Miami, Fl  33136, UsA Tel +1 305 243 9754 Fax +1 305 243 7096 email apalacio2@med.miami.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Palacio et al Running head recto: Patient choice and anticoagulants DOI: http://dx.doi.org/10.2147/PPA.S64295",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ppa-9-133.PMC4309777.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5e/50/ppa-9-133.PMC4309777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-10-749.PMC4309778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 749–763International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  749OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6283 7Bio-functionalized dense-silica nanoparticles for  Mr/NIrF imaging of cD146 in gastric cancer Pu Wang1,*  Yazhuo Qu2,*  chuan li3  li Yin2  caifei shen1  Wei chen3  shiming Yang4  Xiuwu Bian2  Dianchun Fang1 1Institute of gastroenterology,   2Institute of Pathology, 3Department  of radiology, southwest hospital,   The Third Military Medical  University, chongqing, People’s  republic of china; 4Department  of gastroenterology, Xinqiao hospital,   The Third Military Medical University,   chongqing, People’s republic of china *These authors contributed equally  to this workPurpose:  Nano dense-silica ( dSiO2) has many advantages such as adjustable core–shell  structure, multiple drug delivery, and controllable release behavior.",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-10-749.PMC4309778.pdf
"Nanotechnology offers an important novel tool to detect and modulate a variety of  biomedical processes in vivo.1 But the use of nanotechnology in gastric cancer (GC)  is rarely reported; more than 930,000 patients are newly diagnosed with GC per year correspondence: Xiuwu Bian;  Dianchun Fang Institute of gastroenterology, southwest  hospital, The Third Military Medical  University, chongqing, People’s republic  of china, 400038  email b ianxiuwu@263.ne t;  fangdianchun@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: MR/NIRF imaging of CD146 in gastric cancer DOI: http://dx.doi.org/10.2147/IJN.S62837",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-10-749.PMC4309778.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-10-749.PMC4309778.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/fe/ijn-10-749.PMC4309778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/14/ijn-10-711.PMC4309779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 711–726International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  711OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7544 5Fluorescent magnetic iron oxide nanoparticles  for cardiac precursor cell selection from stromal  vascular fraction and optimization for magnetic  resonance imaging  Vinod Kumar Verma1 suguna ratnakar Kamaraju1 ravindranath Kancherla1 lakshmi K Kona1 syed sultan Beevi1 Tanya Debnath1 shalini P Usha1 rammohan Vadapalli2 ali syed arbab3 lakshmi Kiran chelluri1 1Department of Transplant  Biology, Immunology and stem  cell laboratory, global hospitals,   2Department of Imageology, Vijaya  radiology centre, hyderabad, India;   3Department of Biochemistry and  Molecular Biology, georgia regents  University, augusta, ga, UsaAbstract:  Fluorescent magnetic iron oxide nanoparticles have been used to label cells for imaging  as well as for therapeutic purposes.",Non-OADS,/arxiv_data1/oa_pdf/08/14/ijn-10-711.PMC4309779.pdf
"Hence, the primary strategic approach is to correspondence: lakshmi Kiran chelluri Department of Transplant Biology,  Immunology and stem cell laboratory,  global hospitals, 6-1-1040/1 to 4, lakdi- ka-pul, hyderabad 500 004, Telangana,  India Tel +91 40 302 44501 cell +91 98 481 12342 email lkiran@globalhospitalsindia.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Verma et al Running head recto: Cardiac precursor nanoprobe for cell selection and imaging  DOI: http://dx.doi.org/10.2147/IJN.S75445",Non-OADS,/arxiv_data1/oa_pdf/08/14/ijn-10-711.PMC4309779.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/08/14/ijn-10-711.PMC4309779.pdf
